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 Salmonella enterica subspecies enterica serovar Typhimurium is a 
Gram-negative pathogen causing salmonellosis. Salmonella Typhimurium-
targeting bacteriophages have been proposed as alternative biocontrol agents 
to antibiotics. To further understand infection and interaction mechanisms 
between the host strains and the bacteriophages, the receptor diversity of 
these phages needs to be elucidated. Twenty-five Salmonella phages were 
isolated and their receptors were identified by screening several mutant 
strains of S. Typhimurium SL1344. Among them, only three types of 
receptors were identified: flagella, vitamin B12 uptake outer membrane 
protein, BtuB and lipopolysaccharide-related O-antigen. TEM observation 
revealed that the phages using flagella (group F) or BtuB (group B) as a 
receptor belong to Siphoviridae family, and the phages using O-antigen of 
LPS as a receptor (group L) belong to Podoviridae family. Interestingly, 
while some of group F phages (F-I) target FliC host receptor, others (F-II) 
target both FliC and FljB receptors, suggesting that two subgroups are 
II 
present in group F phages. Cross-resistance assay of group B and L revealed 
that group L phages could not infect group B phage-resistant strains and 
reversely group B phages could not infect group L SPN9TCW-resistant 
strain. In addition, the host receptors of group B or group L SPN9TCW 
phages hinder other group phage infection, probably due to interaction 
between receptors of their groups. This study provides novel insights into 
phage-host receptor interaction for Salmonella phages and will inform 
development of optimal phage therapy for protection against Salmonella. 
 To understand phage infection and host lysis mechanisms with 
pathogenic Salmonella, a novel Salmonella Typhimurium-targeting 
bacteriophage SPN9CC, belonging to the Podoviridae family, was isolated 
and characterized. The phage infects S. Typhimurium via the O-antigen of 
lipopolysaccharide (LPS) and forms unique clear plaques with cloudy 
centers due to lysogen formation. Phylogenetic analysis of phage major 
capsid proteins (MCPs) revealed that this phage is a member of lysogen-
forming P22-like phage group. However, comparative genomic analysis of 
SPN9CC with P22-like phages indicated that their lysogeny control regions 
and host lysis gene clusters share very low identities, suggesting that 
lysogen formation and host lysis mechanisms may be diverse among phages 
in this group. Analysis of the expression of SPN9CC host cell lysis genes 
encoding holin, endolysin, and Rz/Rz1-like proteins individually or in 
combinations in S. Typhimurium and E. coli hosts revealed that 
III 
collaboration of these lysis proteins is important for both host lysis, and 
holin is a key protein. To further investigate the role of the lysogeny control 
region in phage SPN9CC, a ΔcI mutant (SPN9CCM) of phage SPN9CC was 
constructed. The mutant does not produce a cloudy center in the plaques, 
suggesting that this mutant phage is virulent and no longer temperate. 
Subsequent comparative one-step growth analysis and challenge assays 
revealed that SPN9CCM has shorter eclipse/latent periods and a larger burst 
size as well as higher host lysis activity than SPN9CC. The present work 
indicates the possibility of engineering temperate phages as promising 
biocontrol agents similar to virulent phages. 
 The Bacillus cereus group phages infecting B. cereus, B. anthracis, 
and B. thurigiensis (Bt) have been studied at a molecular level and recently 
at a genomic level to control pathogens of B. cereus and B. anthracis and to 
prevent phage contamination of the natural insect pesticide Bt. A 
comparative phylogenetic analyses revealed three different phage groups 
with different morphologies (Myoviridae for group I, Siphoviridae for group 
II, and Tectiviridae for group III), genome size (group I > group II > group 
III), and lifestyle (virulent for group I and temperate for group II and III). A 
subsequent phage genome comparison using a dot plot analysis showed that 
phages in each group are highly homologous, substantiating the grouping of 
B. cereus phages. Endolysin is a host lysis protein that contains two 
conserved domains such as a cell wall binding domain (CBD) and an 
IV 
enzymatic activity domain (EAD). In B. cereus sensu lato phage group I, 
four different endolysin groups were detected, according to combinations of 
two types of CBD and four types of EAD. Whereas group I phages share 
two copies of tail lysins and one copy of endolysin, the functions of the tail 
lysins are still unknown. In the B. cereus sensu lato phage group II, the B. 
anthracis phages have been studied and applied for typing and rapid 
detection of the pathogenic host strains. In the B. cereus sensu lato phage 
group III, the B. thuringiensis phages, such as Bam35 and GIL01, were 
studied to understand phage entry and lytic switch regulation mechanisms. 
In this study, I suggest that further study of the B. cereus group phages 
would be useful for various phage applications, such as biocontrol, typing, 
and rapid detection of the pathogens B. cereus and B. anthracis and for the 
prevention of phage contamination of the natural insect pesticide Bt. 
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 In 1915 and 1917, Twort and d’Herelle independently discovered a 
microorganism that lyse and kill bacteria (25, 27, 75). d’Herelle described 
these microorganisms as “ultraviruses” and termed them as “bacteriophage” 
(25), which is derived from a Greek word meaning to devour/swallow 
bacteria. Bacteriophages are described as bacterial viruses of prokaryotes. 
They invade specific bacterial hosts, replicate using the host’s DNA 
replication and protein biosynthesis systems, and lyse the hosts for 
propagation (48). In addition, they can selectively infect host bacteria 
without affecting other bacteria in the same habitat (14, 48). Bacteriophages 
are ubiquitous in the world. They are found in every part of the biosphere 
where their hosts live such as the oceans, soil, water, and even in food. They 
are the most abundant microorganism and their numbers in nature have been 
estimated to be over 10
30
 particles (77). It comes as surprise that research on 





I-1-2. Taxonomy of bacteriophage 
 Bacteriophages are classified by the International Committee on 
Taxonomy of Viruses (ICTV) according to phage morphology and nucleic 
acid type (dsDNA, ssDNA, dsRNA, and ssRNA) (Table 1.1) (44). 
Approximately 96% of all bacteriophages belong to the order Caudovirales, 
and a minority belongs to the order Ligamenvirales. Some phages that have 
been classified into families (Tectiviridae, Inoviridae, Cystoviridae, 
Leviviridae, and so on) are yet to be classified into orders (53). Within the 
order Caudovirales, those bacteriophages with tails can be subtyped into 
three different families; Myoviridae with a contractile tail consisting of a 
sheath and a central tube, Siphoviriade with a long non-contractile tail, and 
Podoviridae with a short and non-contractile tail (44). In this order, phage 
lambda, T4, T5, and T7 are best-well studied. The order Ligamenvirales 
consists of two sub-families; Lipothrixviridae, lipoprotein enveloped rod 
shaped phages, and Rudiviridae, non-enveloped straight and rigid rod 
shaped phages. Phages in this order are specific to Archaea only. Lastly, 
those that are not assigned to an order are classified according to their 
morphologies such as cubic symmetry (Microviridae, Corticoviridae, 
Tectiviridae, Leviviridae, Cystoviridae), helical symmetry (Inoviridae), and 
pleomorphic morphologies (Plasmaviridae, Fuselloviridae, Guttaviridae). 
4 
Table 1.1. Taxonomy of bacteriophages 
Order Nucleic acid
a
 Family Morphology Examples 
Caudovirales  dsDNA (linear) Myoviridae  Nonenveloped, contractile tail T4 
 dsDNA (linear) Siphoviridae Nonenveloped, non-contractile tail 
(long) 
Lambda, T5 
 dsDNA (linear) Podoviridae Nonenveloped, non-contractile tail 
(short) 
T7 
     
Ligamenvirales  dsDNA (linear) Lipothrixviridae Enveloped, rod-shaped, lipids TTV1 
 dsDNA (linear) Rudiviridae Nonenveloped, rod-shaped SIRV-1 
     
Unassigned dsDNA (linear) Ampullaviridae Enveloped, bottle-shaped ABV 
 dsDNA (circular) Bicaudaviridae  Nonenveloped, lemon-shaped ATV 
 dsDNA (circular) Clavaviridae Nonenveloped, rod-shaped APBV1 
 dsDNA (circular, supercoiled) Corticoviridae Nonenveloped, double capsid, lipids PM2 
 dsRNA (linear, multipartite) Cystoviridae Enveloped, spherical, lipids Phi6 
 dsDNA (circular, supercoiled) Fuselloviridae Nonenveloped, lemon-shaped, lipids SSV1 
 
5 
Table 1.1. Taxonomy of bacteriophages (continued) 
Order Nucleic acid
a
 Family Morphology Examples 
Unassigned dsDNA (linear) Globuloviridae Enveloped, isometric PSV 
 dsDNA (circular, 
supercoiled) 
Guttaviridae Nonenveloped, droplet-shaped, ovoid SNDV 
 ssDNA (circular) Inoviridae  Nonenveloped, long filamentous fd, MV-L51 
 ssRNA (linear) Leviviridae Nonenveloped, isometric MS2 
 ssDNA (circular) Microviridae  Nonenveloped, conspicuous capsomers phiX174 
 dsDNA (circular, 
supercoiled) 
Plasmaviridae Enveloped, no capsid, pleomorphic, lipids L2 
 dsDNA (linear) Tectiviridae Nonenveloped, double capsid, pseudo-tail, lipids PRD1, 
Bam35 
a
, dsDNA, double stranded DNA; ssDNA, single stranded DNA; dsRNA, double stranded RNA; ssRNA, single stranded RNA. 
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I-1-3. Early history 
 In 1915, the first report on bacteriophages and the beginnings of the 
phage study was made by Frederick W. Twort (75). His study of phages started 
from an observation of glassy micrococci colonies that he found could be 
transferred to other fresh colonies by inoculation with a bit of substance from the 
glassy colony. By microscopy, he observed that the bacterium was lysed and 
formed small granules. And in 1917, Felix d’Herelle independently reported a 
microorganism that has lysis activity in broth culture as well as on the surface of 
agar plates overlaid with bacteria (25). Further, Herelle found that the titer of 
phage in patients with infectious disease rose during the recovery progress, and 
hence, was the first to establish the concept of phage therapy for the control of 
infectious diseases. Later, he reported the use of phages for control of the avian 
typhosis (gastrointestinal disease) and bovine hemorrhagic septicemia (23). 
 
 The first therapeutic use of bacteriophage was reported by Bruynoghe 
and Maisin in 1921 (12). They prepared staphylococcal phage that could be used 
for the reduction in swelling, pain and even fever. In parallel, d’Herelle worked to 
expand the use of phage treatment to human in the 1920s (24). In the view of 
current standard for human trials, these phage treatments for human are rough and 
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rudimentary in scientific and ethical respects. However, d’Herelle’s approaches in 
phage application were highly acclaimed for, and he was accredited as a pioneer 
in the field of phage research. 
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I-1-4. General overview of the infection process 
 The lifecycle of a bacteriophage has to two major parts; the lysogenic 
cycle for phage genome integration into the host chromosome, and the lytic cycle 
for lysis of the bacterial host due to bactericidal activity (14, 48, 53). While 
virulent phages have only the lytic cycle, temperate phages have both lytic and 
lysogenic cycles. The general infection process of tailed phages consists of host 
recognition/adsorption, DNA transfer, DNA replication, morphogenesis/DNA 
packaging, and host lysis. The initial interaction between the phage’s receptor 
binding proteins (such as tail fiber or tail spike) and the host’s surface molecules 
(host receptors) is specific allowing phages to discriminate their hosts. In Gram-
negative bacteria, various lipopolysaccharide (LPS) components and outer 
membrane proteins were reported as host receptors for phage infection. On the 
other hand, in Gram-positive bacteria, peptidoglycan elements, embedded 
teichoic acids and lipoteichoic acids, and associated proteins act as host receptors. 
Then, the DNA transfer step requires correct positioning of the phage tail on the 
host cell surface to penetrate and transfer phage DNA into the host. After DNA 
ejection into the host, phage DNA replication and head/tail morphogenesis is 
conducted by exploiting the host’s transcription/translation system or phage’s 
own system. Subsequently, phage DNA molecules are packaged into the prohead 
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structure and progeny phage particles are constructed by combining the head and 
tail components. Lastly, host cell is lysed by the lysis system containing holin and 
endolysin. Holin makes holes in the cytoplasmic membrane. This hole is used as 
a transport channel for endolysin, which digests the peptidoglycan layer in the 
membrane. In addition, Rz/Rz1-like proteins often help endolysin activity as 
accessory proteins. 
 Some phages integrate their nucleic acid into the host genome or exist as 
episomes such as a linear plasmid. In the lysogenic cycle, in which the host cells 
are not lysed or phage progenies are not produced within host. Furthermore, some 
of these temperate phages can alter the phenotype of the host bacteria such as the 
chemical properties of the LPS. They can also be harbored in the host bacteria for 
several generations as prophages. In general, the induction of these prophages is 




I-1-5. Bacteriophage applications as biocontrol/therapeutic agents 
 Host lysis activity and host specificity have made bacteriophages 
research targets for various applications such as the removal of selective host 
strains. In the early history of phage application, d’Herelle used phages to treat 
several infectious diseases. One of the ways he evaluated the safety of phage 
theraphy was to injecthis family and colleagues with the phages. However, with 
the development of antibiotics that were able to effectively kill bacteria, further 
research on phage and phage therapy were essentially stopped. Recently, as a 
result of increasing outbreaks of food poisoning and emergence of antibiotic-
resistant strains, bacteriophage biology has been revisited in search for a novel 
biocontrol/therapeutic agent against food-borne pathogens and antibiotic-resistant 
strains, respectively (13, 22, 59). Phages are particularly good candidates as they 
are able to target specific pathogens without affecting other beneficial bacteria in 
foods and even in humans. Further, they infect only bacterial hosts and not human 
cells, allowing safe applications in humans (62). As an example, a phage 
treatment on rats using Listeria monocytogenes-specific phage at a dose of 10
12
 
PFU/kg body weight/day showed that there were no side effects. And clinical 
trials in which healthy volunteers were given oral doses of T4 phage, and another 
in which volunteers with HIV and other immunodeficiency diseases were 
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intravenously injected with phiX174 phage, indicated that phage treatment in 
humans is also safe (11). In addition, already thousands of people have undergone 
phage therapy in the former Soviet Union and Poland. Another safeness of the use 
of phage can be demonstrated by the fact that phages are ubiquitous by nature, 
and are isolated from various foods such as pork, mushrooms, chicken, cheese, 
yogurt, beef, and lettuce, suggesting that they are readily ingested by people. 
Moreover, a cocktail (ListShield
TM
, Intralytix, Inc., Baltimore, MD, USA) of 
Listeria-infecting bacteriophages was approved by the US Food and Drug 
Administration in 2006, gaining the status of “Generally Recognized as Safe 
(GRAS)” (13, 59). Consequently, this FDA approval of phage preparations for 
preservation of food has triggered the researches and applications of phages. 
Therefore, development of novel biocontrol/therapeutic agents using 
bacteriophages has been recently spotlighted (13, 22, 59, 62). 
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I-1-6. Bacteriophage resistance mechanisms 
 When bacteriophages infect bacterial cells, they encounter the antiviral 
host defense mechanisms (49, 53, 74). These bacteriophage resistance 
mechanisms could be classified into at least three categories: the blocking of 
phage adsorption, the degradation of phage DNA, and the abortive infection 
systems. 
 
 The blocking of phage adsorption. In the general infection process, the 
adsorption of phages to host cell surface receptors is the initial step for host 
recognition. To obtain resistance to phages, bacteria have evolved adsorption-
blocking mechanisms such as the blocking of host receptors and the production of 
extracellular matrix. For example, Escherichia coli-specific phage T5 encodes 
lipoprotein (Llp) that binds to host receptor protein, FhuA (ferrichrome-iron 
receptor) to prevent superinfection (63). Some bacteria produce TraT protein to 
screen host receptor (OmpA) for T-even phages (67). Furthermore, the production 
of extracellular polymers can form a physical barrier between host receptors and 
phages. The extracellular polysaccharide capsules produced by E.coli and 
Staphylococcus aureus showed resistances to T7 (71) and M
Sa
 (15) , respectively. 
  
13 
 The degradation of phage DNA. Restriction-modification (RM) 
systems are well known as the protection system from foreign DNA (65). When 
phage injects its unmethylated DNA to host cells that have a RM system, the host 
detects phage DNA as of a foreign source and degrades this DNA using the RM 
system. Recently, the function of clustered regularly interspaced short 
palindromic repeats (CRISPR) ans the CRISPR-associated (cas) genes were 
reported in the prokaryotic immune system (7, 73). CRISPRs are loci within the 
bacterial genome that contain multiple short direct repeats with short segments of 
foreign DNA (spacers) that serve as a memory of past exposures. This CRISPR-
Cas system targets foreign nucleic acids such as phage genomes and plasmids. 
Although the detailed mechanisms of this system are still unknown, the molecular 
method behind this type of phage resistance by bacteria is beginning to be 
characterized (41). The RM system provides a form of innate immunity whereas 
the CRISPR system provides a form of acquired immunity in microorganisms. 
  
 The abortive infection systems. The abortive infection (Abi) systems 
lead to cell death and limit phage replication and reproduction among the 
bacterial population (58). While Abi systems differ from the antiviral systems 
described above, the systems provide population-wide protection by promoting 
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suicide of the phage-infected cell. For example, the Rex system of phage lambda-
lysogenic E. coli strain is the best well known Abi system (61). This system is a 
two-component system containing RexA (intracellular sensor) and RexB (ion 
channel). When phage infects E. coli strains harboring the Rex system, RexA is 
activated by the production of a phage protein-DNA complex. In turn, RexA 
activates anchored RexB, leading to a decline of the cellular ATP level for cell 
multiplication. Furthermore, toxin-antitoxin (TA) systems have been recently 
reported as a type of Abi systems (29). The ToxIN system in Erwinia carotovora 
subspecies atroseptica acts as phage defense mechanisms by aborting phage-
infected cell.  
 One of the notable obstacles in the field of phage application/therapy is 
the risk of the emergence of phage-resistant bacterial strains. While some studies 
of phage resistance mechanisms using a single phage-host model have been done, 
the emergence of phage-resistant strains may arise from a combination of 
different host defense mechanisms for phages. To overcome this hindrance for 
successful phage application/therapy, various phage-host interactions should be 
studied and elucidated. 
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I-2. Samonella enterica serovar Typhimurium and specific 
bacteriophages 
 
 Salmonella infection ranks second among causes of food-borne illnesses 
(more than 30% of all bacterial foodborne poisoning) (6). Salmonella causes 
about 1.4 million cases of salmonellosis including 17,000 hospitalization and 600 
deaths every year in US and these numbers have increased by 10% in recent years 
(18, 56). Salmonella is a Gram-negative, motile, rod-shaped, and non-spore 
forming bacterium belonging to the Enterobacteriaceae family. Based on DNA-
DNA hybridization, this genus is classified as two species (Salmonella enterica 
and Salmonella bongori). And S. enterica consists of six subspecies such as 
arizonae, diarizonae, enterica, houtenae, indica, and salamae (10). 
 
 Salmonella causes typhoid fever that normally can be treated with broad-
spectrum antibiotics, including tetracycline, chlorotetracycline, oxytetracycline, 
demeclocycline, methacycline, doxycycline, minocycline and a number of other 
semisynthetic derivatives. However, Salmonella resistance to antibiotics has 
become a problem in recent years. Moreover, emergence of multi-drug resistant 
Salmonella such as S. Typhimurium phage type DT104 has become more 
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problematic (30, 57). Therefore, use of S. Typhimurium bacteriophages is now 
recieiving more attention than ever as an alternative approach for the treatment of 
antibiotic-resistant pathogens. 
 
 Recent reports have described the isolation of new Salmonella 
bacteriophages and evaluated their bactericidal effects (35, 54, 55, 60). For 
example, Salmonella-specific phage st104a or st104b reduced the bacterial cell 
number by up to 2 logs within 1 h of each phage infection (60). Φ25 phage 
reduced the S. Typhimurium viable cell numbers up to 2.19 logs within 24 h (4, 
40). However, the rapid emergence of phage-resistant Salmonella is an obstacle to 
use phages as effective biocontrol agents (1, 4, 13, 16, 33). As a preventative 
measure against phage-resistance, phage cocktails have been developed and 
found to be effective for the control of phage-resistant Salmonella (1, 20, 38, 78). 
For example, a phage cocktail containing 45 different phages reduced Salmonella 
cell numbers up to 5 log in 2 h (1). The phage cocktail approach can also broaden 
the host range, for example, one phage cocktail designed for serovar 
Typhimurium increased the host range to include S. enterica serovar Enteritidis 
and serovar Kentucky (79).  
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 Because the attachment of bacteriophage to a specific receptor of the host 
bacteria is the critical first step of phage infection (52) , mutation of the receptor 
is the most frequent route to phage-resistance made by the host. To date, several 
Salmonella host receptors for phage infection were experimentally determined 
and characterized, such as the flagella (40, 69), Vi capsular antigen (64), LPS 
(68) , and host outer membrane proteins (OmpC (36), BtuB (37, 42), TolC (66), 
and FhuA (17)).  
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I-3. Bacillus cereus group and specific bacteriophages 
 
 Bacillus is a Gram-positive, rod-shaped, and spore forming bacterium 
belonging to the Firmicutes phylum. And Bacillus species are ubiquitous in nature 
and classified as obligate aerobes or facultative anaerobes. The Bacillus cereus 
group consists of B. cereus, B. anthracis, B. thuringiensis, B. mycoides, B. 
pseudomycoides, and B. weihenstephanensis (39, 76). Among them, B. cereus, B. 
anthracis, and B. thuringiensis have been suggested as a single species of B. 
cereus sensu lato (26, 34). These species are important pathogens infecting 
humans, animals, and even insects (9, 31, 32). 
 Bacillus cereus is a food-borne pathogen producing enterotoxins such as 
hemolysin BL (HBL), nonhemolytic enterotoxin (NHE), and cytotoxin K (47). 
Due to these toxins, the uptake of contaminated foods can cause vomiting, 





 CFU per gram of contaminated food) is required for disease outbreak (51). 
However, responses to infection in humans such as diarrheal syndrome (8 to 16 h) 
and emetic syndrome (0.5-6 h) are relatively quick, due to toxins produced and 
released by B. cereus (19, 51). The outbreaks of Bacillus species in the European 
Union were reported to contribute up to 1.4% of all food-borne pathogenic 
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outbreaks in 2005 (2) , and the number of B. cereus outbreaks has been increasing 
in developed countries, highlighting the importance of controlling B. cereus 
levels in foods (21, 43, 47). In addition, B. anthracis is a category A biothreat 
agent causing fatal anthrax disease in humans and animals. Its endospore has 
been used as a biological weapon in 2001, resulting in more than 45% mortality 
(8). To generally control pathogens, various antibiotics have been widely used. 
However, B. cereus is generally insusceptible to penicillin-related antibiotics due 
to its production of β-lactamase and even to other antibiotics such as 
erythromycin and tetracycline (45, 70). In addition, long-term antibiotic treatment 
with various antibiotics against B. anthracis showed a rapid acquisition of 
antibiotic resistance activities (3). Therefore, due to such emergence of antibiotic 
resistant strains, alternative biocontrol approach against these pathogens needs to 
be developed. Treatment of bacteriophages infecting B. cereus or B. anthracis 
could be an effective method to control these pathogens. And already some 
studies on bacteriophages infecting B. cereus have been studied and reported (5, 
28, 46, 50, 72). As an example, two B. cereus phages, FWLBc1 and FWLBc2 
were isolated from a soil sample and treated with mashed potatoes, resulting in 
more than 5 log reduction, suggesting that phage application to foods may be 
useful for control of food-borne pathogens such as B. cereus (50). Bandara et al. 
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 are required to 
enhance the host lysis activity of the bacteriophage in fermented foods. In 
addition, B. cereus phage BCP1-1 showed high host specificity and inhibited only 
B. cereus, not fermentative bacteria such as B. subtilis in Korean fermented 
soybean food, suggesting selective growth inhibition of only the target bacterium. 
Interestingly, about 40% of the fermented foods contained B. cereus-infecting 
phages, suggesting that B. cereus is prevalent in fermented foods where 
bacteriophages probably inhibit its growth and consequently, limit contamination 
(72). 
 However, B. thuringiensis (Bt) has been well known and used as a 
biological pesticide for biocontrol of insect pests. It produces the insecticidal 
crystal proteins (ICPs) which is highly toxic to the pest larvae, but not to humans 
and animals. While Bt has been widely used for insect control, bacteriophage 
contamination causes great damage to Bt during fermentation. To overcome this 
problem, bacteriophages infecting B. thuringiensis should be studied to 





I-4. Objectives of this study 
 
 Bacteriophages are good candidates as novel biocontrol/therapeutic 
agents against food-borne pathogens such as Salmonella Typhimurium and 
Bacillus cereus. There were serveral reports about the applications of Salmonella-
specific bacteriophages in beef/poultry products, cheeses, and plant products. 
However, these phage treatments and applications have limitations in that there is 
fast recovery of phage-resistant Salmonella strains. To solve this limitation 
against the use of Salmonella-specific phages, more insight into the molecular 
and genomic aspects about phage-host interaction and phage infection 
mechanisms should be gained. On the other hand, there exist only a few reports 
about B. cereus-specific phages. In this respect, there is pressing need to isolate 
new virulent phages specific to B. cereus and to characterize about their lysis 
activity at the molecular and genomic level. Therefore, these studies were 
performed with the objectives below. 
 
 1. Understanding the infection, interaction, and host lysis 
mechanisms between  Salmonella Typhimurium host and its bacteriophages 
through molecular and genomic study. 
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 2. Evaluation of the possibility of engineered temperate 
bacteriophage as promising biocontrol agents similar to the virulent 
bacteriophages. 
 
 3. Investigation of the Bacillus cereus-targeting bacteriophage 
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 Emergence of antibiotic-resistant pathogens due to abuse of various 
antibiotics is driving the development of alternative approaches to pathogen 
control. Bacteriophages are considered a possible biocontrol agent for 
bacterial pathogens (23, 50). This approach has advantages including 
narrow species specificity and safety for human applications (8). As an 
example, a clinical trial in which volunteers were given oral doses of T4 
phage indicated that it was safe (6). In addition, a cocktail (ListShield
TM
, 
Intralytix, Inc., Baltimore, MD, USA) of Listeria-infecting bacteriophages 
was approved by the US Food and Drug Administration in 2006, gaining the 
status of “Generally Recognized as Safe” (7, 50), supporting that 
bacteriophage may be a good candidate as a biocontrol agent for human 
applications. 
 Salmonella is a Gram-negative foodborne pathogen causing 1.4 
million cases of salmonellosis including 17,000 hospitalization and 600 
deaths every year in US (11, 49). S. enterica serovar Typhimurium is 
common serotype in human infection and is frequently isolated from clinical 
and non-clinical samples from chicken sources. A large proportion of S. 
Typhimurium strains are resistant to several antimicrobial drugs, for 
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example the multi-drug resistant S. Typhimurium phage type DT104 (12). 
Therefore, use of S. Typhimurium bacteriophages is now getting more 
attractive as an alternative approach in the treatment for antibiotic-resistant 
pathogens. 
 Recent reports have described the isolation of new Salmonella 
bacteriophages and evaluation of their bactericidal effects (28, 47, 48, 51). 
For example, Salmonella-specific phage st104a or st104b reduced the 
bacterial cell number by up to 2 logs within 1 h of each phage infection (51). 
Φ25 phage reduced S. Typhimurium viable cell number up to 2.19 logs 
within 24 h (4, 38). However, the rapid emergence of phage-resistant 
Salmonella is an obstacle to effective biocontrol using phages (3, 4, 7, 9, 24). 
To reduce the impact of phage-resistance, phage cocktails have been 
developed and found to be effective in control of phage-resistant Salmonella 
(3, 13, 33, 67). For example, a phage cocktail containing 45 different phages 
reduced Salmonella cell numbers up to 5 log in 2 h (3). The phage cocktail 
approach can also broaden the host range, for example, one phage cocktail 
designed for serovar Typhimurium increased the host range to include S. 
enterica serovar Enteritidis and serovar Kentucky (68). 
 Because attachment of bacteriophage to the specific receptor of the 
host bacteria is the critical first step of phage infection (45), mutation of the 
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receptor is the most frequent route to phage-resistance of the host. To date, 
several Salmonella phage receptors are known including FhuA (10), TolC 
(57), BtuB (32, 39), OmpC (30), Vi capsular antigen (55), 
lipopolysaccharide (LPS) (58), and flagella (38). The study of phage 
receptors is expected to provide insight into the emergence of phage-
resistance in Salmonella and guide optimization of phage cocktails for 
Salmonella control. 
 In this study, host receptors for 25 new Salmonella phages were 
determined using several mutants of S. Typhimurium. Cross infection 
studies with these phages and resistant strains revealed novel phage-host 
interactions and infection mechanisms. Further investigation of diversity of 
host receptors in Salmonella phages will increase our ability to circumvent 
phage resistance using phage cocktails and thus prevent food spoilage due to 
S. Typhimurium.  
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II-2. Materials and Methods 
 
II-2-1. Bacterial strains and growth conditions 
 Bacterial strains used in this study are listed in Table 2.1. All strains 
were grown in Luria-Bertani (LB) broth medium (Difco,
 
Detroit, MI, USA) 
at 37°C with shaking for 12 h. Salmonella enterica serovar Typhimurium 
strain SL1344 was used for isolation of Salmonella-infecting phages from 
the collected samples, and prophage-free S. Typhimurium strain LT2C (20) 












Salmonella enterica   Salmonella Typhimurium SL1344 mutants  
serovar Typhimurium  ΔbtuB (39) 
SL1344 NCTC ΔfhuA (32) 
UK1 (69) ΔflgK (16) 
LT2 (46) ΔfliC (16) 
LT2C
 
 (20) ΔfliR (16) 
  [Prophage-cured LT2 strain]  ΔfljB (16) 
ATCC 14028 ATCC ΔfliC ΔfljB (16) 
ATCC 19586 ATCC ΔlamB This study 
ATCC 43147 ATCC ΔompC Laboratory collection 
DT104 (56) ΔrfaL (53) 
serovar Enteritidis ATCC 13078 ATCC ΔrfbG (53) 
serovar Typhi Ty 2-b IVI   
serovar Paratyphi  Gram-negative bacteria  
A IB 211 IVI Shigella flexineri 2a strain 2457T IVI 
B IB 231 IVI Shigella boydii IB 2474 IVI 
C IB 216 IVI Vibrio fischeri ES-114 ATCC 700601 ATCC 
serovar Dublin IB 2973 IVI Pseudomonas aeruginosa ATCC 27853 ATCC 
subsp. arizonae ATCC 13314 ATCC Cronobacter sakazakii ATCC 29544 ATCC 
subsp. arizonae ATCC 12324 ATCC   
subsp. salamae ATCC 15793 ATCC Gram-positive bacteria  
subsp. salamae ATCC 43972 ATCC Enterococcus faecalis ATCC 29212 ATCC 
subsp. indica ATCC 43976 ATCC Staphylococcus aureus ATCC 29213 ATCC 
subsp. houtenae ATCC 43974 ATCC Bacillus cereus ATCC 14579 ATCC 




Table 2.1. The bacterial strains and plasmids used in this chapter (continued) 
Strains References
a
 Plasmid [Description] References
a
 
E. coli   Plasmid  
K-12 (26)    pKD13 (17) 





DH10B (19)   pKD46 (17) 
      [pSC101(Ts) ori, Amp
R
, and ParaBAD γ β exo]  
E. coli O157:H7    pCP20 (15) 




, cI857, and λPRflp]  
ATCC 43895 ATCC   





II-2-2. Bacteriophage isolation and propagation 
 Bacteriophages isolated in this study were listed in Table 2.2. No 
live chickens were used in this study. Seventy-six samples obtained from 
chicken feces collected from farms and commercially processed broiler 
skins obtained from markets were used as sources for isolation of 
Salmonella-specific bacteriophages. The chicken feces were collected with 
permissions from the farm owners and the samples were collected for the 
purpose of this research only. Twenty-five grams of each sample were 
mixed with 225 ml of sodium chloride–magnesium sulfate (SM) buffer (100 
mM NaCl, 10 mM MgSO4·7H2O and 50 mM Tris·HCl, pH 7.5) without 
gelatin in sterile bags. Twenty-five milliliters of each homogenized sample 
were mixed with 25 ml of 2× concentrated LB broth and incubated with 
shaking at 37°C for 12 h. After centrifugation (5,000 × g for 10 min), the 
supernatant was filtered using 0.22-µm pore size filters (Millipore, Billerica, 
MA, USA). Ten milliliters of each filtered sample were mixed with 50 ml 
LB broth with 10
7 
CFU/ml of overnight cultured S. Typhimurium SL1344. 
The mixture was incubated with shaking at 37°C for 12 h. After 
centrifugation (5,000 × g for 10 min), the supernatant was filtrated using 
0.22 µm pore size filters. The presence of phages was assessed using a 




of S. Typhimurium SL1344. After incubation at 37°C for 12 h, individual 
plaques were picked and eluted with 1 ml of SM buffer without gelatin. 
Plaque isolation and elution were repeated more than five times for pure 
isolation of individual phages in S. Typhimurium LT2C. One liter of 
exponentially growing S. Typhimurium LT2C (OD600 nm = 1.0) was infected 
with each SPN phage at a multiplicity of infection (MOI) of approximately 
1 and incubated with shaking at 37°C for 4 h. Cell debris was removed by 
centrifugation at 5,000 × g for 10 min and filtered using 0.22-µm pore size 
filters. Phage particles were precipitated from the filtrate by addition of 10% 
polyethylene glycol 6,000 (Sigma, St. Louis, MO, USA). Finally, a stepped 
CsCl density ultracentrifugation (himac CP 100β, Hitachi, Japan) with step 
densities of 1.3, 1.45, 1.5, and 1.7 g/ml at 78,500 × g for 2 h was conducted 
at 4°C. The bands of viral particles were withdrawn from the tube with a 








Table 2.2. Characteristics of the isolated S. Typhimurium-specific 
bacteriophages and their identified receptors 
Group
a
 (Family) Phage Source 
Mutated genes of  
the phage-resistant 
strains 
F-I (Siphoviridae) SPN2T  Chicken feces1 flgK, fliR
b
 or fliC 
 SPN3C  Chicken feces2 flgK, fliR or fliC 
 SPN8T  Processed broiler skin1 flgK, fliR or fliC 
 SPN9T  Processed broiler skin2 flgK, fliR or fliC 
 SPN11T  Soil1 flgK, fliR or fliC 
 SPN13B  Water1 flgK, fliR or fliC 
 SPN16C Chicken feces3 flgK, fliR or fliC 
F-II (Siphoviridae) SPN4S  Processed broiler skin3 flgK or fliR 
 SPN5T  Processed broiler skin4 flgK or fliR 
 SPN6T  Processed broiler skin5 flgK or fliR 
 SPN19 Processed broiler skin6 flgK or fliR 
    
B (Siphoviridae) SPN7C  Processed broiler skin7 btuB
c
 
 SPN9C  Processed broiler skin2 btuB 
 SPN10H  Soil2 btuB 
 SPN12C  Soil3 btuB 
 SPN14  Soil4 btuB 
 SPN17T  Silky fowl feces btuB 
 SPN18  Processed broiler skin8 btuB 
    
L (Podoviridae) SPN1S  Water2 rfaL
d
 or rfbG 
 SPN2TCW Chicken feces1 rfaL or rfbG 
 SPN4B  Processed broiler skin3 rfaL or rfbG 
 SPN6TCW  Processed broiler skin5 rfaL or rfbG 
 SPN8TCW  Processed broiler skin1 rfaL or rfbG 
 SPN13U  Water3 rfaL or rfbG 
 SPN9TCW  Processed broiler skin2 rfaL or rfbG 
aF-I and F-II, flagella-specific phage group; B, BtuB-specific phage group; L, LPS-specific phage 
group. 
bflgK, fliR mutations were complemented using pACYC184 vector expressing the flgK+ or fliR+ gene.  
cbtuB mutation was complemented using pACYC184 vector expressing the btuB+ gene.  
drfaL mutation was complemented using pUHE21-lacIq vector expressing the rfaL+ gene.   
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II-2-3. Receptor screening and host range determination by spotting 
assay 
 To screen mutant strains resistant to each SPN phage and to 
determine host range of each SPN phage, double layer spotting assay was 
used. A 100-µl aliquot of bacterial culture was added to 6 ml molten 0.4% 
LB agar and then poured on a 1.5% LB agar plate. After solidification of the 





plaque forming unit/ml was spotted on the top agar and the plates were 
incubated at 37°C for 12 h. After incubation, the sensitivity of indicator 
strains to the tested phages was determined by degrees of clearing in the 
spots or plaques. The plaque assay was performed in triplicate. 
 
II-2-4. Construction of deletion mutant 
 S. Typhimurium SL1344 derivatives with deletions of lamB gene 
was constructed using the lambda red recombination method (17). The 
kanamycin resistance (Kan
R
) cassette from plasmid pKD13 was amplified 
using primers specific for lamB gene, lamB-lamb-F1 and lamB-lamb-R1. 
Sequences of all primers for this construct are provided in Table 2.3. The 
polymerase chain reaction (PCR) products were transformed into S. 
Typhimurium SL1344 harboring pKD46 and integrated into the 
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chromosomal lamB gene. Finally, the Kan
R
 cassette was removed using 









Table 2.3. Primers used in this chapter 
Target Primer Sequence Reference 
lamB     











    
Real-time PCR    
btuB forward RT_btuB_F 5’-AGGACACTAGCCCGGATACC-3’ This study 
btuB reverse RT_btuB_R 5’-CAGTACATGGCTGGAGTTGG-3’ This study 
fliC forward RT_fliC_F 5’-CTCGGCTACTGGTCTTGGTG-3’ This study 
fliC reverse RT_fliC_R 5’-AGTTGCAAATGCTGATTTGA-3’ This study 
Control forward RT_rrsH_F 5’-CGGACGGGTGAGTAATGTCT-3’ This study 




II-2-5. Electron microscopy 
 The morphology of CsCl-purified SPN phages was determined 
using transmission electron microscopy (TEM). Concentrated viral samples 
were diluted with SM buffer without gelatin and 5 μl of each phage sample 
was applied to the surface of carbon coated copper grids. Excess volume 
was removed by carefully touching the side of grid with filter paper and 5 μl 
2% uranyl acetate (pH 4.0) was spotted on the grid for negative staining and 
removed after a short interval. The prepared samples were observed using 
TEM (LIBRA 120, Carl Zeiss, Switzerland) at 80 kV. Taxonomy of the SPN 
phages was determined according to the guidelines of the International 
Committee on Taxonomy of Viruses (22). 
 
II-2-6. Isolation of phage-resistant strains and determination of cross 
resistance 
 To investigate influence of resistance against one type of receptor to 
infection by phages using different receptors, resistance strains were 
developed against phages and then they were used for the infections by 
phages using different host receptors. Group L phage-resistant strains 
showing resistance to re-infection were isolated using high-titer overlay 
assay following modified Kim and Ryu’s protocol (39). In this modified 
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protocol, separate colonies of group L phage-resistant strains were obtained 
by additional streaking on LB agar plate. Because high-titer overlay assay 
did not work for isolation of transiently phage-resistant strains by group F, 
group B, and group L SPN9TCW phage infections, they were isolated using 
high-titer broth assay to increase the yield of the phage-resistant strains and 
to maintain resistance in the presence of phages. For the high-titer broth 
assay, phages were added to an LB broth culture of S. Typhimurium LT2C 
(OD600 nm = 1.0) at MOI=100, and the culture was incubated with shaking at 
37°C until the OD600 nm reached 1.0, again. To remove excessive phages, the 
phage-infected cells were then harvested by centrifugation at 5,000 × g for 
10 min, resuspended in 200 µl ice-cold molecular grade water and used as a 
host for the second infection of SPN phages using different host receptors. 
The host resistance to the second infection was monitored using plaquing 
assays as described above. 
 
II-2-7. Lysogen induction 
 All phage-resistant strains of S. Typhimurium LT2C were cultivated 
at 37°C until OD600 nm reached to 1.0 and 0.5 μg/ml of mitomycin C (Sigma) 
was added to the cultures. Then, these cultures were additionally incubated 
at 37°C for 2 h. After incubation, the cells were removed by centrifugation 
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and filtration and the supernatant was collected. The spotting assay of this 
supernatant with S. Typhimurium LT2C was conducted to confirm the 
lysogen formation. To confirm the unstable lysogen formation of group F 
phage-resistant strains, the group F, B, L-SPN9TCW phage-resistant strains 
were plate in green plate (Evans blue uranine agar plate, 0.5% NaCl, 1% 
Tryptone, 0.5% Yeast extract, 0.5% K2HPO4, 0.04 M Glucose, 0.04% Evans 
blue, 0.04% Uranine, and 1.5% Micro agar, final concentration) as the 
procedure developed by Chan et al. (13). 
 
II-2-8. Real-time reverse transcription (RT)-PCR 
 Total RNA was isolated from S. Typhimurium using the RNeasy 
Mini Kit (Qiagen) and converted to cDNA using the Omniscript RT Kit 
(Qiagen) and random hexamers (Invitrogen, Carlsbad, CA, USA) using 
manufacturer’s instructions. Quantitative real-time RT-PCR was performed 
as previously described (34) with primers listed in Table 2.3. 
 
II-2-9. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
 Flagellin of S. Typhimurium was isolated as previously described 
(52), and suspended in loading buffer (0.05 M Tris·HCl pH 8.0, 1.6% SDS, 
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25% glycerol, 5% 2-mercaptoethanol, 0.003% bromophenol blue, final 
concentration). Samples were heated in boiling water for 3 min, and then 
loaded in a well of a 12% acrylamide gel in 1X Tank Buffer (0.025 M Tris, 
0.192 M glycine, and 0.1% SDS, final concentration). Gel electrophoresis 







II-3-1. Bacteriophage isolation 
 Between September and December 2009, 25 bacteriophages were 
newly isolated from 18 of 76 samples (23.7% phage recovery frequency). 
All phages in Table 2.2 were designated as Salmonella Phage Number (SPN) 
and specific numbers were used to indicate the sample sources and 
sometimes characters were used to differentiate the isolated phages from the 
same samples, respectively. 
 
II-3-2. Grouping of bacteriophages based on their receptors 
 To determine the host receptors for 25 phages, previously 
constructed mutants of S. Typhimurium SL1344 (listed in Table 2.1) were 
used. Interestingly, receptor screening using several specific deletion 
mutants revealed that only three different types of receptors were detected: 
flagellar production genes, the gene encoding the vitamin B12 uptake outer 
membrane protein, and genes involved in LPS-related O-antigen production. 
The mutant screening results were confirmed by complementation 
experiments. The host receptor genes deleted by the lambda red 
recombination method are indicated in the receptor gene clusters presented 
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in Fig. 1. Based on the deleted specific genes for formation of phage 
receptors, 25 phages were grouped into group F, group B, and group L 








Figure 2.1. Genetic map of the receptor gene clusters and the mutated 
genes of resistant strains. Genes involved in the synthesis of flagella (flgK, 
fliQ, fliC and fljB), BtuB (btuB), and LPS (rfaL and rfbG) inactivated by 
transposon insertion were indicated by open arrows. Black arrow marked 
with hin is a promoter that transcribes the fljB gene. The numbers are locus-








Figure 2.2. Host receptors of SPN phages. F, F-I, F-II, B, and L marked in 
the phage heads indicate group F, group F-I, group F-II, group B, and group 
L phages, respectively. (A) Group F, group B, and group L phages use 
flagella (FliC/FljB), BtuB, and O-antigen of LPS as host receptors, 
respectively. (B) Group F-I and group F-II phages use FliC (grey-colored) 




 The deleted genes involved in flagella production included genes 
encoding the flagella hook-filament junction protein (flgK), a putative 
component of the type III flagella export apparatus (fliR), and the gene 
encoding flagellin (fliC). Because S. Typhimurium expresses either one of 
two flagellin genes, fliC or fljB (42), whether the group F phages can use 
both flagellins was tested by phage infection analysis of fliC and fljB 
deletion mutants. The group F phages can be categorized into two groups, F-
I and F-II, as shown on Table 2.4 and Fig. 2B. The group F-I phage could 
not infect the fliC mutant or the fliC/fljB double mutant, but could infect the 
fljB mutant, suggesting that the group F-I phage can only use FliC as a 
receptor. Group F-II phage could not infect the fliC/fljB double mutant but 
could infect the fliC and the fljB single mutants, suggesting that the group F-
II phage can use either FliC or FljB as a receptor (Table 2.4 and Fig. 2B). 
 One group of resistant mutants has deletion mutations in the btuB 
gene encoding the membrane transporter for vitamin B12, suggesting that 
BtuB is a group B phage receptor. The mutated genes in the O-antigen 
biosynthesis are O-antigen ligase (rfaL) and CDP glucose 4,6-dehydratase 
(rfbG). Complementation of the deleted genes with pACYC184 and 
pUHE21-lac
q 
expression vectors containing the wild-type genes restored 
susceptibility, supporting that O-antigen is a receptor for group L phage 
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infection. Overall, 11 out of 25 phages use flagella (group F phage), seven 
out of 25 use BtuB (group B phage), and another seven out of 25 use LPS-
related O-antigen (group L phage) as receptors. Although the Salmonella 
outer membrane proteins (OMPs) such as TolC (57), FhuA (10) and OmpC 
(30) are known receptors for some phages, no phages using those receptors 
was present in this set of 25 phages. It is not clear why BtuB was the only 










Table 2.4. Flagellin-targeting phages: receptor and sensitivity patterns 
based on specific gene mutation 
 




F-I phage F-II phage 
ΔfliC FljB only R S 
ΔfljB FliC only S S 
ΔfliC ΔfljB neither R R 
a
F-I, flagella-targeting phage group I; F-II, flagella-targeting phage group II. 
b








 All 25 phages could be categorized into three morphological groups 
(Fig. 2.3). Interestingly, this morphological grouping is correlated with the 
grouping of Salmonella-specific phages based on their receptors (Table 2.2). 
All of the group F and B phages have isometric heads and non-contractile, 
cross-banded tails that are longer than the tails of the group L phages (Fig. 
2.3). These phages can be classified into the B1 morphotype of the 
Siphoviridae family, although the group F phages have a single, long, kinky 
tail fiber structure and the group B phages have four or five L-shaped fibers 
(Fig. 2.3A and 2.3B). The group L phages are classified as members of the 
Podoviridae family. They have isometric heads with very short tails that are 






Figure 2.3. TEM morphology of representative SPN phages. Each phage 
name is indicated in the upper left corner of the picture. The representative 
tails of each group of phage were marked with boxes and the enlarged 
pictures were shown on the right. (A) Phages using flagella as a receptor. (B) 
Phages using BtuB as a receptor. (C) Phages using LPS as a receptor.  
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II-3-4. Host range of the isolated bacteriophages 
 Infection analysis of 25 Salmonella-specific bacteriophages was 
conducted with 21 Salmonella strains, five E. coli strains and nine other 
species of Gram-negative and Gram-positive bacteria (summarized in Table 
2.5). In general, SPN bacteriophages infect S. Typhimurium strains but not 
other Gram-negative and Gram-positive bacteria, suggesting that they are 
specific to S. Typhimurium. The group F phages also infect S. enterica 
subsp. arizonae and subsp. salamae, and the group B phages can infect 
several strains of E. coli, indicating that these bacteriophages have a host 
range that extends to other Salmonella subspecies or E. coli strains. In 
addition, group L phages and some group F phages infect S. Paratyphi. The 
group B phages have much broader host range than the group F and L 
phages. They can infect E. coli and Shigella flexneri strains as well as 
Salmonella (Table 2.5), suggesting that the BtuB proteins of S. 
Typhimurium, E. coli, and Shigella flexneri are similar. Comparative 
sequence analysis of BtuB proteins in the group B phage susceptible strains 
S. Typhimurium LT2, E. coli MG1655 and Shigella flexineri 2a strain 2457T 
revealed >87% identity at the amino acid level between S. Typhimurium and 
the other two species, whereas S. Typhimurium and Vibrio fischeri ES-114, 
which is not susceptible to group B phage, share <35% identity at the amino 
57 
acid level. These findings support the hypothesis that the group B phage 
receptor motifs are shared among Salmonella, E. coli and Shigella. 
Comparative host range analysis of group F-I and F-II phages revealed that 
F-II phages infect a larger number of S. Typhimurium isolates (data not 
shown), probably because the F-II phages can use either the FliC or the FljB 





Table 2.5. Host range of isolated bacteriophages 
Host 
Lytic spectrumsa,b 
Group F-I  Group F-II 
I II III  IV V 
Salmonella enterica        
serovar Typhimurium       
SL1344 T T T  T T 
UK1, LT2, LT2Cc* T T T  T T 
ATCC 14028 - - -  T I 
ATCC 19586 C T C  T T 
ATCC 43147 T T T  T T 
DT104 T T T  T T 
serovar Enteritidis ATCC 13078 - - -  - - 
serovar Typhi Ty 2-b - - -  - - 
serovar Paratyphi       
A IB 211 T - -  - T 
B IB 231 - - -  - - 
C IB 216 - - -  - - 
serovar Dublin IB 2973 - - -  - - 
subsp. arizonae ATCC 13314 - T T  T T 
subsp. arizonae ATCC 12324 - T T  T T 
subsp. salamae ATCC 15793 T T T  T T 
subsp. salamae ATCC 43972 - - -  - - 
subsp. indica ATCC 43976 - - -  - - 
subsp. houtenae ATCC 43974 - - -  - - 
subsp. diarizonae ATCC 43973 - - -  - - 
E. coli        
K-12, DH5α, DH10B - - -  - - 
E. coli O157:H7       
ATCC 43888 - - -  - - 
ATCC 43895 - - -  - - 
Gram-negative bacteria       
Shigella flexineri 2a strain 2457T - - -  - - 
Shigella boydii IB 2474 - - -  - - 
Vibrio fischeri ES-114 ATCC 700601 - - -  - - 
Pseudomonas aeruginosa ATCC 27853 - - -  - - 
Cronobacter sakazakii ATCC 29544 - - -  - - 
Gram-positive bacteria       
Enterococcus faecalis ATCC 29212 - - -  - - 
Staphylococcus aureus ATCC 29213 - - -  - - 
Bacillus cereus ATCC 14579 - - -  - - 




Table 2.5. Host range of isolated bacteriophages (continued) 
Host 
Lytic spectrumsa,b 
Group B  Group L 
VI VII VIII IX X  XI XII 
Salmonella enterica          
serovar Typhimurium         
SL1344 C C C C C  T C 
UK1, LT2, LT2Cc* C C C C C  T T 
ATCC 14028 T T T T T  T T 
ATCC 19586 C C C C T  T C 
ATCC 43147 - I - - I  T C 
DT104 - - - - -  T C 
serovar Enteritidis ATCC 13078 C C T T C  T C 
serovar Typhi Ty 2-b - T - - T  - - 
serovar Paratyphi         
A IB 211 C C C C C  - - 
B IB 231 T T T T T  T C 
C IB 216 T T T T T  T - 
serovar Dublin IB 2973 - T T T C  - - 
subsp. arizonae ATCC 13314 - - - - -  - - 
subsp. arizonae ATCC 12324 C C C C C  - - 
subsp. salamae ATCC 15793 - - - - -  - - 
subsp. salamae ATCC 43972 - - - - C  - - 
subsp. indica ATCC 43976 T C T T C  - - 
subsp. houtenae ATCC 43974 - - - - -  - - 
subsp. diarizonae ATCC 43973 T T T C T  - - 
E. coli          
K-12, DH5α, DH10B C C C C C  - - 
E. coli O157:H7         
ATCC 43888 - - C - -  - - 
ATCC 43895 - - T - -  - - 
Gram-negative bacteria         
Shigella flexineri 2a strain 2457T C - C C -  - - 
Shigella boydii IB 2474 - - - - -  - - 
Vibrio fischeri ES-114 ATCC 700601 - - - - -  - - 
Pseudomonas aeruginosa ATCC 27853 - - - - -  - - 
Cronobacter sakazakii ATCC 29544 - - - - -  - - 
Gram-positive bacteria         
Enterococcus faecalis ATCC 29212 - - - - -  - - 
Staphylococcus aureus ATCC 29213 - - - - -  - - 
Bacillus cereus ATCC 14579 - - - - -  - - 
Listeria monocytogenes ATCC 19114 - - - - -  - - 
aLytic spectrum: I contains SPN2T, SPN3C, and SPN13B; II contains SPN8T and SPN9T; III contains SPN11T, 
SPN16C; IV, SPN4S, and SPN19; V contains SPN5T and SPN6T; VI contains SPN7C and SPN9C, VII, SPN10H; 
VIII contains SPN12C and SPN17T; IX, SPN14; X, SPN18; XI contains SPN1S, SPN2TCW, SPN4B, SPN6TCW, 
SPN8TCW, and SPN13U; XII, SPN9TCW. 
bC, clear plaque; T, turbid plaque; I, inhibition zone; -, no infection. 
cProphage-cured strain of S. Typhimurium LT2. 
60 
II-3-5. Lysogenization 
 It is intriguing that while the group F and L phages generally make 
turbid plaques, and thus may be temperate phages, the group B phages make 
clear plaques and may be virulent phages (36). Induction experiments in 
which mitomycin C was used to induce lytic growth indicate that the group 
L phage-resistant S. Typhimurium LT2C strains carry an inducible prophage. 
In contrast, mitomycin C treatment of the group L SPN9TCW phage-
resistant and group B phage-resistant Salmonella strains did not yield phage, 
indicating that these phages do not make lysogens in the LT2C strain 
consistent with the clear plaque morphology (Table 2.5). Most of the group 
F phage-resistant Salmonella strains did not yield phage after treatment with 
mitomycin C even though they make turbid plaques. Five percent of the 
group F phage-resistant Salmonella made phage in response to mitomycin C, 
but they also lose resistance easily upon subculturing in the absence of the 
phages, suggesting the possibility of formation of unstable lysogens or 
pseudolysogens (1) (Table 2.6). To confirm if transient resistance is due to 
unstable lysogeny or pseudolysogeny, the green plate (Evans blue uranine 
agar plate) experiment was conducted (Fig. 2.4). In the green plate 
experiment, only the cells lysed by phage induction make blue colonies due 
to pH change. It revealed that while the resistant strains to the virulent 
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phages in group B and group L-SPN9TCW did not show any blue colony, 
the resistant strains to group F phages did show small number of blue 
colonies (approximately 5% of all colonies) in the green plates. These 
results indicate that a few of the strains resistant to group F phages were 







Table 2.6. Cross resistance of phage-resistant strains 
Resistant strain Phage sensitivity pattern
a














Group F R1  S  S N
c
 
Group B S  R1  R1 N 
Group L (SPN9TCW) S  R1  R1 N 
Group L (Other) S  S  R2 I 
aR1, transiently resistant; R2, stably resistant; S, sensitive. 
bN, not induced; I, induced. 
cAlthough most of the group F phage-resistant Salmonella were not induced, <5% of the resistant 








Figure 2.4. Green plate experiment of representative phages in three 
phage groups. (A) Group B SPN10H-resistant strain (B) Group L 
SPN9TCW-resistant strain (C) Group F SPN19-resistant strain. Red 
triangles indicate blue colonies on green plate. 
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II-3-6. Cross-resistance of phage-resistant Salmonella to the different 
receptor group phages 
 To understand the interaction of phage with the specific host 
receptors, derivatives of S. Typhimurium LT2C that are resistant to the 
group F, group B and group L phages described here were isolated and 
characterized. Group B phage-resistant Salmonella (39) were transiently 
resistant to re-infection with group B phages, and most group F phage-
resistant and group L SPN9TCW phage-resistant strains also showed 
transient resistance to re-infection with phages from their own group. All 
group L phage-resistant strains, except for the strain resistant to phage 
SPN9TCW, showed stable phage resistance to group L phages. Interestingly, 
all group L phage-resistant strains except those resistant to SPN9TCW were 
lysogens, suggesting that the resistance for the group L phages is due to 
prevention of superinfection by a stable prophage (Table 2.6 and Fig. 2.5B) 
(5, 31). Cross-infection of group F phages on other phage-resistant strains 
showed sensitivity to these phages, suggesting no mutual influence between 
flagellin and other phage receptors on the sensitivity to the phages (Table 
2.6 and Fig. 2.5). However, cross-infection of group B phages on group L 
phage-resistant strains yielded two different patterns. While the group L 
phage-resistant strains are sensitive, the SPN9TCW phage-resistant strain is 
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resistant to group B phage infection, depending on the formation of lysogen 
(Table 2.6 and Fig. 2.5BD). Furthermore, group L phages were not able to 
infect group B phage-resistant strains, suggesting a possible influence 
between the BtuB and LPS receptors on the sensitivity to the phages (Table 










Figure 2.5. Cross-resistance of phage-resistant Salmonella to the 
different receptor group phages. F, B, and L marked in the phage heads 
indicate group F, group B, and group L phages, respectively. Each receptor 
in the phage-resistant strains is white-colored. (A) Group F phage-resistant 
strain is sensitive to group B and group L phages. (B) Group L phage-
resistant strain is sensitive to group F and group B phages, but resistant to 
group L phages, due to modification of O-antigen of LPS. Modified O-
antigen is indicated by white triangles. (C) Group B phage-resistant strain is 
sensitive to group F, but resistant to group B as well as group L phages, 
probably due to putative interaction between BtuB and O-antigen of LPS. 
(D) Group L (SPN9TCW phage)-resistant strain is sensitive to group F, but 
resistant to group B as well as group L phages, probably due to putative 







 The details of the molecular interactions between phages and their 
host receptors that determine host specificity are not fully understood yet. 
Here, I isolated 25 Salmonella-specific phages, identified their receptors, 
studied their host specificity, and examined cross-resistance among the 
phages and phage resistant hosts. Although this study on Salmonella phage 
receptors using 25 phages does not represent the complete range of infection 
mechanisms used by Salmonella-infecting bacteriophages, the results 
provide novel insights into general host-phage interactions of typical 
Salmonella-infecting bacteriophages. 
 Bacteriophages tend to use structures exposed on the outer 
membrane of the host bacteria as a receptor because they are easily 
accessible. Unexpectedly, only three kinds of receptors were identified in 
this study, flagella, O-antigen, and the outer membrane protein BtuB, 
although several other outer membrane proteins, including FhuA, TolC, and 
OmpC, are characterized as phage receptors of Salmonella. One possible 
reason may be the complex nature of Salmonella Typhimurium LPS (21, 25), 
which may block access of phage to some outer membrane proteins, making 
it more challenging to isolate those phages. In a seeming contradiction, LPS 
69 
may help attachment of group B phage to BtuB on a S. Typhimurium host. 
T5 phage, for example, has both a receptor-binding tail protein Pb5 and a L-
shaped tail fiber protein on the phage tail that targets the host outer 
membrane protein and LPS, respectively (27, 65). The Pb5 as a major host 
specificity protein is reported to mediate irreversible binding to a specific 
outer membrane protein and the L-shaped tail fiber protein as a helper 
protein provides reversible binding to LPS. Therefore, the L-shaped tail 
fiber protein increases the infection rate of T5 phage by stabilization of 
binding between phage and an outer membrane receptor via Pb5. Group B 
phages are in the same family as T5 phage, Siphoviridae, and have a similar 
tail structure containing an Pb5-like protein possibly targeting BtuB and an 
L-shaped tail fiber protein possibly targeting LPS (Fig. 2.3). Due to this 
similarity between T5 and group B phages, it is suggested that this tail fiber 
protein may help the binding of Pb5-like protein to BtuB to increase the 
infection rate of group B phages, but this proposed binding mechanism 
needs further study.  
 Morphological characterization of the group F and group L 
bacteriophages also provided insight into the interaction of these phages 
with host receptors. The group F phages have relatively long, non-
contractile and cross-banded tails with a single and twisted tail fiber 
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structure. This structure is very similar to that of chi phage that infects E. 
coli, Salmonella and Serratia through flagella filament receptors (59, 61), 
suggesting possible interaction between the group F twisted tail fibers and 
bacterial flagella. Group L phages are morphologically belong to 
Podoviridae and use LPS as a main receptor like other phages including ε15 
(14, 37), P22 (35) and T7 (41), which all interact with LPS via major host 
specificity proteins. However, Salmonella phages of Myoviridae family 
were not isolated in this study. It is not clear why I failed to isolate phages 
of Myoviridae family. The standard phage isolation protocol employed in 
our study may not be suitable for isolation of Salmonella phages in 
Myoviridae family because the genome sizes of Salmonella phages of 
Myoviridae family except for Pedovirinae subfamily are generally bigger 
than those of other family phages (2, 44, 53, 60, 62). Otherwise, there might 
be unknown bias in the phage isolation. 
 Host range analysis of group F-I phages showed that they 
successfully infected all S. Typhimurium strains tested except strain ATCC 
14028. It is not clear why the group F-I phages that use only FliC as a 
receptor could not infect ATCC 14028 while the group F-II phages could. 
The complete genome sequence of strain ATCC 14028 (GenBank accession 
number CP001363) showed that it has a fliC gene and multiple sequence 
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alignment with the fliC genes of susceptible Salmonella strains revealed no 
sequence differences. Real-time RT-PCR and SDS-PAGE analysis 
confirmed that the fliC gene is expressed and translated for flagella 
formation, indicating that FliC in the strain ATCC 14028 is functional (data 
not shown). The group B phages also infected all S. Typhimurium strains 
except one, strain DT104. Sequencing and real-time RT-PCR analyses of the 
btuB gene in strain DT104 showed that it is expressed (data not shown), so 
it is not clear why the strain is resistant. These two examples imply that 
there may be an additional unknown factor(s) that makes the phage and host 
receptor interaction more specific and complicated. However, only S. 
Typhimurium ATCC 14028 has Gifsy-3 prophage, so this prophage could 
cause superinfection exclusion to group F-I phages. 
 The phages that can make lysogen normally make turbid plaques 
but many other factors are involved in turbid plaque formation that it is not 
simple to distinguish lysogen formation based on plaque turbidity. While the 
lysogen generally resists superinfection by expression of the phage genes, 
acquisition of phage resistance by host mutation has been hardly found in 
lysogen. Therefore, the aim of this lysogenization experiment was to test 
whether the resistance against phage infection was due to lysogenization or 
other factors related with a host receptor. To confirm their lysogen formation, 
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mitomycin C was treated to induce the prophages. Group L phages except 
for SPN9TCW did yield phage after mitomycin C induction, substantiating 
the lysogen formation by most of group L phage infection. However, most 
of group F phage-resistant strains did not yield phage by mitomycin C 
induction, even though these phages make turbid plaques, suggesting that 
these phages may make unstable lysogen, resulting in very low frequency of 
mitomycin C induction (approximately 5%) in the resistant strains. It has 
been known that Mu-like prophages were generally not induced by 
mitomycin C treatment (54), suggesting the possibility that group F phage 
may be mitomycin C-insensitive phage. To verify this, I performed PCR 
detection of group F phage genomes in the resistant hosts and the green 
plate experiment. Recently, the genomes of four phages in group F were 
completely sequenced and phage-specific primers were designed. Using 
these phage-specific primers, PCR was conducted to detect group F phage 
genomes in the genomes of group F phage-resistant S. Typhimurium LT2C 
strains. Interestingly, very low number of group F phage-resistant strains 
(approximately 5%) showed the presence of group F phage genomes in the 
host genomes, suggesting the formation of very unstable lysogens, 
supporting our observation of low mitomycin C induction with group F 
phage-resistant strains (data not shown). And green plate experiments also 
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showed that most of group F phage infection does not make stable lysogens. 
This very distinct feature of group F phages for unstable lysogen formation 
was not still understood and it needs to be elucidated soon. 
Analysis of cross resistance among phage-resistant strains revealed 
that group F phage-resistant strains are sensitive to group L or B phages 
(Table 2.6 and Fig. 2.5A). This sensitivity indicates that the host resistance 
of group F phages does not disrupt the interactions between these other 
phages and the cell surface receptors. In contrast, group B phage-resistant 
strains are resistant to their phages as well as group L phages (Table 2.6 and 
Fig. 2.5C). The concurrent resistance to both group B and group L phages 
imply that BtuB may influence the interaction between LPS and phage, as in 
the case of E. coli phage T5 (27, 65). The interaction between LPS and 
phage has been reported to accelerate adsorption of phage T5 to E. coli even 
though an outer membrane protein is the cell surface receptor.  
All but one group L phage-resistant strain was sensitive to infection 
by group B phages (Table 2.6 and Fig. 2.5B). The group L SPN9TCW 
phage-resistant strain was resistant to group B phages (Table 2.6 and Fig. 
2.5D), even though phage SPN9TCW uses LPS as a receptor and the 
resistant strain does not appear to be a lysogen. Therefore stable lysogen 
formation of group L phages may be a key to determine the host resistance 
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against group B phages (Table 2.6). Further analyses of group B phage-
resistant Salmonella strains are required to elucidate the mechanism of 
cross-resistance observed against the group B and L phages. 
 Many Salmonella-specific phages that use LPS as a receptor modify 
LPS as a mechanism to protect from superinfection when they lysogenize a 
host (40, 64). The recent complete genome sequence analysis of a lysogenic 
SPN1S phage in group L revealed that the phage genome encodes a GtrA 
and two copies of lipopolysaccharide modification acyltransferase, 
supporting this (63). Even though the LPS modification protects the lysogen 
from a superinfection by other group L phages, the lysogen is still sensitive 
to phages that target other receptors such as flagella and BtuB (Table 2.6 
and Fig. 4B). Furthermore, group F, group B and group L SPN9TCW phage-
resistant strains showed transient resistance to re-infection of the same 
phages (Table 2.6). These resistant strains were collected for the cross 
resistant experiment after the bacterial growth resumed in the presence of 
the phage. In this case, these collected phage-resistant strains are probably 
not lysogens, suggesting that host defense mechanisms such as CRISPR (18, 
43) or restriction-modification systems (29, 66) or still unknown host 
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II-6-1. Complete Genome Sequence Analysis of Bacterial Flagellum-
Targeting Bacteriophage Chi 
(Accepted in Archives of Virology, 2013, In Press) 
 
II-6-1-1. Abstract 
 Bacteriophage Chi is a well-known phage infecting pathogens such 
as E. coli, Salmonella, and Serratia via bacterial flagella. To further 
understand its host-phage interaction and infection mechanism via host 
flagella, the genome was completely sequenced and analyzed. The phage 
genome contains 59,407-bp length DNA with GC content of 56.51% 
containing 75 open reading frames (ORFs) with no tRNA genes. Its 
annotation and functional analysis revealed that Chi is evolutionarily very 
close to Enterobacter phage Enc34 and Providencia phage Redjac. However, 
most of the annotated genes encode hypothetical proteins, indicating that 
further genomic study of phage Chi is required to elucidate bacterial 
flagellum-targeting infection mechanism of phage Chi. 
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II-6-1-2. Main text 
 Intake of food-borne pathogens such as E. coli and Salmonella via 
contaminated foods causes food poisoning accompanied by high fever, 
diarrhea and vomiting (2, 14, 19). Although many food preservatives have 
been developed and used to control these food-borne pathogens, the number 
of food poisoning outbreaks is increasing every year (10, 11, 20). Therefore, 
effective and safe novel biocontrol agents should be developed to control 
food-borne pathogens.  
 Bacteriophages are bacterial viruses to infect and lyse specific 
bacterial host cells suggesting their bactericidal activity (6). In addition, they 
infect only specific host bacteria without affecting other bacteria in the same 
habitat (7). Recently human feeding trials showed  efficient inhibition of 
specific bacterial host without side effects, suggesting that phage treatment 
should be safe for human applications (4). Therefore, phage applications 
have been reconsidered and tested as alternative approaches to inhibit food-
borne pathogens in foods (5, 12, 22). 
 Bacteriophage Chi infecting major food-borne pathogens such as E. 
coli, Salmonella, and Serratia was first isolated and characterized in 1930’s 
(25). While other bacteriophages generally infect host strains via 
extracellular membrane receptors such as lipopolysaccharide (LPS) and 
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outer membrane proteins (like BtuB, FhuA, and OmpC) (17), phage Chi is 
the first reported bacteriophage to infect host strains via flagella (21). 
However, the infection mechanism of Chi phage via the host flagella is not 
understood fully in genomic level yet. In this study, to further understand 
this receptor specificity and host-phage interaction, the genome of phage 
Chi was completely sequenced and analyzed. 
 The Chi phage (ATCC 9842-B1
TM
) was obtained from American 
Type Culture Collection (ATCC). For propagation of phage Chi, it was 
added to the culture of Salmonella enterica serovar Typhimurium SJW1103 
(27) at a multiplicity of infection (MOI) of 1 when optical density (OD) of 
the culture reaches to 1.0 at 600 nm wavelength. The mixture was incubated 
at 37°C for 4 h with vigorous shaking and phage particles were recovered by 
centrifugation at 6,000 × g for 10 min and subsequent filtration using 0.22 
µm pore size filters (Millipore, Billerica, MA, USA). To purify the phage 
particles, precipitation with polyethylene glycol (PEG) 6,000 (Sigma, St. 
Louis, MO, USA) and ultracentrifugation (Himac CP 100β, Hitachi, Japan) 
with gradient CsCl2 from 1.3 to 1.7 g/ml densities at 25,000 × g, 4°C for 2 h.  
 The genomic DNA of phage Chi was isolated as previously 
described by Wilcox et al. (26). Prior to isolation of phage genomic DNA, 
phage particles were treated with DNase I and RNase A at 37°C for 1 h to 
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remove bacterial host DNA and RNA, respectively. And then phage particles 
were lysed with standard lysis buffer (50 µg/ml of proteinase K, 0.5% of 
sodium dodecyl sufate (SDS), and 20 mM of EDTA) for 2 h at 56°C. In the 
final step, phenol-chloroform treatment and ethanol precipitation of 
genomic DNA were conducted as described by Sambrook et al. (23). 
 Purified genomic DNA of phage Chi was sheared and randomly 
sequenced using the Genome Sequencer FLX (GS-FLX) (Roche, Mannheim, 
Germany) and the qualified filtered reads were assembled using the Newbler 
2.3 program (Roche) at Macrogen, Inc. (Seoul, South Korea). Open reading 
frames (ORFs) were predicted using gene prediction programs such as 
Glimmer3 (13), GeneMarkS (3), and FgenesB (Softberry, Inc. Mount Kisco, 
NY, USA) programs and confirmed using RBSFinder program (J. Craig 
Venter Institute, Rockville, MD, USA). Their annotation and functional 
analysis were performed using BLASTP (1) and InterProScan (28) 
databases. Genomic DNA and annotation data were handled and edited 
using Artemis14 (8). Phylogenetic analysis of major capsid proteins (MCPs) 
of bacteriophages including phage Chi was conducted using MEGA5 based 
on the neighbor-joining method with P distance values (15). The lifestyle of 
phage Chi was predicted using PHACTS program (18). 
 Bacteriophage Chi genome contains 59,407-bp length DNA with 
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GC content of 56.51% containing 75 ORFs with no tRNA genes (Fig. 2.6). 
Annotated functions of all predicted ORFs in phage Chi were listed in Table 
2.7. The average gene length is 748-bp and the gene coding percentage is 
94.5%. The predicted functions of ORFs in phage Chi were classified into 
five functional groups; structure (head-tail joining protein (chi_053), 
decorator protein (chi_0056), major capsid protein (chi_057), tape measure 
protein (chi_065), tail assembly protein 1 and 2 (chi_067 and chi_068), tail 
fiber protein (chi_071), and prohead protease (chi_055)), packaging 
(terminase small and large subunits (chi_051 and 052, respectively), phage 
portal protein (chi_054)), host lysis (lysis protein A (chi_003) and B 
(chi_002), endolysin-like protein (chi_004), and Rz1 protein (chi_005)), 
DNA manipulation (recombination associated protein (chi_023), primase 
(chi_042), DNA polymerase I (chi_048), and helicase (chi_050)), and 
additional function (N-6-adenine-methyltransferase (chi_017)).  
 BLASTP analysis of the functional ORFs showed that this phage 
genome is very similar to those of Enterobacter phage Enc34 and 
Providencia phage Redjac (Table 2.8). Interestingly, phage head proteins are 
very similar to those of Enterobacter phage Enc34 with 66 to 92% protein 
sequence identity. Furthermore, host lysis proteins are also similar to those 
of Enterobacter phage Enc34 with 57 to 76% protein sequence identity. 
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However, phage tail proteins are very similar to those of Providencia phage 
Redjac with 70 to 90% protein sequence identity, suggesting that phage Chi 
structural genes may be derived from the common ancestor. BLASTP best 
matches of DNA manipulation genes are mixed with those of two different 
bacteriophages, supporting this hypothesis (Table 2.8). In addition, further 
phylogenetic analysis of phage Chi and other bacteriophages based on major 
capsid proteins (MCPs) revealed that phage Chi is evolutionarily very close 
to these phages, Enterobacter phage Enc34 and Providencia phage Redjac, 
substantiating their close evolutionary relationship (Fig. 2.7). To further 
elucidate type of phage Chi, additional phylogenetic analysis of phage Chi 
was performed based on terminase large subunit following Casjens and 
Gilcrease’s method (9) and the analysis result showed that phage Chi 
belongs to λ-like 5’-extended COS ends group (Fig. 2.8). To predict the 
lifestyle of phage Chi, PHACTS analysis was conducted with amino acid 
sequences of all predicted ORFs. However, clear lifestyle prediction was not 
possible for phage Chi probably due to extremely low amino acid sequence 
identities of predicted ORFs in Chi phage to those of other phages (data not 
shown). 
 While bacterial flagellum infection model of phage Chi was 
suggested to follow the “nut and bolt” model infecting through counter 
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clock-wise rotating flagella (24), the infection mechanism of phage Chi via 
host flagella based on its complete genome sequence analysis is not clearly 
understood yet, probably due to insufficient database information on the 
bacterial flagellum-targeting bacteriophages. Genome annotation result 
showed that 52 of 75 predicted ORFs encode hypothetical proteins, 
supporting this. Therefore, further functional genome study of phage Chi 
would explain the infection mechanism via host flagella in the near future. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of bacteriophage Chi is available in GenBank database under 
accession number JX094499. 
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Table 2.7. The annotated sequence records of Chi phage 
Locug_tag Start End Strand Product 
chi_001 29 1921 + hypothetical protein 
chi_002 1986 2324 + lysis protein B 
chi_003 2328 3041 + lysis protein A 
chi_004 3038 3292 + endolysin like protein 
chi_005 3219 3422 + possible Rz1 protein 
chi_006 3423 3884 - hypothetical protein 
chi_007 3881 4780 - hypothetical protein 
chi_008 4770 5483 - hypothetical protein 
chi_009 5485 5937 - hypothetical protein 
chi_010 5934 6245 - hypothetical protein 
chi_011 6242 6523 - hypothetical protein 
chi_012 6604 7116 - hypothetical protein 
chi_013 7098 7352 - hypothetical protein 
chi_014 7342 7563 - hypothetical protein 
chi_015 7560 7754 - hypothetical protein 
chi_016 7765 8583 - hypothetical protein 
chi_017 8661 9347 - possible N-6-adenine-methyltransferase 
chi_018 9347 10447 - hypothetical protein 
chi_019 10444 11118 - hypothetical protein 
chi_020 11115 11855 - hypothetical protein 
chi_021 12051 12326 - hypothetical protein 
chi_022 12331 12564 - hypothetical protein 
chi_023 12567 13640 - possible recombination associated protein RdgC 
chi_024 13621 13962 - hypothetical protein 
chi_025 13949 14284 - hypothetical protein 
chi_026 14271 14711 - hypothetical protein 
chi_027 14783 15154 - hypothetical protein 
chi_028 15627 15800 + hypothetical protein 
chi_029 15915 16175 + hypothetical protein 
chi_030 16189 16728 + hypothetical protein 
chi_032 16743 16943 + hypothetical protein 
chi_031 16946 17428 + hypothetical protein 
chi_033 17440 17643 + hypothetical protein 
chi_034 17656 18204 + hypothetical protein 
chi_035 18201 18422 + hypothetical protein 
chi_036 18548 19702 + hypothetical protein 
chi_037 19714 19986 + hypothetical protein 
chi_038 19989 20195 + hypothetical protein 
chi_039 20188 20442 + hypothetical protein 
chi_040 20435 20686 + hypothetical protein 
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Table 2.7. The annotated sequence records of Chi phage (continued) 
Locug_tag Start End Strand Product 
chi_041 21843 22130 + helix-turn-helix domain-containing protein 
chi_042 22171 24756 - possible primase 
chi_043 24753 25034 - hypothetical protein 
chi_044 25276 25692 + hypothetical protein 
chi_045 25755 26084 + hypothetical protein 
chi_046 26077 27417 + conserved hypothetical protein 
chi_047 27472 28068 + conserved hypothetical protein 
chi_048 28135 30174 + putative DNA polymerase I 
chi_049 30176 30463 + VRR-NUC domain-containing protein 
chi_050 30510 31985 + possible helicase 
chi_051 31972 32541 + possible terminase small subunit 
chi_052 32531 34606 + putative terminase large subunit 
chi_053 34617 34871 + possible head-tail joining protein Lambda W 
chi_054 34868 36550 + phage portal protein, lambda family 
chi_055 36577 37863 + putative prohead protease ClpP 
chi_056 37878 38297 + possible decorator protein 
chi_057 38310 39374 + putative major capsid protein 
chi_058 39436 39729 + hypothetical protein 
chi_059 39732 40097 + hypothetical protein 
chi_060 40184 40723 + hypothetical protein 
chi_061 40720 41223 + hypothetical protein 
chi_062 41237 42382 + hypothetical protein 
chi_063 42479 42940 + hypothetical protein 
chi_064 42985 43182 + hypothetical protein 
chi_065 43175 47470 + putative tape measure protein 
chi_066 47476 49164 + hypothetical protein 
chi_067 49174 49992 + putative conserved tail assembly protein 1 
chi_068 50004 50234 + putative conserved tail assembly protein 2 
chi_069 50234 50473 + hypothetical protein 
chi_070 50463 54353 + hypothetical protein 
chi_071 54428 55093 + possible tail fiber protein 
chi_072 55103 56110 + hypothetical protein 
chi_073 56121 57083 + hypothetical protein 
chi_074 57097 58116 + hypothetical protein 
chi_075 58131 59360 + hypothetical protein 
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Table 2.8. Comparative analysis of predicted ORFs using BLASTP 
Locus_tag Predicted function Lengtha BLASTP best match Identity (%)b 
chi_002 lysis protein B 112 holin [Enterobacter phage Enc34] 64/112 (57.1) 
chi_003 lysis protein A 237 endolysin [Enterobacter phage Enc34] 181/237 (76.4) 
chi_004 endolysin like protein 84 putative Rz protein [Enterobacter phage Enc34] 56/84 (66.7) 
chi_005 possible Rz1 protein 67 putative Rz1 protein [Enterobacter phage Enc34] 51/67 (76.1) 
chi_017 possible N-6-adenine-methyltransferase 228 DNA methyltransferase [Enterobacter phage Enc34] 173/228 (75.9) 
chi_023 possible recombination associated protein RdgC 357 recombination-associated protein [Enterobacter phage Enc34] 208/357 (58.3) 
chi_041 helix-turn-helix domain-containing protein 95 hypothetical protein PaP1_gp024 [Pseudomonas phage PaP1] 23/95 (24.2) 
chi_042 possible primase 861 DNA primase [Enterobacter phage Enc34] 624/861 (72.5) 
chi_048 putative DNA polymerase I 679 DNA polymerase I [Providencia phage Redjac] 529/679 (77.9) 
chi_049 VRR-NUC domain-containing protein 95 VRR-NUC domain protein [Enterobacter phage Enc34] 62/95 (65.3) 
chi_050 possible helicase 491 DNA helicase [Providencia phage Redjac] 382/491 (77.8) 
chi_051 possible terminase small subunit 189 terminase small subunit [Enterobacter phage Enc34] 161/189 (85.2) 
chi_052 putative terminase large subunit 691 terminase large subunit [Providencia phage Redjac] 624/691 (90.3) 
chi_053 possible head-tail joining protein Lambda W 84 head-to-tail joining protein [Enterobacter phage Enc34] 56/84 (66.7) 
chi_054 phage portal protein, lambda family 560 phage portal protein [Providencia phage Redjac] 509/560 (90.9) 





Table 2.8. Comparative analysis of predicted ORFs using BLASTP (continued) 
Locus_tag Predicted function Lengtha BLASTP best match Identity (%)b 
chi_056 possible decorator protein 139 phage structural protein [Enterobacter phage Enc34] 109/139 (78.4) 
chi_057 putative major capsid protein 354 major capsid protein E [Enterobacter phage Enc34] 326/354 (92.1) 
chi_062 bacterial Ig-like domain-containing protein 381 phage structural protein [Providencia phage Redjac] 304/381 (79.8) 
chi_065 putative tape measure protein 1431 tape measure protein [Providencia phage Redjac] 1002/1431 (70.0) 
chi_067 putative conserved tail assembly protein 1 272 conserved tail assembly protein [Providencia phage Redjac] 247/272 (90.8) 
chi_068 putative conserved tail assembly protein 2 76 tail assembly protein [Enterobacter phage Enc34] 60/76 (78.9) 
chi_071 possible tail fiber protein 221 tail fiber protein [Providencia phage Redjac] 162/221 (73.3) 
a
, base pairs (bp) 
b












Figure. 2.6. Genome map of bacteriophage Chi. Functional ORFs were classified into five groups. Red, purple, green, blue, and 
orange arrows indicate host lysis, additional function, DNA manipulation, packaging, and structure-related ORFs, respectively. The 








Figure. 2.7. Phylogenetic analysis of MCPs in phage Chi and other 
various bacteriophages. MCPs were compared by ClustalW alignments 
(16) and the phylogenetic tree was generated by the neighbor-joining 
method with P distance values using MEGA5 (15). S, Siphoviridae; P, 






Figure. 2.8. Comparative phylogenetic analysis of terminase large 
subunits in phage Chi and other various bacteriophages. Amino acid 
sequences of terminase large subunits were compared by ClustalW 
alignments  and the phylogenetic tree was generated by the neighbor-
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SPN3US 
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II-6-2-1. Abstract 
 Salmonella bacteriophage SPN3US was isolated from a chicken 
fecal sample. It is a virulent phage belonging to the Myoviridae family, 
showing effective inhibition against Salmonella enterica and a few E. coli 
O157:H7. Here, we announce the completely sequenced first genome of a 
Salmonella phage using flagella as a receptor. It is the largest genome 




II-6-2-2. Main text 
 Salmonellosis is one of the most serious diseases caused by 
foodborne pathogens (8). While antibiotics have been broadly used to treat 
this disease, emergence of antibiotics resistance in Salmonella is getting 
more problematic (4). Bacteriophage is now considered as a good 
alternative biocontrol agent to inhibit this pathogen (9). Because the 
bacteriophage treatment gained the status of “Generally Recognized as Safe” 
by US FDA in 2006 (3), this approach as a phage therapy could be useful to 
inhibit pathogenic Salmonella.  
 The Salmonella bacteriophage SPN3US was isolated from chicken 
feces using a host strain S. enteria serovar Typhimurium LT2. The receptor 
study revealed that this phage infects Salmonella using flagella as a receptor 
(data not shown). Although flagella were previously reported as the phage 
receptor (6), the complete genome sequence of the Salmonella flagella-
targeting phage has never been reported yet.  
 The genomic DNA was extracted from the stock using alkaline lysis 
method (11). A pyrosequencing approach was used with the Genome 
Sequencer FLX (GS-FLX) Titanium by Macrogen in Korea (55X coverage) 
and the quality filtered reads were assembled into a complete genome 
sequence using 454 Newbler 2.3 assembler. Prediction of open reading 
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frames (ORFs) was performed using GAMOLA automatic annotation 
program (1) and predicted ORFs were confirmed using Glimmer 3.02 (5), 
GeneMark.hmm (7) and FgeneV software (http://www.softberry.com). 
Annotation of predicted ORFs was conducted using the results of BLASTP 
(2) and InterProScan analyses (12).  
 The complete genome of phage SPN3US revealed 240,413 bp 
lengths with GC content of 48.54%, 264 ORFs and two tRNAs, suggesting 
the largest genome among Salmonella phages to date (Fig. 2.9) (10). The 
gene average length is 855 bp and gene density is 1.098 genes per kb. 87.5% 
of ORFs are positioned in one of two DNA strands. 
 While the gene coding percentage is 93.9% in the genome, 79.2% 
of ORFs were annotated to be hypothetical, probably due to insufficient 
database information on the functional genes of Salmonella phage genomes. 
This genome contains functional genes related to phage structure and 
packaging (major capsid protein, unknown phage structure proteins and 
terminase), tail structure for host interaction (tail fiber protein, tail sheath 
protein and tail-associated protein), replication/transcription (helicase, 
DNA-directed RNA polymerases, SbcCD nuclease, endodeoxyribonuclease, 
ribonuclease H and transcription regulator), host lysis (endolysin without 
holin) and additional functions (phage DNA adenine methylase for 
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protection from host restriction-modification system and dihydrofolate 
reductase/thymidylate kinase/thymidylate synthase for probably folate 
metabolism). However, these functional genes do not position in the same 
gene clusters but they are scattered over the genome. Interestingly, the 
repeats of six RNA polymerase beta subunits suggest that transcription of 
phage genes may be dominant rather than gene transcription of the host. 
This phage genome has only one phage fiber protein, probably interacting 
with the host flagella for infection. The complete genome analysis of this 
phage provides a new insight into its characteristics and interactions with 
Salmonella. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of Salmonella phage SPN3US is available in GenBank under the 









Figure 2.9. Genome map of bacteriophage SPN3US. Outer circle indicates the gene coding regions by strand. The color of each 
gene refers to the functional categories such as phage structure and packaging (blue), regulation (orange), replication/transcription 
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II-6-3. Complete Genome Sequence of Salmonella enterica serovar 
Typhimurium Bacteriophage SPN1S 
(Published in Journal of Virology, 2012, 86: 1284-1285) 
 
II-6-3-1. Abstract 
 To understand the interaction between pathogenic Salmonella 
enterica serovar Typhimurium host and its bacteriophage, the bacteriophage 
SPN1S was isolated from environmental water. It is a lysogenic phage in the 
family of Podoviridae, using O-antigen of lipopolysaccharides (LPS) as a 
host receptor. Comparative genomic analysis between phage SPN1S and S. 
enterica serovar Anatum-specific phage ε15 revealed the different host 
specificities probably due to low homology of host specificity-related genes. 
Here, we report the complete circular genome sequence of S. Typhimurium-
specific bacteriophage SPN1S and its analysis results are shown.  
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II-6-3-2. Main text 
 Salmonella outbreak is one of the most common foodborne illnesses 
(more than 30% of all bacterial foodborne poisoning) (4, 5). More than 1.4 
million cases of foodborne Salmonella outbreak have been reported every 
year in the United States and they have increased by 10% in recent years (4, 
9, 13). Moreover, emergence of multi-drug resistant Salmonella such as S. 
Typhimurium phage type DT104 has been getting more problematic (7, 14). 
To control these drug-resistant Salmonella strains, applications of 
Salmonella-specific bacteriophage have been proposed (8, 15). Therefore, it 
is important to understand the infection mechanism between Salmonella 
host and Salmonella-specific phages. To increase our knowledge on this 
interaction, a S. Typhimurium-specific phage SPN1S was isolated from 
environmental water and its genome was completely sequenced. 
 The genomic DNA of phage SPN1S was isolated using an alkaline 
lysis method (16) and sequenced using the Genome Sequencer FLX (GS-
FLX) Titanium technology in Macrogen, Korea with 130X coverage. 
Sequence assembly of quality filtered reads was performed using 454 
Newbler 2.3 assembler. From the complete genome sequence of phage 
SPN1S, open reading frames (ORFs) were predicted using GAMOLA 
automatic annotation program (1) and confirmed using GeneMarkS (3), 
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Glimmer 3.02 (6) and FgenesV (http://www.softberry.com). Conserved 
protein domain analysis was conducted using BLASTP (2), InterProScan 
(17) and NCBI Conserved Domain Database (CDD) (12). Prediction of 
tRNAs was carried out using tRNAscan-SE program (11). 
 Bacteriophage SPN1S has a circular genome consisting of 38,684 
bp with GC content of 50.16%, 52 ORFs but no tRNA (Fig. 2.10). The 
annotation of this genome reveals that phage packaging (terminase small 
and large subunits), morphogenesis (a phage head-tail connector protein, an 
endoprotease, a major capsid protein and a minor structural protein), host 
specificity (a tailspike protein), conversion of host LPS (a GtrA and two 
copy of lipopolysaccharide modification acyltransferase), host lysis (a holin, 
an endolysin, a Rz-like protein and a Rz1), DNA replication/modification (a 
DNA replication protein, an integrase, an exonuclease VIII/RecE-like 
protein and an adenine methylase) and transcription regulation (a 
transcriptional activator and transcriptional regulators). 
 Comparative genome analysis of phage SPN1S and S. enterica 
serovar Anatum-specific phage ε15 (GenBank accession number AY150271) 
revealed that while these two phages are closely related in the DNA level, 
host specificity-related genes encoding tailspike/tail fiber proteins are quite 
different. In addition, the receptor study of phage SPN1S showed that the 
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tailspike protein (SPN1S_0022) interacts with O-antigen of LPS in S. 
Typhimurium, suggesting that this phage infects the host strain via LPS as a 
host receptor (Fig. 2.11). Interestingly, Rz1 and Rz-like protein collaborate 
with the endolysin for host lysis. A single gene expression of the endolysin 
gene using E. coli gene expression system does not lyse the host strain, but 
co-expression of the genes encoding endolysin, Rz1 and Rz-like protein 
really do (10). The genome study of this phage SPN1S would increase our 
knowledge on interaction between S. Typhimurium host and its 
bacteriophages. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of S. enterica serovar Typhimurium phage SPN1S is available in 








Figure 2.10. Genome map of bacteriophage SPN1S. Outer circle indicates the gene coding regions by strand. The color of each 
gene refers to the functional categories. Yellow, packaging; Blue, structure; Brown, host interaction; Green, host lysis; Red, DNA 







Figure 2.11. Comparative genomic analysis of SPN1S phage and Epsilon15 phage. Comparative analysis of complete genome 
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II-6-4. Complete Genome Sequence of Salmonella enterica serovar 
Typhimurium Bacteriophage SPN3UB 
(Published in Journal of Virology, 2012, 86: 3404-3405) 
 
II-6-4-1. Abstract 
 Salmonella is one of the major pathogenic bacteria causing food 
poisoning. To elucidate the host infection mechanism of S. enterica serovar 
Typhimurium-targeting phages, the bacteriophage SPN3UB was isolated 
from a chicken fecal sample. This phage morphologically belongs to 
Siphoviridae family and infects the host via O-antigen of LPS. To further 
understand its infection mechanism, the genome was completely sequenced 
and analyzed. Here, we announce its complete genome sequence and show 




II-6-4-2. Main text 
 Salmonella is a pathogenic bacterium causing salmonellosis via 
contaminated foods (6, 7). To develop phages as a biocontrol agent for 
controlling this pathogen in foods, understanding of the host infection 
mechanism of Salmonella phages is important (2, 3, 10). While O-antigen of 
lipopolysaccharides (LPS) is a common host receptor for infection in 
Myoviridae (FelixO1) (11) and Podoviridae (P22, ε34) families (4, 13, 14), 
the phages in Siphoviridae family using this host receptor such as SETP3 
are rare (8). S. Typhimurium-targeting SPN3UB phage belonging to 
Siphoviridae family could not infect the rfaL (O-antigen ligase)-deficient 
mutant strain of S. Typhimurium SL1344 (data not shown), suggesting that 
it infects the host via O-antigen of LPS (12). To further understand its host 
infection mechanism, the genome was completely sequenced and analyzed. 
 Phage genomic DNA was isolated using standard alkaline lysis 
method (15) and sequenced using the Genome Sequencer FLX Titanium by 
Macrogen, Korea. Assembly of quality filtered reads was performed using a 
454 Newbler 2.3 assembler and open reading frames (ORFs) were predicted 
using GeneMarkS (5), Glimmer 3.02 (9), and FgenesV (Softberry, Inc., 
Mount Kisco, KY) and their ribosomal binding sites were confirmed using 
RBSfinder (J. Craig Venter Institue, Rockville, MD). Annotation of the 
116 
predicted ORFs was conducted using BLASTP (1) and InterProScan (16).  
 SPN3UB phage has a circular dsDNA-based genome consisting of 
47,355-bp length with a GC content of 49.61% and 71 ORFs but no tRNA, 
indicating that it is the largest genome sequence in Siphoviridae phage using 
O-antigen of Salmonella LPS as a host receptor (Fig. 2.12). This phage 
genome encodes head/tail structure proteins (major capsid protein, tape 
measure protein, minor tail protein M and L, tail assembly protein K and I, 
and tail fiber protein J), phage packaging (terminase large and small 
subunits), integration and recombination (integrase, excisionase-like protein, 
RecT recombinase, and RecE exodeoxyribonuclease), lysogeny control (Cro, 
CI, and CII), phage replication (PrpO replication protein and DnaC DNA 
replication protein), antitermination (antitermination protein Q), host cell 
lysis (endolysin and Rz/Rz1 endopeptidases), and additional functions (Arc-
like DNA binding protein, antirepressor family protein, Eaa protein, DinI 
DNA damage-inducible protein, NinG, and KilA-N domain protein). 
Because this phage has only one tail fiber protein J, it may play an important 
role in the host infection via O-antigen of LPS. The lysogeny control 
proteins and antitermination protein Q may contribute to formation of 
lysogen during infection and reconstruction of the phage from the lysogen 
was confirmed by mitomycin C induction (data not shown). Interestingly, 
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some of replication proteins such as helicase, primase, etc. are missing. 
Probably, this phage takes advantage of host replication proteins or they are 
annotated to hypothetical proteins due to too low identity with other phage 
replication proteins in GenBank database. The complete genome sequence 
of S. Typhimurium SPN3UB phage provides extended information about 
host infection and interaction mechanisms with this phage. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of S. Typhimurium bacteriophage SPN3UB is available in 











Figure 2.12. Genome map of bacteriophage SPN3UB. Outer circle indicates the gene coding regions by strand. The color of each 
gene refers to the functional categories. Yellow, packaging; Blue, structure; Brown, integration and recombination; Green, host lysis; 
replication, DNA manipulation; Pink, antitermination; Orange, regulation; Purple, additional functions. The inner circle with red line 
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 Food poisoning is generally caused by uptake of foods or drinks 
contaminated by foodborne pathogenic bacteria, such as Salmonella, E. coli, 
Listeria, and Campylobacter (44). Among these bacteria, Salmonella is one 
of the most common pathogens. The bacterium causes salmonellosis with 
various symptoms, such as diarrhea, vomiting, high fever, and even death (3, 
11). In the United States, more than 1.4 million cases of Salmonella have 
been reported, and the number has increased by more than 10% annually in 
recent years (11, 22, 44). Although antibiotics have been widely used to 
control this pathogen and salmonellosis, multi-drug resistant Salmonella 
strains, such as S. Typhimurium DT104, have appeared (12, 53). 
 Due to the emergence of antibiotic-resistant Salmonella, a novel 
approach using bacteriophage has been proposed to control them (21, 48). 
To take advantage of the phage treatment against salmonellosis, it is 
necessary to characterize Salmonella phages phenotypically and 
genotypically. Moreover, understanding of infection mechanisms between 
Salmonella host and Salmonella-targeting phages is important for this 
purpose. The major host-phage infection processes include the phage 
attachment via host receptor, control of the host lytic-lysogenic cycle, and 
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the host lysis mechanism.  
Several Salmonella host receptors for phage infection have been 
experimentally determined and characterized, such as flagella (30, 62), Vi 
capsular antigen (52), LPS (60), and host outer membrane proteins (OmpC 
(26), BtuB (29, 31), TolC (58), and FhuA (9)). These receptors play a role in 
the determination of host specificity of the phages, suggesting that host 
receptor study would be able to provide novel insights in the infection 
mechanisms between Salmonella host and the phages. Lambdoid lysogenic 
phages generally contain a lysogeny control region consisting of cro, cI, cII, 
cIII, N, and Q (6, 67). Constitutive bacteriophage promoters, PL and PR, 
express N and Cro proteins. N protein binds to all terminators for 
antitermination. During this early gene expression, CII, CIII and Q proteins 
are produced. Among these proteins, CII-CIII complex activates PRE and PI 
promoters, resulting in the lysogenic cycle by production of integrase and 
CI protein, which are related to phage genome integration and blocking of 
all phage gene expressions. At this point, if the host HflA proteolytic 
enzyme is activated in the presence of low concentration of cAMP due to a 
sufficient supply of glucose to the host, it digests CII protein such that CII-
CIII complex cannot produce CI protein, resulting in the prevention of the 
lysogenic cycle. Furthermore, Q protein activates gene expression related to 
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phage structure and host cell lysis. Therefore, the study of the lysogeny 
control region is important to understand the phage lytic/lysogenic cycles in 
the host. Holin and endolysin are known to be important for host cell lysis 
(73). Holin creates holes in the cytoplasmic membrane. This hole is used as 
a transport channel for endolysin, which digests the peptidoglycan layer. In 
addition, Rz/Rz1-like proteins often enhance endolysin activity as endolysin 
accessory proteins (34). 
 Salmonella-targeting P22 phage belongs to the family of 
Podoviridae morphologically and has been well-characterized to develop 
genetic transfer tools via lysogenization (6, 67). Host receptor studies have 
revealed that the phage tailspike protein plays a role in the interaction with 
the host by interacting with the O-antigen of LPS in S. Typhimurium (4, 69). 
The complete genome sequence analysis of P22 phage also revealed the 
presence of functional genes related to lysogenization and host specificity 
determination (6, 51). In addition, comparative genomic analysis of P22 and 
closely related phages revealed the presence of the P22-like phage group 
(10). This group includes ε34, ST104, ST64T, SE1, c341, and HK620. They 
share phage morphogenesis and assembly genes for similar morphology and 
generally infect Salmonella, E. coli, and Shigella in the Enterobacteriaceae 
family. However, while ant moron regions in phage P22 have been known to 
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be involved in the regulation of gene expression, these regions are 
completely or partially missing in other P22-like phages (72). Although the 
role of this region is not clearly understood yet, it may be related to 
lysogeny conversion (41). Further genome studies of these P22-like phages 
indicate that morphogenesis-related genes are highly conserved, but other 
genes are variable, suggesting that even though they have similar phage 
morphologies, the host specificity of these P22-like phages may differ 
among them. Therefore, further study of these P22-phages would provide 
new information on the host infection of the phages in this group. 
 To understand the infection mechanisms of the bacteriophage at the 
genomic level, the complete genome of SPN9CC was analyzed and 
compared with P22-like phage genomes. In addition, a ΔcI mutant of the 
lysogen-forming P22-like SPN9CC phage was constructed and 
characterized. This study will be useful for increasing our knowledge of the 






III-2. Materials and Methods 
 
III-2-1. Bacterial strains and growth conditions 
 The bacterial strains used in this study and gene knockout mutant 
strains for the host receptor study are listed in Table 3.1. Prophage-free 
Salmonella enterica serovar Typhimurium LT2C was used for the isolation 
and propagation of S. Typhimurium-targeting phages (19) (Cancer Research 
Center, Colombia, MO, USA). All of the bacteria listed in Table 3.1 were 
cultivated at 37°C for 12 h in Luria-Bertani (LB) broth medium (Difco, 
Detroit, MI), and the agar medium was prepared with 1.5% agar 








Table 3.1. Host range of SPN9CC bacteriophage 







Salmonella enterica serovar Typhimurium   
    LT2 +++ (43) 
    LT2C +++ (19) 
    SL1344 +++ NCTC 
    UK1 +++ (16) 
    ATCC 14028s +++ ATCC 
    DT104 + (53) 
    ATCC 43174 ++ ATCC 
   
Salmonella enterica serovar Enteritidis   
    ATCC 13076 + ATCC 
   
Salmonella enterica Paratyphi   
    A IB 211 ++ IVI 
    B IB 231 - IVI 
    C IB 216 - IVI 
   
Salmonella enterica Dublin   
    IB 2973 + IVI 
   
E. coli   
    K-12 MG1655 - (25) 
    DH5α - ATCC 
    O157:H7 ATCC 35150 - ATCC 
    O157:H7 ATCC 43890 - ATCC 
   
Gram-negative bacteria   
    Shigella flexneri 2a strain 2457T - IVI 
    Shigella boydii IB 2474 - IVI 
    Vibrio fischeri ATCC 700601 - ATCC 
    Pseudomonas aeruginosa ATCC 27853 - ATCC 
    Cronobacter Sakazakii ATCC 29544 - ATCC 
   
Gram-positive bacteria   
    Enterococcus faecalis ATCC 29212 - ATCC 
    Staphylococcus aureus ATCC 29213 - ATCC 
 Bacillus cereus ATCC 14579 - ATCC 
    Listeria monocytogenes ATCC 19114 - ATCC 
   
Mutants of S. Typhimurium SL1344   
    ΔflgK +++ (63) 
ΔbtuB +++ (31) 
ΔrfaL - (50) 
ΔrfaL (pUHE21-lacI
q
 ::rfaL) +++ (50) 
a
, +++, EOP 1 to 00.1; ++, EOP 0.01 to 0.0001; +, EOP, less than 0.001; -, no susceptible to 
SPN9CC. 
b
, NCTC, National Collection of Type Cultures; ATCC, American Type Culture Collection; 
KCTC, Korean Collection for Type Cultures; IVI, International Vaccine Institute. 
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III-2-2. Bacteriophage isolation and propagation 
 Commercially processed broiler skin samples were collected from 
the Moran traditional market, Seongnam, South Korea and used for isolation 
of S. Typhimurium-targeting bacteriophage SPN9CC with S. Typhimurium 
LT2C strain. The basic procedures for the isolation and propagation of 
bacteriophage SPN9CC were previously described by Shin et al.(63). 
 
III-2-3. Lysogen induction 
 Selected SPN9CC lysogens of S. Typhimurium LT2C were 
cultivated at 37°C until the OD600 nm reached 1.0, and 0.5 μg/ml of 
mitomycin C (Sigma, St. Louis, MO) was added to the cultures. Then, these 
cultures were additionally incubated at 37°C for 2 h. After incubation, the 
cells were removed by centrifugation and filtration, and the supernatant was 
collected. The spotting assay of this supernatant with S. Typhimurium LT2C 
was conducted to confirm the presence of induced SPN9CC phage. 
 
III-2-4. Electron microscopy 
 A transmission electron microscope (TEM) was used for 
morphological analysis of purified SPN9CC phage. This TEM analysis was 
performed using the procedure described by Shin et al. (63). The 
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morphological classification of SPN9CC phage was conducted according to 
the guidelines of the International Committee on Taxonomy of Viruses (20). 
 
III-2-5. Host range determination by spotting assay 
 The host range and comparative efficiency of plaquing (EOP) test 
of SPN9CC phage were determined using a spotting assay with S. 
Typhimurium, S. Paratyphi, E. coli, and other gram-negative and gram-
positive bacterial strains using the procedure previously described by Park 
et al. (50). 
 
III-2-6. Genome sequencing and bioinformatics analysis 
 Genomic DNA of SPN9CC phage was isolated and purified as 
described by Sambrook et al. (61). The construction of a genomic DNA 
library and pyrosequencing using Genome Sequencer FLX (GS-FLX) 
Titanium (Roche, Mannheim, Germany) were conducted by Macrogen, 
Korea. The prediction of open reading frames (ORFs) was conducted using 
Glimmer 3.02 (18), GeneMarkS (5), and FgenesV (Softberry, Inc., Mount 
Kisco, NY). The prediction of ribosomal binding sites (RBS) of ORFs was 
performed using RBSfinder (J. Craig Venter Institute, Rockville, MD). The 
annotation of predicted ORFs was conducted using BLASTP (2) and 
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InterProScan (75) with conserved protein domain databases. The GenBank 
data file was generated using GAMOLA (1) and Sequin programs (National 
Center for Biotechnology Information, Bethesda, MD). The phylogenetic 
analysis of major capsid proteins from bacteriophages, including SPN9CC, 
was performed using MEGA5 with the neighbor-joining method using p-
distance values (35). The program Mobyle was used for comparative codon 
usage analysis of the S. Typhimurium SL1344 host and SPN9CC phage (46). 
Comparative genomic analysis of SPN9CC with other P22-like phages and 
visualization were conducted using BLASTN (2) and ACT12 (7). 
 
III-2-7. Gene expression of the host lysis gene cluster 
 The SPN9CC_0042, SPN9CC_0043, SPN9CC_0044 and 
SPN9CC_0044_1 genes encoding holin, endolysin, and Rz/Rz1 
endopeptidases, respectively, in the host lysis gene cluster were amplified 
using PCR with the primers listed in Table 3.2. These PCR products were 
double-digested using EcoRI and SalI and cloned into the multiple cloning 
site (MCS) of pBAD18 (24) individually or in combination with more than 
two genes. These cloned plasmids are listed in Table 3.3. S. Typhimurium 
SL1344 and E. coli MG1655 were used as gene expression hosts of the 
cloned pBAD18 plasmids after transformation. The expression of the cloned 
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genes was induced by addition of 0.2% arabinose (final concentration) after 
a 2 h incubation of the sub-inoculated cultures. To test the lysis activity of 
host lysis proteins during incubation and the induction of the cultures, 





Table 3.2. Primers used in this chapter 
Primer Sequence (5’ to 3’)
a
 Reference 
SPN9CC_0042_F TAAAAGAATTCAAATCCCCTCAATAAAGGGGGTAGAG This study 
SPN9CC_0042_R TTTTTGTCGACTTATCGCCGCTATTACGCTATTTC This study 
SPN9CC_0043_F AAAAAGAATTCAAACGCAAAGAGCGTGAGGACAG This study 
SPN9CC_0043_R TTTTTGTCGACATAATCGCGGTTACTCTGCTCATTG This study 
SPN9CC_0044_F AAATTGAATTCTTGAGCGTGAAGTCTGTTTGTGGG This study 











9CC-BRED_conf_F TATCTCATCAGGCCATTGGCTGGCTACAAC This study 
9CC-BRED_conf_R TAATGACAAACTGCACCACGCGTACAACCG This study 












Table 3.3. Plasmids used in this chapter 
Plasmid  Description Reference 
pBAD18 ParaC, ColE1 ori, and Amp
R
 (24) 
pBAD18-42 pBAD18 expressing SPN9CC_0042 This study 
pBAD18-43 pBAD18 expressing SPN9CC_0043 This study 
pBAD18-44 pBAD18 expressing SPN9CC_0044 This study 
pBAD18-42/43 pBAD18 expressing SPN9CC_0042 and 
SPN9CC_0043 
This study 
pBAD18-43/44 pBAD18 expressing SPN9CC_0043 and 
SPN9CC_0044 
This study 
pBAD18-42/43/44 pBAD18 expressing SPN9CC_0042, 


















expressing flgK (63) 











III-2-8. Deletion of cI gene in SPN9CC genome using BRED 
 The cI gene of SPN9CC was specifically deleted using 
Bacteriophage Recombineering of Electroporated DNA (BRED) method 
previously described by Marinelli et al. (42). To delete cI gene using the 
BRED method, a 200-bp dsDNA substrate containing a 100-bp region 
upstream and the other 100-bp region downstream the cI target gene was 
PCR amplified using primers (9CC-BRED_C, 9CC-BRED_CF and 9CC-
BRED_CR, listed in Table 3.2). A S. Typhimurium SL1344 electroporation 
host with pKD46 encoding recombinase was induced with arabinose and 
used for electrocompetent cell preparation (17). The phage genomic DNA 
and 200-bp DNA substrate were co-electroporated into the arabinose-
induced electrocompetent cells for homologous recombination. After a 1 h 
shaking incubation of the transformants at 37°C, 6 ml of 0.4% molten LB 
top agar containing 200 μl of the transformant culture was overlaid on the 
1.5% LB base agar and incubated overnight. Plaques were randomly picked 
and plaque-PCR was performed with specific primers (9CC-BRED_conf_F 
and 9CC-BRED_conf_R, listed in Table 3.2). The plaque-PCR products 
were partially sequenced with the same primers to confirm the deletion of cI 
gene. The cI gene-deleted phage (SPN9CCM) was purified using the single-
picking method and was propagated previously described above. 
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III-2-9. One-step growth curve and bacterial challenge test 
 S. Typhimurium SL1344 was used as a host strain in these assays. 
The overall procedures for the performed one-step growth curve assay and 
challenge test followed the protocol described by Park et al. (50). 
 
III-2-10. Nucleotide sequence accession number 
 The GenBank accession number for the complete genome sequence 









III-3-1. Isolation and morphology of SPN9CC phage 
 For the development of new biocontrol agents, Salmonella-targeting 
bacteriophages were isolated from a commercially processed broiler skin 
sample using a host strain of S. Typhimurium LT2C. Among these phages, 
SPN9CC phage produced distinct clear plaques with cloudy centers (Fig. 
3.1A), suggesting the possibility of lysogen formation in the cloudy center. 
Mitomycin C treatment of the colonies isolated from the cloudy centers of 
the clear plaques revealed the induction of SPN9CC phage, confirming 
lysogen formation (data not shown). TEM morphological observation 
revealed that this phage has the typical short tails belonging to the 













Figure 3.1. Morphological characteristics of SPN9CC phage. Bulls-eye 
shape plaque morphology in dotting assay (A) and TEM morphology (B). 





III-3-2. Host range and host receptor study 
 The host range test of SPN9CC phage demonstrated specific 
inhibition against S. Typhimurium, S. Paratyphi, and S. Dublin. However, 
various gram-positive and gram-negative bacteria, including other 
Salmonella strains, were not inhibited by this phage, suggesting that this 
phage specifically infects certain strains of Salmonella (Table 3.1). To 
determine the host receptor for SPN9CC phage, previously constructed 
mutants of S. Typhimurium SL1344 were used, including ΔflgK (encoding 
flagellar hook-associated protein), ΔbtuB (encoding a vitamin B12-uptake 
protein), and ΔrfaL (encoding O-antigen ligase) (31, 50, 63). Only the ΔrfaL 
mutant displayed resistance to SPN9CC phage, suggesting that the O-
antigen of LPS is a host receptor for phage infection. Subsequent 
complementation of this mutant with the pUHE21-lacI
q 
::rfaL expression 
vector (50) confirmed O-antigen as a receptor of SPN9CC (Table 3.1). 
 
III-3-3. Bacteriophage genome analysis 
 The complete genome sequencing of SPN9CC was performed with 
approximately 90 times coverage using the next-generation sequencing 
(NGS) technology with a 454 pyrosequencer, revealing 40,128-bp with a 
GC content of 47.33%, 63 putative ORFs, and 2 tRNAs (tRNA_Thr and 
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tRNA_Asn) (Fig. 3.2). The comparative codon usage preference analysis of 
tRNA_Thr between S. Typhimurium SL1344 host and SPN9CC phage 
indicated a different preference in threonine, suggesting that this tRNA may 
play a role in the translation of phage mRNA, and not of the host mRNA. In 
addition, gene density was observed to be 1.545 genes per kb, and the 
coding percentage was 90.9%. The average length of each ORF was 
determined to be 588-bp. Comparative phylogenetic analysis using major 
capsid proteins from various phages revealed that SPN9CC phage is closely 
related to Salmonella-targeting P22-like phages, such as P22, ST64T, ST104, 
and ε34 (Fig. 3.3). 
 Annotation and functional analysis of ORFs in this genome 
revealed that 44 of 63 ORFs have putative functions. Functional 
categorization of these genes revealed 14 groups, such as LPS modification 
and superinfection exclusion (O-antigen conversion proteins, GtrABC and 
superinfection exclusion protein B), integration (phage integrase), P22 ea 
genes (Eaa and Eai), recombination (Erf recombination protein, Abc1 and 
Abc2 anti-RecBCD proteins), antitermination (antitermination protein N 
and Q), lysogeny control (Cro, CI, and CII), replication (DNA replication 
protein and helicase), nin genes (NinABEFHXZ), host cell lysis (holin, 
endolysin, and Rz/Rz1 endopeptidases), DNA packaging (terminase large 
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and small subunits), head (portal protein, scaffolding protein, and major 
capsid protein), tail (DNA stabilization proteins/tail accessory proteins (Gp4, 
Gp10, and Gp26), head assembly protein, and DNA transfer 
proteins/ejection proteins)), Ant moron (Mnt regulatory protein), and host 
specificity (tailspike protein). 
 The roles of LPS modification proteins (GtrABC) and 
superinfection exclusion protein B are the prevention of other phage 
infections after lysogen formation via modification of its host O-antigen of 
LPS (6, 67). Among the recombination proteins, Abc1 and Abc2 anti-
RecBCD proteins are involved in phage recombination and protect both 
ends of linear phage genome from host RecBCD exonuclease, and Erf 
recombination protein circularizes this linear genome by ligation of both 
ends of the phage genome (54). Lysogeny control and antitermination 
determine the phage lytic/lysogenic cycles depending on the host status. 
Replication proteins are produced during early gene expression, and they are 
responsible for phage genome replication. However, the functions of ea 
genes and nin genes are unknown (15). Host cell lysis proteins such as holin, 
endolysin, and Rz/Rz1-like proteins are suggested to cooperate in bursting 
the host cell after replication and reconstruction of the phage (34). Holin 
creates pinholes in the host inner membrane and subsequent secretion of 
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endolysin via these pinholes results in the host cell lysis. Although the 
regions of ant moron have been found in P22-like phages, these regions are 
highly variable among them (72), and the function of ant moron is not 
clearly understood. SPN9CC phage also has only one gene in this region, a 
mnt gene encoding repressor protein, which is very similar to ST104 and 
ST64T phages. This Mnt repressor was suggested to control the expression 
of ant gene encoding an anti-repressor (71). As with other P22-like phage of 
Podoviridae members, SPN9CC phage has only a tailspike protein without a 
tail fiber protein. This tailspike protein is homologous to other tailspike 

















Figure 3.2. Genome map of SPN9CC phage. (A) Functions of gene 
clusters (B) Predicted ORFs by strand. The colors indicate the function of 
each gene cluster. Black-colored ORFs encode hypothetical proteins. (C) 
Comparative ORF analysis of SPN9CC phage with P22 phage at the amino 
acid sequence level. ORF homology between SPN9CC and P22 phages 
indicates different darkness of each block (See the figure legend). (D) 
Comparative genomic analysis of SPN9CC phage with P22 phage at the 
DNA sequence level. (E) tRNA prediction is indicated by blue arrows. (F) 









Figure 3.3. Comparative phylogenetic analysis of major capsid proteins 
(MCPs) from various bacteriophages. The MCPs were compared with 
ClustalW multiple alignment algorithm, and the phylogenetic tree was 





III-3-4. Comparative genomic analysis of SPN9CC with P22-like phages 
 Comparative genomic analysis of SPN9CC phage with P22-like 
phages such as P22 and ε34 revealed that DNA packaging and 
morphogenesis (heads and tails) gene clusters are highly conserved, 
indicating that P22-like phages commonly share phage structure genes and 
belong to Podoviridae family (Fig. 3.4A). Recent comparative genomic 
study of P22-like phages supports our analysis result (10). However, the 
tailspike protein of ε34 differs enough from those of P22 and SPN9CC 
phages that it most likely has different host specificity (Fig. 3.4A). While 
host range analysis of P22 and SPN9CC phages displayed the same 
inhibition spectrum, the specific infection of ε34 phage to S. Anatum 
substantiates this (68). The lysogeny control region (Cro, CI, and CII) of 
SPN9CC phage differs from P22 phage but similar to ε34 phage, suggesting 
that SPN9CC and ε34 may share lytic/lysogenic decision and lysogen 
formation mechanisms (Fig. 3.4B). Comparative analysis of the host lysis 
gene clusters in SPN9CC, P22, and ε34 phages revealed that they are not 
conserved among them, suggesting that they most likely lyse the host strains 
in different manners (Fig. 3.4C). Although the functions of genes in this 
gene cluster of P22 phage were experimentally confirmed (8, 32, 47), the 
function of each gene in the host lysis gene cluster of SPN9CC phage 
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cannot be deduced from those in the gene cluster of P22 phage due to low 
amino acid sequence identities of these genes between P22 and SPN9CC 
phages. To understand the host cell lysis mechanism of SPN9CC phage, the 
function of each gene in the host cell lysis gene cluster of SPN9CC phage 
should be confirmed experimentally. Interestingly, the genes in this gene 
cluster of SPN9CC phage are similar to those of ST104 and even E. coli K-
12 prophage DLP12, suggesting that they may share the same mechanism 
for host cell lysis (Fig. 3.4D). Successful cell lysis results from S. Typhi 
using endolysin from E. coli phage DLP12 supports this (65). However, 
whereas the amino acid sequence identities of host lysis proteins, such as 
holin, endolysin, and Rz/Rz1-like proteins, between two host lysis gene 
clusters in SPN9CC and ST104 phages are extremely high, the gene 
functions in the gene cluster of ST104 are not experimentally confirmed. 
Therefore, the expression of these genes in S. Typhimurium and E. coli host 
strains needs to be examined to elucidate the function of each gene in the 
host cell lysis gene cluster of SPN9CC phage and their cooperation effect 




























Figure 3.4. Comparative genomic analysis of P22-like phages (SPN9CC, 
P22, ST104, and ε34) and E. coli K-12 prophage DLP12. (A) 
Comparative analysis of complete genome sequences of SPN9CC, P22, and 
ε34 using BLASTN and ACT12. Various colors were used to indicate each 
function of gene clusters in genomes. Comparative analyses of lysogeny 
control regions (B) and host cell lysis gene clusters (C) in SPN9CC, P22, 
and ε34. (D) Comparative analysis of host cell lysis gene clusters in 
SPN9CC, ST104, and E. coli K-12 prophage DLP12. The identities of 




III-3-5. Function of host cell lysis gene cluster 
 Interestingly, high amino acid sequence identity of host lysis 
proteins (except for holin) encoded in the host cell lysis gene clusters of S. 
Typhimurium-targeting SPN9CC phage and E. coli K-12 DLP12 prophage 
suggests that host cell lysis proteins encoded by the genes in this cluster of 
SPN9CC phage should function in both Salmonella and E. coli. To elucidate 
the host cell lysis mechanism of this phage, each gene in this cluster was 
cloned in pBAD18 and transformed into S. Typhimurium and E. coli hosts, 
respectively. 
 The expression of a single gene encoding holin (SPN9CC_0042) in 
S. Typhimurium resulted in host cell lysis (Fig. 3.5A). However, the 
expression of a single gene encoding endolysin (SPN9CC_0043) or 
encoding Rz/Rz1-like proteins (SPN9CC_0044) in S. Typhimurium did not, 
suggesting that the endolysin needs holin for crossing the cytoplasmic 
membrane. To elucidate their cooperation effects for host cell lysis of S. 
Typhimurium, various combinations for the expression of more than two 
genes were prepared, and those genes are co-expressed in S. Typhimurium. 
The gene expression combinations of holin and endolysin or all four cell 
lysis proteins (holin + endolysin or holin + endolysin + Rz/Rz1-like proteins) 
in S. Typhimurium resulted in much higher host cell lysis efficiency than 
152 
expression of holin gene alone (Fig. 3.5A). However, gene expression 
combinations without holin (endolysin + Rz/Rz1-like proteins) did not lyse 
the host cells, suggesting that holin is a key protein for lysis of S. 
Typhimurium (Fig. 3.5A). 
 However, the expression of these genes in E. coli host displayed 
different host cell lysis patterns (Fig. 3.5B). As for the S. Typhimurium host, 
endolysin alone did not contribute to cell lysis of E. coli host, but the co-
expression of endolysin and other proteins (endolysin + holin or endolysin + 
Rz/Rz1-like proteins) in E. coli host did result in host cell lysis, suggesting 
that endolysin may need support for crossing the E. coli cytoplasmic 
membrane and that either holin or Rz/Rz1-like proteins could help 
endolysin to cross the membrane (Fig. 3.5B). It is intriguing to note that the 
main difference of host cell lysis patterns between E. coli and Salmonella by 
the SPN9CC lysis gene cluster is the role of Rz/Rz1-like proteins, which 

















Figure 3.5. Confirmation of host lysis system of SPN9CC phage via 
expression of host lysis genes encoding holin, endolysin, and Rz/Rz1 in S. 
Typhimurium SL1344 (A) and E. coli MG1655 (B). The black, red, blue, 
and green colors indicate negative control without gene expression, single 
gene expression, co-expression of two genes, and the co-expression of all of 
the genes in this cluster, respectively. The red circle, red triangle, and red 
square indicate the gene expressions of SPN9CC_0042 (holin), 
SPN9CC_0043 (endolysin), and SPN9CC_0044/0044.1 (Rz/Rz1), 
respectively. The blue circle and blue triangle indicate co-expression of 
SPN9CC_0042/0043 and SPN9CC_0043/0044/0044.1, respectively. Green 





III-3-6. Conversion of phenotypes in SPN9CC phage by deletion of cI 
gene 
 CI, CII, and Cro, are key proteins in the lysogeny control region (27, 
55, 74). Among them, CI is a repressor for termination of gene expression in 
the phage genome. Therefore, mutation of the cI gene can inhibit lysogen 
formation. The effects of cI gene deletion on the life cycle of SPN9CC 
phage was studied by constructing the ΔcI mutant phage with the BRED 
method (42). Interestingly, whereas SPN9CC phage generates distinct clear 
plaques with cloudy centers as lysogens, the ΔcI mutant phage SPN9CCM 
does not produce cloudy centers in the plaques, suggesting that the 
phenotype of ΔcI mutant phage may be converted from temperate to virulent 
(Fig. 3.1C). To further understand the plaque morphology change by cI 
deletion, one-step growth analysis and bacterial challenge assay of SPN9CC 
and SPN9CCM phages were compared. The one-step growth analysis 
revealed that while SPN9CC phage has relatively long eclipse/latent periods 
and a small burst size, SPN9CCM phage has much shorter eclipse/latent 
periods and larger burst sizes (Fig. 3.6). The eclipse/latent periods of 
SPN9CC and SPN9CCM were 15/30 min and 10/20 min, respectively. The 
burst sizes of SPN9CC and SPN9CCM phages were 220 and 280 PFU per 
cell, respectively, suggesting that the efficiency of phage multiplication was 
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increased for SPN9CCM most likely due to an inability to form lysogens. 
Furthermore, bacterial challenge assays of SPN9CC and SPN9CCM phages 
with S. Typhimurium SL1344 demonstrated that the inhibition activity of 

















Figure 3.6. One-step growth curve analysis of SPN9CC (A) and 
SPN9CCM (B) phages. The circle indicates chloroform-untreated samples, 
and the triangle indicates chloroform-treated samples. The error bars 
indicate the standard deviation in triplicate experiments. E, eclipse period; L, 











Figure 3.7. Bacterial challenge assay of SPN9CC and SPN9CCM 
phages against S. Typhimurium LT2C. The circle indicates phage-
untreated samples, and the triangle indicates SPN9CC-treated samples, and 
a rectangle with dotted line indicates SPN9CCM-treated sample. 
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III-3-7. Bacterial challenge test of SPN9CC phage 
 GGrowth curve analysis and subsequent viable cell counting of 
SPN9CC-sensitive S. Typhimurium SL1344 after infection of SPN9CC 
were performed to determine the bacteriophage-insensitive mutants (BIMs). 
Thirty minutes after phage infection with different MOIs (namely, 1, 10, and 
100), viable cell numbers were reduced by 0.81 log(CFU/ml) average, and 
they were recovered in an additional 3 h incubation, suggesting the 
generation of BIMs (Fig. 3.8). In addition, the BIM frequencies of S. 





, and 5.62 × 10
-1
, respectively. These very low viable cell 
reduction and high BIM frequencies may be due to the formation of lysogen 
during phage infection. Subsequent induction of infected S. Typhimurium 
cells 30 min after infection supports this conclusion (data not shown). In 
addition, the viable cell reduction at MOI = 10 was maximum at 30 min 
after phage infection and not at MOI = 100, suggesting that high MOI 
promotes lysogen formation, resulting in higher cell viability against phage 
infection (33, 45) (Fig. 3.8). Based on this result, the presence of highly 
concentrated phages in the center of SPN9CC phage plaques may promote 
lysogen formation, resulting in the formation of unusual clear plaques with 










Figure 3.8. Bacterial challenge test of SPN9CC phage with S. 
Typhimurium LT2C. The circle, square, triangle, and diamond indicate an 
SPN9CC-uninfected sample (dotted line) and SPN9CC-infected samples 
with MOI = 1, 10, and 100, respectively. The error bars indicate the standard 





 Salmonellosis is one of the most common types of food poisoning 
caused by foodborne pathogens all over the world. To reduce this food 
poisoning, the bacteriophage approach has recently been appearing more 
attractive than antibiotics treatment due to the emergence of multidrug-
resistant Salmonella strains (12, 53). To maximize the efficiency of this 
phage approach, further understanding of phage infection and host lysis 
mechanisms is required (31, 37). P22 phage has been studied in the context 
of the development of a molecular transduction tool (6, 67), the 
identification of host specificity and receptor (4, 69), the tail structure for 
host interaction (14, 38), the lysogeny control region (39, 56), 
superinfection exclusion (28, 57), and other areas. The P22-like phage group 
was previously proposed based on the homology of virion assembly genes, 
which includes ST104, ε34, ST64T, L, Sf6, c341, and HK620, among others. 
(10). Recent improvement of genome sequencing and analysis technologies, 
such as next-generation sequencing and bioinformatic tools, enabled us to 
analyze the full genome sequences of these P22-like phages and to study 
their characteristics in genomic level. Recent comparative genomic analysis 
revealed that while their genomic characteristics are diverse, most likely due 
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to horizontal gene transfer/exchange in the group, morphogenesis and DNA 
packaging are highly conserved (10, 72). However, the diversity of other 
genomic features may determine the specific characteristics of each phage in 
the group, such as host specificity, lysogeny control region, and host cell 
lysis system, involved in the host infection and lysis mechanisms.  
 The Salmonella-targeting temperate phage SPN9CC was isolated 
from a commercially processed broiler skin sample, and its complete 
genome analysis suggests that SPN9CC phage is in the P22-like phage 
group. One-step growth analysis of SPN9CC phage revealed a longer latent 
period and smaller burst size than other lytic phages, such as T7-like 
Podoviridae phages (Fig. 3.6A) (36, 49, 70), suggesting that lysogen 
formation during phage infection may affect the host cell lysis activity of 
SPN9CC phage. A high frequency of observed bacteriophage-insensitive 
mutants (BIMs) of this phage during bacterial challenge test also supports 
this (Fig. 3.8). It is well known that the host receptor is modified once the 
host is lysogenized phage (6, 59, 72). SPN9CC has LPS modification 
proteins homologous to the GtrABC (SPN9CC_003, 002, and 001, 
respectively), which modify LPS to prevent super-infection of SPN9CC 
lysogen. Furthermore, the resistance activity of the host lysogen caused by 
LPS modification during lysogenization may contribute to forming cloudy 
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centers in SPN9CC plaques (Fig. 3.1A). In the center of the plaques, high 
phage concentration may promote lysogenization of SPN9CC phage, similar 
to the P22 phage (33, 45) (Fig. 3.1A).  
 Complete genome sequence and comparative genomic analyses of 
SPN9CC phage with other P22-like phages revealed a diversity of phage 
infection and host lysis mechanisms in the group (Fig. 3.2 and 3.4A). P22-
like phages are in the family Podoviridae and have short tails, indicating 
that the tailspike protein is a major determinant for host specificity in P22-
like phages (23, 66, 69). However, the tailspike protein is variable in the 
group, suggesting that host specificity and host range for P22-like phage 
infection could be variable. Whereas P22, ST104, ST64T phages with 
homologous tailspike proteins infect S. Typhimurium, ε34 and Sf6 phages 
with different types of tailspike proteins infect S. Anatum and even Shigella, 
respectively, supporting the notion of a variable host range and specificity 
(10, 40, 68). Comparative analysis of the lysogeny control regions in P22-
like phages indicated that the region in SPN9CC is nearly identical to that of 
ε34 phage but quite different from that of P22 phage, suggesting that 
members of P22-like phages may have diverse lytic/lysogenic decision 
mechanisms (Fig. 3.4B).  
 The characterization of the host cell lysis gene cluster of SPN9CC 
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is important to understanding the host cell lysis mechanism of SPN9CC. 
The host cell lysis gene cluster encodes putative holin, endolysin, and 
Rz/Rz1-like proteins. This gene cluster of SPN9CC phage is quite different 
from those of P22 and ε34 phages but very similar to those of ST104 and 
even E. coli K-12 DLP12 prophage, suggesting the possibility of E. coli cell 
lysis via the activity of lysis proteins that are encoded in the gene cluster of 
SPN9CC phage. The expression of these genes individually or expression of 
their combinations in S. Typhimurium or E. coli hosts revealed that holin is 
a key protein for both host cell lysis, but endolysin could not achieve lysis 
by itself (Fig. 3.5A and 3.5B). These results indicate that endolysin of 
SPN9CC requires holin to cross the cytoplasmic membrane to act on the 
peptidoglycan in the periplasm. Rz/Rz1-like proteins are known accessory 
proteins of endolysin (34), and Rz/Rz1-like proteins alone or in combination 
with endolysin in S. Typhimurium did not exhibit cell lysis activity. 
Interestingly, Rz/Rz1-like proteins alone and even their combination with 
endolysin resulted in growth inhibition of E. coli even though the degree of 
inhibition was relatively low. However, the lysis activity of Rz/Rz1-like 
proteins in E. coli host is not fully understood. Comparative functional 
analysis of this host cell lysis gene cluster between S. Typhimurium and E. 
coli revealed that this lysis protein combination works better in E. coli than 
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in S. Typhimurium (Fig. 3.5A and 3.5B).  
 In this study, comparative analysis of SPN9CC phage with P22-like 
phages provided novel insights into phage infection and host lysis 
mechanisms with S. Typhimurium host strains. This study probably 
contributes to a better understanding of the new approach for bacteriophage 
treatment to inhibit foodborne pathogens as well as to the development of 
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 Since the discovery of bacteriophages in 1915 (65), bacteriophages 
have been known to be viruses of prokaryotes, which invade specific 
bacterial hosts, replicate using the host DNA replication and protein 
biosynthesis systems, and lyse the hosts for propagation (34, 60, 63). The 
lifestyles of bacteriophages include a lysogenic cycle (for phage genome 
integration into the host chromosome) and a lytic cycle (for lysis the 
bacterial host because of bactericidal activity) (25, 34, 63). Bacteriophages 
occur everywhere in the biosphere and are frequently found in the ocean and 
soil. The total biomass of phages and number of phage species in nature 
have been estimated at over 10
30
 particles and more than 10
6
 species, 
respectively (10, 48). Bacteriophages are classified by the International 
Committee on Taxonomy of Viruses (ICTV) according to phage 
morphology and nucleic acid type (26). Approximately 96% of all 
bacteriophages belong to the order Caudovirales and the remaining belong 
to the order Ligamenvirales and an unassigned order including Tectiviridae 
family (2). The bacteriophages in the order Caudovirales belong to three 
different families including Myoviridae with a contractile tail, Siphoviriade 
with a non-contractile tail, and Podoviridae with a short and non-contractile 
176 
tail (26, 34). 
 The Bacillus cereus group consists of B. cereus, B. anthracis, B. 
thuringiensis, B. mycoides, B. pseudomycoides, and B. weihenstephanensis 
(28, 69). Among them, B. cereus, B. anthracis, and B. thuringiensis have 
been suggested to be a single species of B. cereus sensu lato (14, 24). This 
classified species is a pathogen that infects humans, animals, and even 
insects. B. cereus is a well-known, food-borne pathogen, which produces 
enterotoxins that causes diarrhea, vomiting, and nausea (9, 21). In addition, 
B. anthracis is a category A bio-threat agent, causing the fatal anthrax in 
humans and animals (22). In 2001, its endospore was used as a biological 
weapon, resulting in a mortality rate higher than 45% in those exposed (7). 
To generally control bacterial pathogens, various antibiotics have been 
widely used. However, B. cereus is generally insusceptible to penicillin-
related antibiotics (because of its production of β-lactamase) and to 
additional antibiotics, such as erythromycin and tetracycline (31, 50). In 
addition, long-term antibiotic treatment with various antibiotics against B. 
anthracis resulted in its rapid development of antibiotic resistance (5). 
Therefore, because of the emergence of antibiotic resistant strains, 
alternative biocontrol approaches against these pathogens are needed. 
Employing bacteriophages to infect B. cereus or B. anthracis could be a 
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good candidate to control these pathogens. An additional member of the 
Bacillus cereus group, B. thuringiensis (Bt), is highly characterized and used 
as a biological pesticide for the biocontrol of insect pests. It produces 
insecticidal crystal proteins (ICPs), which are highly toxic to the pest larvae 
but not to humans and animals (4, 51). Whereas Bt has been widely used for 
insect pest control, bacteriophage contamination causes damage to Bt 
production via fermentation. To overcome this problem, bacteriophages 
infecting B. thuringiensis should be studied to understand their infection 
mechanism and their lytic/lysogenic determination mechanism. 
 Resulting from the recent developments in genome sequencing and 
bioinformatic technologies, bacteriophage studies at the genomic level have 
been booming, allowing for further applications in novel biocontrol agents 
and phage therapy. In this review, we describe the general features of the B. 
cereus group phages and genomic insights resulting from comparative and 
functional genomic analyses. This genomic information is useful for 
extending our understanding of their general genomic characteristics and 




IV-2. Results and Discussion 
 
IV-2-1. The general genomic features and classification of B. cereus 
group bacteriophages using comparative genomics 
 
 To date, 30 complete genome sequences of B. cereus group 
bacteriophages (18 for B. cereus phages, four for B. anthracis, and eight for 
B. thringiensis) are available in the GenBank database. The general features 
of all 30 complete genome sequences are listed in Table 4.1. Three different 
morphological families are present in all 30 B. cereus group bacteriophages 
such as Myoviridae, Siphoviridae (belonging to the order Caudovirales), 
and Tectiviridae (belonging to the unassigned order) families. Interestingly, 
the phage genome size may be related to the family morphology of the B. 
cereus group bacteriophages. The ranges of phage genome sizes in the 
family Myoviridae, Siphoviridae, and Tectiviridae are 94 to 219-kb, 36 to 
53-kb, and 14.3 to 14.9-kb, respectively (Table 4.1). Furthermore, the phage 
life cycle may also be related to the family morphology of the B. cereus 
group bacteriophages. Whereas all Myoviridae family bacteriophages are 
virulent, Siphoviridae and Tectiviridae family bacteriophages are temperate, 
supporting this hypothesis. Therefore, a close relationship may exist 
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between the family morphology, genome size, and life cycle of the B. cereus 
group phages. Based on these results, there may be three potential phage 
groups in the 30 B. cereus group bacteriophages. To further classify these 30 
different B. cereus group bacteriophages, the comparative phylogenetic 
analyses using the phage major capsid proteins (MCPs) and phage terminase 
large subunits were conducted and revealed that there are three evolutionary 
groups, phage group I, II and III (Fig. 4.1A and 1B). A subsequent 
comparative dot plot analysis of all 30 bacteriophage genomes at the DNA 
level also showed that the phage genomes in each phage group are similar, 
consistent with the phage classification (Fig. 4.2). Recently, Lavigne et al. 
suggested that the Myoviridae family is divided into the three subfamilies 
Peduovirinae, Teequatrovirinae, and Spounavirinae (36). Based on the 
phylogenetic tree in the report, phage group I in the Myoviridae family 
belongs to the subfamily Spounavirinae. This Spounavirinae subfamily was 
also suggested to have two genera such as Spo1-like virus and Twort-like 
virus. However, the phage group I does not belong to these two genera but 
most likely belongs to another new genus, suggesting that this 
Spounavirinae subfamily may be more diverse (17). 
 Although 30 complete genome sequences of the B. cereus group 
bacteriophages are available, 34.9 to 93.5% of the annotated open reading 
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frames (ORFs) are putatively annotated as hypothetical proteins, most likely 
because of insufficient phage gene annotation data in the sequence databases 
(Table 4.1). Therefore, a genomic study of B. cereus group bacteriophages is 
required to extend our understanding to allow further applications in the 






Table 4.1. General genomic features of the B. cereus group bacteriophages 










Morphology Life style Accession 
number 
Group Reference 
B4 B. cereus 162,596 37.71 277 228 (82.3) 90.6 0 Myoviridae Virulent NC_018863 I (37) 
B5S B. cereus 162,598 37.71 272 230 (84.6) 90.5 0 Myoviridae Virulent JN797796 I This study 
Bastille B. cereus 153,962 38.14 273 231 (84.6) 92.6 7 Myoviridae Virulent NC_018856 I (42) 
W.Ph. B. cereus 156,897 36.45 274 250 (91.2) 92.4 0 Myoviridae N/D NC_016563 I - 
BPS10C B. cereus 159,590 38.74 271 232 (85.6) 91.6 0 Myoviridae Virulent JN654439 I (in review) 
BPS13 B. cereus 158,305 38.75 268 231 (86.2) 89.4 0 Myoviridae Virulent NC_018857 I (in review) 
vB_BceM_Bc431v3 B. cereus 158,621 39.98 238 165 (69.3) 90.6 21 Myoviridae Virulent JX094431 I (17) 
BCP78 B. cereus 156,176 39.86 227 181 (79.7) 90.0 18 Myoviridae Virulent NC_018860 I (38) 
BCU4 B. cereus 154,371 39.86 223 171 (76.7) 89.9 19 Myoviridae Virulent JN797798 I This study 
             
BMBtp2 B. thuringiensis 36,932 37.79 53 39 (73.6) 86.9 0 Siphoviridae Temperate NC_019912  (16) 
TP21-L B. cereus 37,456 37.8 56 N/D 89.3 0 Siphoviridae N/D NC_011645  (42) 
             
IEBH B. cereus 53,104 36.42 86 60 (69.8) 85.8 0 Siphoviridae Temperate NC_011167  (56) 
phBC6A51 B. cereus 61,395 37.69 75 56 (74.7) 83.0 0 N/D N/D NC_004820  (27) 
BCD7 B. cereus 93,839 38.04 140 107 (76.4) 90.2 0 Myoviridae Virulent NC_019515  This study 
PBC1 B. cereus 41,164 41.68 50 29 (58.0) 92.0 0 Siphoviridae Virulent NC_017976  (32) 
             
BceA1 B. cereus 42,932 35.66 63 22 (34.9) 88.1 0 Siphoviridae Temperate HE614282  (62) 






Table 4.1. General genomic features of the B. cereus group bacteriophages (continued) 










Morphology Life style Accession 
number 
Group Reference 
AP50 B. anthracis 14,398 38.65 31 14 (45.2) 96.2 0 Tectiviridae Temperate NC_011523 III (58) 
GIL16c B. thuringiensis 14,844 40.07 31 26 (83.9) 98.8 0 Tectiviridae Virulentb NC_006945 III (67) 
Bam35c B. thuringiensis 14,935 39.72 32 30 (93.8) 99.7 0 Tectiviridae Virulentc NC_005258 III (59) 
GIL01 B. thuringiensis 14,931 39.73 30 24(80.0) 96.7 0 Tectiviridae Temperate AJ536073 III (68) 
             
0305phi8-36 B. thuringiensis 218,948 41.8 246 142 (57.7) 95 0 Myoviridae Virulent NC_009760  (64) 
phBC6A52 B. cereus 38,472 34.72 49 31 (63.3) 80.4 0 N/D N/D NC_004821  (27) 
11143 B. cereus 39,077 34.96 49 23 (46.9) 85.3 0 Siphoviridae Temperate GU233956  (40) 
             
BtCS33 B. thuringiensis 41,992 35.22 57 29 (50.9) 85.1 0 Siphoviridae Temperate NC_018085 II (70) 
phIS3501 B. thuringiensis 44,401 34.86 53 25 (47.2) 75.7 1 Siphoviridae Temperate NC_019502 II (44) 
Cherry B. anthracis 36,615 35.26 51 29 (56.9) 91.5 0 Siphoviridae Virulentd NC_007457 II (19) 
Fah B. anthracis 37,974 34.94 50 18 (36.0) 89.6 0 Siphoviridae Virulentd NC_007814 II (43) 
Gamma B. anthracis 37,253 35.22 53 30 (56.6) 90.7 0 Siphoviridae Virulentd NC_007458 II (19, 53) 
Wbeta B. cereus 40,867 35.26 53 27 (50.9) 90.2 0 Siphoviridae Temperate NC_007734 II (53) 
























Figure 4.1. A comparative phylogenetic analysis of major capsid 
proteins (A) and terminase large subunits (B) using MEGA5 (33) and 





















Figure 4.2. A comparative dot plot analysis of all 30 bacteriophage 
genomes using the JDotter program (11) with a maximum plot size for 
700. 1, B4; 2, B5S; 3, Bastille; 4, BPS10C; 5, BPS13; 6, W.Ph.; 7, 
vB_BceM_Bc431v3; 8, BCP78; 9, BCU4; 10, BceA1; 11, MZTP02; 12, 
BtCS33; 13, phIS3501; 14, Cherry; 15, WBeta; 16, Fah; 17, Gamma; 18, 
0305phi8-36; 19, IEBH; 20, BMBtp2; 21, TP21-L; 22, PBC1; 23, 
phBC6A52; 24, BCD7; 25, phBC6A51; 26, 11143; 27, AP50; 28, GIL16c; 




IV-2-2. B. cereus sensu lato phage group I 
 
 According to the phage classification, the B. cereus sensu lato 
phage group I includes all Myoviridae family bacteriophages except for 
BCD7 and 0305phi8-36. Whereas these two distinct bacteriophages belong 
to the Myoviridae family, their genome sizes are different from the phages in 
group I. However, all phages in the Myoviridae family are virulent and 
predominantly infect B. cereus. A comparative genomic analysis of the 
phages in group I showed that functional gene clusters are located in 
identical positions, such as packaging, host lysis, DNA manipulation, phage 
structure, and additional functions, suggesting that genome arrangements in 
phage group I are identical (Fig. 4.3). In addition, a dot plot analysis also 
supports this similarity in the genome arrangements (Fig. 4.2). To further 
understand their functional characteristics, predicted functional genes were 
categorized into seven functional groups such as packaging, host lysis, 
regulation, host interaction, DNA manipulation, phage structure, and 
additional functions (Table 4.2). All predicted functional genes are shared by 
all bacteriophages in phage group I, except for the genes encoding a 
thioredoxin, flavodoxin, and a transcriptional regulator in the phage Bastille 
(Table 4.2). In addition, the putative ribose-phosphate pyrophosphokinase 
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Table 4.2. Core gene analysis in the bacteriophage group I 
Functional group Predicted function W.Ph. BPS10C/BPS13 Bastille B4/B5S Bc431v3 BCP78/BCU4 
Packaging terminase large subunit P P P P P P 
 portal protein P P P P P P 
Lysis endolysin* I I II II III VI 
 putative holin P P P P P P 
Regulation DNA-binding protein P P P P P P 
 transcriptional regulator 1 P P P P P P 
 transcriptional regulator 2 P P - P P P 
Host interaction sporulation sigma factor SigF-like protein P P P P P P 
 putative RNA polymerase sigma factor P P P P P P 
DNA manipulation DNA polymerase 1 P P P P P P 
 DNA recombination/repair protein P P P P P P 
 DNA polymerase 2 P P P P P P 
 DNA primase P P P P P P 
 exonuclease P P P P P P 
 helicase 1 P P P P P P 
 helicase 2 P P P P P P 
*, B. cereus bacteriophage Group I have different type of endolysins. 
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Table 4.2. Core gene analysis in the bacteriophage group I (continued) 
Functional group Predicted function W.Ph. BPS10C/BPS13 Bastille B4/B5S Bc431v3 BCP78/BCU4 
Structure adsorption associated tail protein/ tail fiber P P P P P P 
 baseplate J protein P P P P P P 
 baseplate protein P P P P P P 
 minor structural protein P P P P P P 
 minor structural protein/ putative tail fiber P P P P P P 
 tail lysin 1 P P P P P P 
 tail lysin 2 P P P P P P 
 tail sheath protein P P P P P P 
 major capsid protein P P P P P P 
 prohead protease P P P P P P 
Additional function 3D domain-containing protein P P P P P P 
 thymidylate synthase P P P P P P 
 dephospho-CoA kinase P P P P P P 
 dihydrofolate reductase P P P P P P 
 metal-dependent hydrolase P P P P P P 
 thioredoxin P P - P P P 
 flavodoxin P P - P P P 
 putative ribose-phosphate pyrophosphokinase - P P P P P 
 ribonucleotide-diphosphate reductase subunit 
beta 
P P P P P P 
 ribonucleotide-diphosphate reductase subunit 
alpha 
P P P P P P 
 deoxyuridine 5'-triphosphate 
nucleotidohydrolase 







Figure 4.3. A comparative genomic analysis of phages in the B. cereus 
sensu lato phage group I using Easyfig program (61) at the DNA level. 
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 A comparative protein domain analysis of endolysins in the phage 
group I showed that four different homologous endolysin groups are present: 
endolysin group I containing N-acetylmuramoyl-L-alamine amidase and 
SH3-like domain (phages W.Ph., BPS10C, and BPS13), endolysin group II 
containing cell wall hydrolysis/autolysin and SH3-like domain (phages 
Bc431v3, BCP78, and BCU4), endolysin group III containing peptidase 
M15B/M15C and SH3-like domain (phages B4 and B5S), and endolysin 
group IV containing glycoside hydrolase family 25 and N-acetylmuramoyl-
L-alanine amidase (phage Bastille) (Fig. 4.4). All endolysin groups, except 
for group IV, share the SH3-like domain (PF08460), which has been 
predicted to be a cell wall binding domain. However, the phage Bastille 
maintains a different type of N-acetylmuramoyl-L-alanine amidase 
(PF12123) from other phages in endolysin group I (PF01510). Furthermore, 
the endolysin of the phage Bastille does not have a SH3-like cell wall 
binding domain, indicating that the phage Bastille may have a different type 
of cell wall binding domain in the endolysin. Loessner et al. suggested that 
the C-terminal of endolysin in the phage Bastille has a 77-amino acid repeat 
sequences (located in 211-287 and 288-364 a.a.) and may be involved in cell 
wall binding, such as the SH3-like domain (42). Endolysins in endolysin 
group I have an N-acetylmuramoyl-L-alanine amidase domain, probably 
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involved in cell wall lysis. To characterize this amidase domain (PF01510), 
Park et al. purified the endolysin of the phage BPS13 and tested the cell 
wall lysis mechanism (46). This endolysin cleaves the bond between N-
acetylmuramic acid and L-alanine in the cell wall by its amidase activity. In 
addition, Son et al. purified endolysin of the phage B4 and tested its cell 
wall lysis to characterize peptidase M15B/M15C domain (PF02557), 
revealing that this peptidase domain acts like a L-alanoyl-D-glutamate 
endopeptidase by cutting the peptide bond between L-alanine and D-
glutamate (57). Therefore, these two endolysin domains, N-
acetylmuramoyl-L-alanine amidase and peptidase M15B/M15C, performs 
host cell wall lysis. However, the other two endolysin domains, the cell wall 
hydrolase/autolysin (PF01520) and glycoside hydrolase family 25 
(PF01183), are predicted to perform host cell lysis, but their cell wall lysis 








Figure 4.4. A comparative functional domain analysis of endolysins in 
the B. cereus sensu lato phage group I phages using the InterProScan 
program (72).  
196 
 Two B. cereus phages, BPS10C and BPS13, were characterized and 
compared. The host range analysis for these two phages showed that they 
completely inhibit the growth of B. cereus group strains over 6 h 
(Unpublished, H. Shin, J.-H. Lee, J. Park, and S. Ryu). These two phages 
have a wide range of pH (5 to 8) and temperature (<50°C) stabilities. 
Whereas these two phages showed very similar characteristics, the phage 
BPS13 has higher pH and temperature stabilities than the phage BPS10C. 
As discussed above, the endolysin of the phage BPS13, LysBPS13, belongs 
to the endolysin phage group I. In the presence of glycerol, the lytic activity 
of LysBPS13 is displayed in temperatures up to 100°C, suggesting high 
temperature stability (46). A comparative genome sequence analysis of these 
two phages revealed that they have an endolysin and two copies of tail 
lysins. This gene set encoding an endolysin and two tail lysins is present in 
all nine phage genomes of the B. cereus sensu lato phage group I (Table 4.2). 
Whereas a few endolysins were previously characterized, the characteristics 
of these two tail lysins are still unknown. Therefore, further experiments 
characterizing these tail lysins would extend our understanding about phage 
infection and host lysis mechanisms by the B. cereus sensu lato phage group 
I. The host range of the phage Bc431v3 showed a relatively broad growth 
inhibition spectrum including B. cereus group strains and even B. 
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licheniformis, B. psychrosaccharolyticus, and B. megaterium, but not B. 
subtilis (17). Bc431v3 has a long latent period (85 min) with a high burst 
size (>300 PFU). A comparative genome analysis of the phages BCP78 and 
BCU4 revealed that their genomes are nearly identical (>96% DNA 
sequence identity) (Fig. 4.3). The endolysin group II phages (Bc431v3, 
BCP78, and BCU4) and endolysin group IV (Bastille) have multiple 
numbers of tRNAs in their genomes (Table 4.2). Comparative codon usage 
analysis of B. cereus strains (AH187 and ATCC 14597) and the phage 
BCP78 showed different codon preference in asparagine, phenylalanine, and 
serine, suggesting that extra tRNAs in the phage genome may play a role in 
translation of phage genes, not of host genes (38). Experimental 
characterization and a complete genome sequence analysis of the B. cereus 
phage B4 showed that it has a short eclipse/latent period (10/15 min) and a 
high burst size (>200 PFU) (37). Moreover, a bacterial challenge assay 
showed complete growth inhibition of B. cereus up to 20 h and its endolysin, 
LysB4, also showed efficient host cell lysis in 15 min (57), suggesting that 
the phage B4 could be a good candidate as a novel biocontrol agent against 
B. cereus. Furthermore, a host range analysis of the phage B4 revealed that 
it can inhibit the growth of B. cereus group strains and B. subtilis (Shin et al. 
2013. Arch. Virol.). The B. cereus phage B5S has almost identical genome 
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sequence (>99% DNA sequence identity) with the phage B4. Further 
experimental characterization of the phage B5S also showed it has almost 
identical host cell lysis activity. In addition, characterization of the 
endolysin in the phage Bastille, PlyBa showed the efficient lysis of B. 
cereus and B. thuringiensis (42). 
 The B. cereus sensu lato phage group I contains all virulent phages 
with high host lysis activity against B. cereus. Therefore, the phages in this 
group may be good candidates for various applications as biocontrol agents 
against B. cereus. However, most of the phages (except for the phage 
Bastille) in this group were only recently isolated and their genomic 
annotation information is not sufficient. Further research on the phages in 
this group is needed to increase our understanding and to develop 
applications in the inhibition of the growth of B. cereus.   
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IV-2-3. B. cereus sensu lato phage group II 
 
 According to the phage classification, B. cereus sensu lato phage 
group II includes the phages BtCS33, phIS3501, and Wbeta (Wβ) with 
virulent variants of Cherry, Fah, and Gamma (Wγ) in the Siphoviridae 
family. Their genome sizes (36 to 53-kb) are smaller than those of the B. 
cereus sensu lato phage group I, but larger than those of the B. cereus sensu 
lato phage group III. The phages BtCS33 and phIS3501 were isolated from 
induced strains of B. thuringiensis, and phage Wbeta was isolated from 
induced strains of B. cereus (44, 70). 
 The phage Wbeta and its variants inhibit the growth of B. anthracis 
(Table 4.1). The phages in this group have been widely used for phage 
typing. Furthermore, the phage Wbeta was used to construct a reporter 
phage containing luxAB for rapid detection of B. anthracis within 1 h after 
infection (52). Phage Gamma is a variant of the phage Wbeta and it can 
infect B. cereus W strain with phage Wbeta in the genome as a prophage, 
whereas phage Wbeta cannot re-infect B. cereus W (12, 53). Therefore, 
phage Gamma was obtained from re-infection of phage Wbeta lysate to the 
host strain, B. cereus W. Whereas phage Wbeta cannot infect capsulated B. 
anthracis, phage Gamma infects both encapsulated and non-encapsulated B. 
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anthracis, indicating that phage Gamma can infect a broad range of B. 
anthracis (1). Because of this broad host range, phage Gamma has been 
widely used for identification and indirect detection of B. anthracis (1, 47). 
In addition, phage Gamma has been used to inhibit the growth of B. 
anthracis. Endolysin of the phage Gamma, PlyG was characterized, 
showing that it has two conserved protein domains such as N-terminal T7 
lysozyme-like amidase domain for host cell lysis and C-terminal cell wall 
binding domain (29, 30, 49, 54). Notably, deletion of the binding domain 
abolished the host cell lysis activity of PlyG, suggesting that this binding 
domain may be important for specific host cell lysis by N-terminal catalytic 
domain (30). To further understand this binding domain, several motifs of 
the binding domain were chemically synthesized and their binding activities 
were investigated (49). This study elucidated that the short 10-amino acid 
sequence (LKMTADFILQ) is a key motif for host cell wall binding. This 
short sequence was coupled with Qdot-nanocrystals and used for rapid 
detection of B. anthracis (49). The host receptor study of phage Gamma 
showed that the host receptor of B. anthracis by phage Gamma is a surface-
anchored protein containing a LPXTG motif, designated GamR (15). 
However, the genome sequence of B. cereus ATCC 14579 does not have this 
host receptor protein, GamR, explaining its narrow host specificity (15). 
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Phage Cherry has also been used for typing of B. anthracis but this phage is 
almost identical to phage Gamma in many aspects, such as phenotype, 
morphology and genome sequence (19). In addition, genome sequencing 
and gene expression studies of phage Fah showed the presence of unique 
viral promoters and a unique sigma factor, most likely involved in the host 
transcription event (43). 
 Phage BtCS33 was obtained by the induction of B. thuringiensis 
subsp. kurstaki CS33 (70). This phage efficiently lyses B. thuringiensis 
because of its endolysin, PlyBt33, containing conserved protein domains of 
an N-terminal glycoside hydrolase family 23 and a C-terminal amidase02_C. 
Notably, the C-terminal amindase02_C domain binds to the cell wall of B. 
thuringiensis and B. subtilis (71). Phage phIS3501 was isolated from B. 
thuringiensis var. israelensis ATCC 35646 after induction (44). The 
integration site of this phage is in hlyII, encoding hemolysin II. Therefore, 
this toxic hemolysin II may be activated by the induction of the prophage 
phIS3501. 
 The phages in the B. cereus sensu lato phage group II generally 
infect B. anthracis and B. thuringiensis and they have generally been used 
for typing of these species. The phage Gamma or its endolysin PlyG is a 
good candidate to control B. anthracis, thereby protecting against the fatal 
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anthrax disease. Therefore, these B. anthracis-infecting phages in this group 
should be further studied in the control of the bio-threat posed by B. 
anthracis. In addition, the study of B. thuringiensis-infecting phages would 




IV-2-4. B. cereus sensu lato phage group III 
 
 According to the phage classification, B. cereus sensu lato phage 
group III includes phages AP50, Bam35, GIL16C, and GIL10 in the 
Tectiviridae family. The order including the Tectiviridae family is not yet 
assigned. Phages in this Tectiviridae family have no head-tail structure, but 
instead they possess tail-like tubes and viral membranes consisting of a lipid 
bilayer with inner and outer capsids. Their genome sizes (14.3 to 14.9-kb) 
are the smallest among all B. cereus phages in this report. In 1972, the phage 
AP50 was originally isolated from a soil sample with B. anthracis Sterne as 
a host strain (3, 45). The host range analysis of this phage showed high host 
specificity to B. anthracis, indicating a narrow host range of the phage AP50. 
In addition, whereas phage AP50 makes turbid plaques, the variant AP50c 
showed clear plaques and the CsaB cell surface anchoring protein of B. 
anthracis may be involved in the phage adsorption (8). The phage Bam35 
was initially isolated from B. thuringiensis (3). Notably, this phage has a 
discrete phage entry mechanism. N-acetyl-muramic acid of the host 
membrane is essential for binding of the phage Bam35 to the host, and the 
Bam35 virion has peptidoglycan hydrolysis activity. In addition, the phage 




, for phage 
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penetration (20). The temperate phage GIL01 was isolated from B. 
thuringiensis, and the phage genome was observed to be present in the host 
strain as a linear plasmid form (68). Notably, the induction of the lytic cycle 
in the phage GIL01 was reported to be associated with the host cellular SOS 
response to DNA damage (18). Notably, unlike endolysins of other phages, 
two ORFs encoding Mur1 and Mur2 were expressed, and their functions 
were experimentally confirmed to show peptidoglycan hydrolase activity 
during host lysis (66). In addition, the genome sequence and characteristics 
of the phage GIL16 showed high similarity with the phage GIL01 (67). 
 The phages in the B. cereus sensu lato phage group III infect B. 
anthracis and B. thuringiensis. In this group, the B. anthracis-infecting 
phage AP50 may be useful for B. anthracis typing and biocontrol. For 
example, the application of the endolysin from AP50 may serve as a host 
specific biocontrol. However, B. thuringiensis-infecting phages negatively 
affect the Bt production via fermentation. Therefore, studies of host-phage 
interactions, infection mechanisms, and lytic/lysogenic decision 
mechanisms may be important to provide extended information about the 
characteristics of B. thuringiensis-infecting phages (or prophages), 
ultimately describing a possible technique to prevent phage contamination 
of Bt.  
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IV-2-5. Other B. cereus bacteriophages 
 
 As previously discussed, we categorized the B. cereus group-
infecting phages into three phage groups. We discussed these three groups in 
terms of their general and genomic features. However, several phages are 
not categorized into these groups when using comparative phylogenetic 
analysis (Fig. 4.1). A few phages have their own distinct characteristics, 
such as the B. cereus-infecting phages BCD7 and PBC1 and the B. 
thuringiensis-infecting phage 0305phi8-36. Phage BCD7 has the smallest 
genome whereas phage 0305phi8-36 has the largest genome in the 
Myoviridae family infecting B. cereus group (Table 4.1). Whereas phage 
PBC1 belongs to Siphoviridae family, the other two phages, BCD7 and 
0305phi8-36, belong to the Myoviridae family. The virulent phage PBC1 in 
B. cereus group is the first Siphoviridae phage of which complete genome 
sequence was reported. A genome analysis of phage PBC1 showed the 
absence of lysogeny-related genes, supporting that it is a virulent phage (32). 
The phage BCD7 was isolated from a soybean sample, and displayed a high 
host lysis and growth inhibition activity in broth culture over 20 h 
(Unpublished, H. Shin, J.-H. Lee, and S. Ryu). Its genome has two copies of 
host cell wall hydrolases with a holin. However, a comparative dot plot 
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analysis of the phage BCD7 showed that its genome sequence is not 
homologous to other phage genomes in the B. cereus group-infecting phages 
(Fig. 4.2). In addition, the genome sequence of the phage 0305phi8-36 also 
showed no homology with other phage genomes (23, 64), suggesting that 
phages BCD7 and 0305phi8-36 may have evolved from different ancestors 
from other Myoviridae phages in the B. cereus sensu lato phage group I. The 
different genome sizes of these phages (94-kb for BCD7 and 219-kb for 







 The pathogens B. cereus and B. anthracis and the insect pathogen B. 
thuringiensis are designated as a single species of B. cereus sensu lato (14, 
24). B. cereus is a well-known food-borne pathogen and B. anthracis causes 
anthrax (9, 21, 22) (7). Therefore, control of these pathogens is important in 
the prevention of food poisoning and bio-threats. Antibiotics have been 
widely used to control them. However, penicillin-related antibiotics are 
ineffectual because of the production of β-lactamase (31, 50). Therefore, an 
alternative phage based approach has been suggested for their control. B. 
thuringiensis (Bt) has been widely used as a natural pesticide to kill harmful 
insect pests (4, 51). However, phage contamination negatively affects the Bt 
production via fermentation. Therefore, a Bt phage study is required to 
investigate a process to protect Bt from phage contamination. 
 Bacteriophages are bacterial viruses that specifically invade and kill 
the host bacteria (34, 60, 63). Therefore, phages have been applied to 
control the pathogenic B. cereus and B. anthracis. To control these 
pathogens, generally two approaches have been studied, such as direct 
growth inhibition of these pathogens and host cell lysis using phage 
endolysins. As an example, two B. cereus phages, FWLBc1 and FWLBc2, 
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were isolated from a soil sample and treated with mashed potatoes, resulting 
in a more than 5 log reduction in the cell numbers of B. cereus. This 
suggests that applying phages to foods may be useful in the control of food-
borne pathogens, including B. cereus (39). In addition, the B. cereus phage 
BCP1-1 showed a high host specificity and inhibited only B. cereus, not 
other fermentative bacteria such as B. subtilis in Korean fermented soybean 
food, suggesting selective growth inhibition of only the target bacterium (6). 
In investigating the lysis of the host by phages, several endolysins, such as 
LysB4, LysBPS13, Ply12, Ply21, PlyBa (for B. cereus), and PlyG (for B. 
anthracis), have been characterized (42, 46, 54, 57). Generally, endolysins 
have the two conserved protein domains of a host cell wall binding domain 
(CBD) and an enzymatic activity domain for peptidoglycan lysis (EAD). 
The CBD may provide host specificity, transfer of endolysin, and cell wall 
binding to the specific membrane. The EAD lyses the peptidoglycan in the 
host membrane, but the cleavage site of each endolysin depends on the type 
of EAD domain. To control B. anthracis, PlyG was characterized. This 
endolysin recognizes and cleaves a neutral polysaccharide (NPS) comprised 
of galactose (Gal), N-acetylglucosamine (GlcNAc), and N-
acetylmannosamine (Man-NAc) (13, 55). The application of PlyG (20 U) 
showed the almost sterilization of B. anthracis in 15 min, suggesting that 
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purified endolysin may be useful in the control of pathogens (54). In 
addition to the phage applications, the B. anthracis phages have been used 
for the typing of this pathogen. As an example, the phage Gamma is a 
virulent phage that specifically infects and lyses B. anthracis with >95% 
accuracy (1). In addition, B. anthracis can be detected using real-time PCR 
with the phage Gamma in 5 h with a detection limit of 207 CFU/ml, 
suggesting that the Gamma phage is a good detection tool for B. anthracis 
(47). Furthermore, the phage Wbeta was used to construct the reporter 
phage that contains the luxAB genes. This reporter phage was able to 
produce light in the B. anthracis host in 1 h (52). The detection limit of B. 
anthracis using this reporter phage system was 10
3
 CFU/ml.  
 Because of recent developments in genomic technologies and 
bioinformatics, phage genomics is becoming more popular. Genomics 
provides further information about the physiology, genetics, and host-phage 
infection/interaction mechanisms of the phage. Therefore, 30 complete 
phage genome sequences of the B. cereus group in the families Myoviridae, 
Siphoviridae, and Tectiviridae are currently available (Table 4.1). The 
categorization of the phages into three groups revealed that morphology, 
genome size, and lifestyle may be associated (Table 4.1). Three B. cereus 
phage groups showed different genome size (group I > group II > group III), 
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phage family association (Myoviridae for group I, Siphoviridae for group II, 
and Tectiviridae for group III), and lifestyle (virulent phenotype for group I 
and temperate phenotype for group II and III). Although 30 complete 
genome sequences for phages of the B. cereus group are available in the 
GenBank database, the functions of the proteins encoded by 34.9 to 93.8% 
of the genes in the phage genomes are still unknown (Table 4.1). More than 
69% of the genes in the Myoviridae phage genomes are hypothetical, most 
likely because of insufficient annotation information for their genomes. 
They were recently isolated and their genome sequences were reported. The 
insufficient annotation of the genomes highlighted the shortage of available 
information in the GenBank database (Table 4.1). However, annotation 
information about core genes of the Myoviridae phages, generally involved 
in host infection/interaction and phage replication/reconstruction, is 
available, and the core genes are shared in all phages in group I, suggesting 
that they may have been evolved from a common ancestor (Table 4.2). 
Notably, two phages, BCD7 and 0305phi8-36, belong to the Myoviridae 
family but they are not in phage group I. A comparative phylogenetic and 
comparative dot plot analysis of phage genomes showed that the genome 
sequences of phages BCD7 and 0305phi8-36 are not homologous to those of 
other phages in the phage group I (Fig. 4.1 and 4.2). This finding suggested 
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that their ancestors are different from one another and even different from 
the common ancestor of the phage group I, even though they belong to the 
Myoviridae family and have virulent phenotypes (Table 4.1). The different 
genome sizes of phages BCD7 (94-kb) and 0305phi8-36 (219-kb) support 
this hypothesis (Table 4.1).  
 In this review, we compared B. cereus group phages at the genomic 
level. A comparative genomic analysis of these phages showed that the B. 
cereus group phages can be categorized into three different groups with each 
group maintaining its own set of specific features. Whereas B. anthracis 
phages have been applied in the biocontrol, typing, and rapid detection of B. 
anthracis, the recently isolated and analyzed B. cereus phages were not 
well-suited for the biocontrol of the food-borne pathogen B. cereus. 
Nevertheless, phage group I generally inhibited the growth of B. cereus and 
are all virulent phages. This group of phages may be useful for the efficient 
biocontrol of B. cereus via the infection by the phages or the application of 
the purified endolysins. However, more than 36% of the B. cereus group 
phages are not assigned in this grouping, based on the comparative 
phylogenetic and dot plot analyses. When more phage genome sequences 
are available in the GenBank database, new phage groups could be 
generated from a further comparative phylogenetic analysis, and the phages 
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that are not assigned to a group may belong to these new phage groups. As 
discussed previously, insufficient genome analyses have been conducted for 
the B. cereus group phages. Therefore, further genome sequencing and 
bioinformatic analyses should be performed to overcome the lack of genome 
annotation information, to extend our understanding of these phages, and to 
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IV-5. Appendix :  
Characterization and Genomic Analysis of Bacteriophages 
Targeting Bacillus cereus 
 
IV-5-1. Characterization and Complete Genome Sequence of a Virulent 
Bacteriophage B4 Infecting Food-borne Pathogenic Bacillus cereus 
(Published in Archives of Virology, 2013, in press) 
 
IV-5-1-1. Abstract 
 Bacillus cereus causes food poisoning such as vomiting and 
diarrhea by production of enterotoxins. To control this food-borne pathogen, 
the virulent bacteriophage B4 was isolated and characterized. Bacterial 
challenge assays showed that phage B4 effectively inhibited growth of B. 
cereus group as well as even B. subtilis, and retained its growth inhibition 
for over 20 h. One-step growth analysis also revealed host lysis activity of 
phage B4 with relatively short eclipse/latent times (10/15 min) and high 
burst size (>200 PFU). The complete genome of phage B4 containing a 162-
kb DNA with 277 ORFs was analyzed. The endolysin encoded by phage B4 
genome have accounted for this cell lysis activity. These results suggest that 
phage B4 has potential as a biological agent to control B. cereus propagation.  
221 
IV-5-1-2. Introduction 
 Bacillus cereus is a food-borne pathogen producing enterotoxins 
such as hemolysin BL (HBL), nonhemolytic enterotoxin (NHE), and 
cytotoxin K (20). Due to these toxins, the uptake of contaminated foods can 





 CFU per gram of contaminated food) is required for 
disease outbreak (24). However, responses to infection in humans such as 
diarrheal syndrome (8 to 16 h) and emetic syndrome (0.5-6 h) are relatively 
quick, due to toxins produced and released by B. cereus (8, 24). The 
outbreaks of Bacillus species in the European Union were reported up to 1.4% 
of all food-borne pathogenic outbreaks in 2005 (2), and the number of B. 
cereus outbreaks has been recently increasing in the developed countries, 
highlighting the importance to control B. cereus levels in foods (9, 17, 20). 
 The antibiotic resistance of B. cereus has been reported. Previous 
studies showed that B. cereus is generally insusceptible to penicillin-related 
antibiotics due to production of β-lactamase and sometimes even to 
erythromycin and tetracycline (18, 31). Therefore, an alternative 
bacteriophage approach has been suggested to be effective to reduce this 
pathogen in various foods (10). Due to this positive potential of 
bacteriophage application in foods, some bacteriophages infecting B. cereus 
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have been studied and reported (3) 12, (19) (23) (32). Two phages with 
highly specific host ranges, FWLBc1 and FWLBc2, were isolated and 
characterized to develop biocontrol agents in foods (23). Bandara et al. (3) 






 are required to 
enhance the host lysis activity of the bacteriophage in fermented foods. 
Interestingly, about 40% of the fermented foods contain B. cereus-infecting 
phages, suggesting that B. cereus is prevalent in fermented foods where 
bacteriophages probably inhibit its growth and consequently, limit 
contamination (32). 
 To inhibit the growth of B. cereus, a novel bacteriophage B4 was 
isolated from an environmental sample and characterized using host range 
test, bacterial challenge assay, and one-step growth curve analysis. In 
addition, whole genome of phage B4 was completely sequenced and 
analyzed. In this report, we describe a novel potential biocontrol agent 
bacteriophage B4 and provide genomic information about this phage for 
further applications in foods. 
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IV-5-1-3. Materials and Methods 
 
IV-5-1-3-1. Bacterial strains and growth condition 
B. cereus ATCC 10876 was used as an isolation and propagation 
host for bacteriophage B4. Bacterial strains used for host range test are 
described in Table 4.3. All the bacterial strains were grown at 37°C with 
shaking in Luria-Bertani (LB) broth medium (Difco, Detroit, MI, USA). 
  
IV-5-1-3-2. Isolation and propagation of bacteriophage B4 
Mud samples from Seoul Grand Park (Gwacheon, South Korea) 
were used to screen for bacteriophages that infect B. cereus using strain 
ATCC 10876 as a host. In the case of solid samples, 25 g of the samples 
were homogenized in 225 ml sterile Butterfield’s phosphate-buffered 
dilution water (0.25 M KH2PO4, pH 7.2) with a blender (BacMixer 400; 
Interscience Laboratory Inc., St. Nom, France). After homogenization, 25 
ml of each homogenized sample was added to 25 ml of 2X LB broth and the 
mixture was incubated for 12 h at 37 °C with shaking at 220 rpm. The 
incubated culture was centrifuged at 9,000 × g, 4°C for 10 min and the 
supernatant was filtered to remove bacterial cells using 0.22 µm pore size 
filters (Millipore, Billerica, MA). Ten milliliter of the filtrate was mixed 
with 50 ml LB broth containing 1% overnight culture of B. cereus ATCC 
10876 (final concentration) and the mixture was incubated at 37°C for 12 h 
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with shaking. After incubation, the mixed culture was centrifuged at 9,000 × 
g, 4°C for 10 min and the supernatant was filtered again to remove bacterial 
cells using 0.22 µm pore size filters (Millipore). In order to confirm the 
presence of bacteriophages in the filtered supernatant, tenfold serial 
dilutions of the filtrate were spotted on molten 0.4% LB soft agar containing 
1% B. cereus ATCC 10876 (final concentration). The plates were incubated 
overnight at 37 °C and monitored for formation of plaques. Each single 
plaque was picked with a sterile tip and eluted in 1 ml of sterilized sodium 
chloride-magnesium sulfate (SM) buffer (50 mM Tris-HCl, pH 7.5, 100 mM 
NaCl, 10 mM MgSO4·7H2O). This purification step was repeated at least 
three times. 
The culture of B. cereus ATCC 10876 (OD600 = 1.0) was infected 
with bacteriophages at a multiplicity of infection (MOI) of 1 and incubated 
at 37°C with shaking until the culture became clear. Cell debris was 
removed by subsequent centrifugation at 9,000 × g for 10 min and filtration 
using 0.22 µm pore size filters and phage particles were precipitated by 
treatment of polyethylene glycol (PEG) 6,000 (Sigma, St. Louis, MO, USA). 
Finally, cesium chloride (CsCl) density gradient ultracentrifugation (Himac 
CP 100β, Hitachi, Japan) with different CsCl steps (step density = 1.3, 1.45, 
1.5 and 1.7 g/ml) was carried out at 78,500 × g, 4°C for 2 h. Viral particles 
were recovered and dialyzed with stirring using Spectra/Por 4 dialysis 
membrane tube (Spectrum, Rancho Dominguez, CA, USA) and SM buffer 
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for 1 h at 4°C. 
 
IV-5-1-3-3. Bacteriophage host range 
 A hundred microliter of each test bacterial culture in stationary 
phase was added to 5 ml of the molten 0.4% LB agar and the mixture was 
overlaid on the 1.5% LB agar plate. And then 10 µl of each serially diluted 




 PFU/ml was spotted on the overlaid 
plates and these plates were incubated at 37°C. After incubation, appropriate 
titers forming single plaques were selected and the sensitivity of test 
bacteria to B4 phage was determined. The efficiency of plating (EOP) was 
calculated and determined from comparison of titers between the selected 
test bacterium and the host strain B. cereus ATCC 10876. 
 
IV-5-1-3-4. Transmission electron microscopy (TEM) 
Diluted CsCl-purified bacteriophage B4 in SM buffer was put on 
carbon-coated copper grids and negatively stained with 2% aqueous uranyl 
acetate (pH 4.0) for 2 min. Electroscope microscopy of prepared samples 
was carried out using a transmission electron microscope (LIBRA 120, Carl 
Zeiss, Switzerland) at 80 kV. Bacteriophage B4 was identified and classified 
into its relative family according to the guidelines of the International 




IV-5-1-3-5. Bacterial challenge assay 
An exponentially growing B. cereus ATCC 10876 culture was 
infected with phage B4 (MOI = 1.0) to confirm its lytic activity. After 
adding phages to B. cereus cultures (OD600 nm = 1.0), the optical density was 
monitored at 600 nm every hour, and the culture without phage infection 
was used as a control. 
 
IV-5-1-3-6. One-step growth curve 
When the OD600 nm of the culture of the same reference strain 
reached 1.0, 50 ml of the culture was harvested. B4 phage was added at a 
MOI of 0.01 and allowed to be adsorbed for 5 min at room temperature. The 
mixture was centrifuged and the supernatant was discarded to remove the 
residual phage. The cell pellet was then resuspended with the same volume 
of fresh LB broth medium and the resuspended culture was further 
incubated at 37°C with shaking. Two sets of samples were collected every 5 
minutes. These two sets of samples were immediately diluted and plated for 
phage titration. However, in order to determine the eclipse period, the 
second set of samples was treated with 1% chloroform to release 
intracellular phages before the titration. Latent period and burst size were 
determined based on PFU number per cell. 
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IV-5-1-3-7. Isolation and purification of bacteriophage genomic DNA 
Bacteriophage genomic DNA was isolated from the phage lysate as 
previously described by Wilcox et al. (36). Before purification of phage 
genomic DNA, phage lysate was treated with DNase and RNaseA at 37 °C 
for 1 h to remove bacterial DNA and RNA, respectively. Phage lysate was 
treated with lysis buffer (0.5% of Sodium dodecyl sulfate, 20mM of EDTA 
and 50 µg/ml of proteinase K, final concentration) for 2 h at 56°C. A 
standard phenol-chloroform DNA purification and ethanol precipitation 
were carried out (30). 
 
IV-5-1-3-8. Genome sequencing of bacteriophage B4 and bioinformatics 
analysis 
Extracted B4 phage DNA was sequenced with a Genome Sequencer 
FLX (GS-FLX) titanium sequencer (Roche, Mannheim, Germany) and 
assembled with GS de novo assembler software (Roche) at Macrogen Inc., 
South Korea. Prediction of open reading frames (ORFs) was carried out 
using GeneMarkS (4) and Glimmer v3.02 (11) and FgenesB softwares 
(Softberry, Inc. Mount Kisco, NY), and confirmed by RBSfinder (J. Craig 
Venter Institue, Rockville, MD). Prediction of tRNA genes was carried out 
using tRNAscan-SE program (25). Annotation of ORFs was performed 
using BLASTP (1) and InterProScan programs (37). The complete genome 
sequence and its annotation data were handled and edited by Artemis14 (7). 
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Evolutionary phylogenetic analysis of phage B4 was conducted using 
MEGA5 with neighbor-joining method (21). 
 
IV-5-1-3-9. Nucleotide sequence accession number 
 The complete genome sequence of B. cereus phage B4 is available 
in GenBank database under accession number JN790865. 
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IV-5-1-4. Results and Discussion 
 
IV-5-1-4-1. Isolation and characterization of bacteriophage B4 
Bacteriophage B4 was isolated from a mud-sample as a clear-
plaque former against strain B. cereus ATCC 10876. TEM analysis revealed 
that phage B4 had an isometric head with a nonflexible and contractile tail, 
suggesting that it belongs to the Myoviridae family (Fig. 4.5). Diameters of 
the isometric head and tail were about 85 nm and 21 nm, and non-contracted 
and contracted tail lengths were about 213 nm and 101 nm, respectively (Fig. 
4.5). Morphological comparison of phage B4 and other B. cereus phages in 
Myoviridae family (3, 12) showed that the head size of phage B4 is smaller 
than those of BCP1-1 and BCP8-2 (>95 nm) but similar to that of Bc431v3 
phage (85.4 ± 3 nm). However, the tail size of phage B4 is longer than that 
of Bc431v3 phage (180 ± 3 nm) but similar to those of BCP1-1 and BCP8-2 
phages (220 nm and 210 nm), suggesting that phage B4 has relatively small 
head and long tails. A host range test of phage B4 revealed that phage B4 
showed relatively broad inhibition against B. cereus group (B. cereus, B. 

















Gram positive bacteria   
Bacillus cereus ATCC 10876 CC ATCC 
Bacillus cereus ATCC 13061 C ATCC 
Bacillus cereus ATCC 14579 C ATCC 
Bacillus cereus ATCC 21768 C ATCC 
Bacillus cereus ATCC 27348 CC ATCC 
Bacillus subtilis ATCC 23857 CC ATCC 
Bacillus mycoides ATCC 6462 CC ATCC 
Bacillus thuringiensis subsp. kurstaki ATCC 35866 CC ATCC 
Bacillus thuringiensis ATCC 29730 CC ATCC 
Enterococcus faecalis ATCC 29212 - ATCC 
Staphylococcus aureus ATCC 29213 - ATCC 
Staphylococcus epidermis ATCC 35983 - ATCC 
Listeria monocytogenes ATCC 19114 - ATCC 
   
Gram negative bacteria   
Samonella enterica serovar Typhimurium LT2 - (26) 
Salmonella enterica serovar Enteritidis ATCC13076 - ATCC 
E. coli K-12 - (16) 
Shigella flexineri 2a strain 2457T - (35) 
a
, CC, EOP 1 to 0.1; C, EOP 0.1 to 0.001;, -, no susceptible to phage B4. 
b











Figure 4.5. Transmission electron microscopy of bacteriophage B4 




IV-5-1-4-2. Bacterial challenge assay 
 A bacterial challenge assay performed in liquid culture showed 
bacterial growth inhibition by phage B4. When phage B4 was added to the 
exponentially growing B. cereus ATCC 10876, the reduction of OD600 nm 
was already observed within the first 30 min (Fig. 4.6). The growth 
inhibition activity was maintained for more than 20 h, indicating that the 











Figure 4.6. Bacterial challenge assay of phage B4 against B. cereus 
ATCC 10876 at a multiplicity of infection (MOI) of 1.0. Closed circle 
indicates non-phage treated B. cereus ATCC 10876 and closed triangle 
indicates phage treated B. cereus ATCC 10876. 
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IV-5-1-4-3. One-step growth curve of bacteriophage B4 
The eclipse and the latent periods as well as the burst size of the B4 
phage were determined by one-step growth curve analysis with B. cereus 
ATCC 10876 (Fig. 4.7). The eclipse and the latent periods of B4 phage were 
10 min and 15 min, respectively. The burst size was more than 200 plaque 
forming unit (PFU) per infected host cell. The short latent period with large 










Figure 4.7. One-step growth curve analysis of B. cereus ATCC 10876 
infected by B4 phage. E, eclipse period; L, latent period; B, burst size. 
Closed circle indicates chloroform-treated sample and closed square 
indicates chloroform-untreated sample. 
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IV-5-1-4-4. Genomic analysis of bacteriophage B4 
 The complete genome of B. cereus bacteriophage B4 is 162,596-bp 
long with a GC content of 37.71%. A total of 277 ORFs was identified but 
no tRNA gene was detected (Fig. 4.8). The functional ORFs of phage B4 
were categorized into eight groups such as packaging, lysis, regulation, host 
interaction, structure, DNA replication, RNA metabolism, and additional 
function and listed in Table 4.4. The phage genome encodes all necessary 
phage structural proteins including major capsid protein, structural protein, 
minor structural protein, portal protein, and several tail proteins (tail fiber 
protein, tail-lysins, tail sheath protein, putative tail protein, and baseplate 
proteins). In addition, this genome encodes many DNA replication proteins 
such as DNA polymerases, primase, helicases, exonucleases, and 
recombinase, implying that these proteins may collaborate with the host 
DNA replication proteins in replicating the phage genome. Interestingly, this 
genome also has its own putative sigma factors such as SigF-like protein 
(BCB4_0143) and phage RNA polymerase sigma factor (BCB4_0181). 
Although SigF is known to be involved in transcription of specific genes for 
sporulation, protein sequence identity of BCB4_0143 is less than 25% to 
those of other known B. cereus host SigF proteins, suggesting that its role 
for host sporulation cannot be deduced (12). However, phage RNA 
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polymerase sigma factor is relatively similar to other phage RNA 
polymerase sigma factors (40% protein sequence identity to that of 
Enterococcus phage phiEF24C), but no homology to B. cereus host RNA 
polymerase sigma factors, suggesting that this sigma factor may play a role 
in transcription of phage genes. Functions of sigma factors in these phages 
are not clearly understood yet, so further experiments may be needed to 
characterize them. Furthermore, the phage genome also encodes many 
additional functional genes such as metallophosphoesterase, ribonucleotide-
diphosphate reductases, flavodoxin, thioredoxin, thymidylate synthase, 
dephospho-CoA kinase, and dihydrofolate. While their roles in the phage or 
in the host are not clearly understood yet, a few enzymes such as 
ribonucleotide-diphosphate reductases and thymidylate synthase were 
previously suggested to be involved in preparation of nucleotides for DNA 
synthesis (27). Additional evolutionary phylogenetic analysis of major 
capsid proteins (MCPs) of Bacillus bacteriophages revealed that phage B4 is 
closely related to other Bacillus phages such as Bastille (NC_018856), 
BPS13 (NC_018857) and BCP78 (NC_018860, (22)) phages in the 
Myoviridae family but quite different from other families such as 
Siphoviridae and Podoviridae, consistent with the previous morphological 
observation (Fig. 4.9). Furthermore, this genome does not have genes 
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associated with toxin production and bacterial virulence, suggesting the 





Table 4.4. Functional grouping of predicted ORFs in bacteriophage B4 
Functional Groups Predicted function Locus_tag 
Packaging terminase large subunit BCB4_0004 
 putative portal protein BCB4_0270 
   
Lysis endolysin BCB4_0006 
 putative holin BCB4_0179 
   
Regulation putative DNA-binding protein 1 BCB4_0089 
 putative DNA-binding protein 2 BCB4_0168 
 putative DNA-binding protein 3 BCB4_0208 
 putative transcriptional regulator 1 BCB4_0234 
 putative transcriptional regulator 2 BCB4_0235 
 putative transcriptional regulator 3 BCB4_0272 
   
Host interaction cell division FtsK/SpoIIIE-like protein BCB4_0127 
 sporulation sigma factor SigF-like protein BCB4_0143 
 putative RNA polymerase sigma factor BCB4_0181 
   
Structure Ig-like domain containing protein BCB4_0133 
 putative tail protein BCB4_0238 
 putative baseplate J protein BCB4_0240 
 putative baseplate protein BCB4_0241 
 putative minor structural protein BCB4_0246 
 putative tail fiber BCB4_0247 
 putative tail lysin 1 BCB4_0248 
 putative tail lysin 2 BCB4_0249 
 structural protein BCB4_0258 
 putative tail sheath protein BCB4_0259 
 putative capsid protein BCB4_0266 






Table 4.4. Functional grouping of predicted ORFs in bacteriophage B4  
(continued) 
Functional Groups Predicted function Locus_tag 
DNA replication putative DNA polymerase 1 BCB4_0176 
 DNA recombination/repair protein BCB4_0184 
 putative DNA polymerase 2 BCB4_0200 
 putative primase BCB4_0226 
 putative exonuclease 1 BCB4_0228 
 putative exonuclease 2 BCB4_0230 
 putative helicase 1 BCB4_0233 
 putative helicase 2 BCB4_0236 
   
RNA metabolism putative RNA ligase BCB4_0100 
   
Additional function PhoH family protein BCB4_0011 
 thymidylate synthase BCB4_0015 
 dephospho-CoA kinase BCB4_0017 
 putative dihydrofolate reductase BCB4_0021 
 beta-lactamase superfamily hydrolase BCB4_0138 
 putative methyltransferase type 11 BCB4_0151 
 band 7 protein BCB4_0201 
 thioredoxin BCB4_0212 
 putative flavodoxin BCB4_0214 
 ribonucleoside-diphosphate reductase BCB4_0215 
 ribonucleotide-diphosphate reductase subunit alpha BCB4_0219 
 putative dUTP pyrophosphatase BCB4_0225 
 putative metallophosphoesterase BCB4_0231 
 3D domain protein BCB4_0253 










Figure 4.8. Genome map of phage B4. Outer circle indicates the gene coding regions by strand. The color of each gene refers to 
the functional categories such as phage structure (blue), regulation (orange), host-phage interaction(brown), replication (red), cell 
lysis (green), packaging (yellow), and additional function (purple). The inner circle with red line indicates the G+C content. Scale 









Figure 4.9. Phylogenetic tree of major capsid proteins (MCPs) in 
Bacillus bacteriophages. MCPs were compared by ClustalW multiple 
alignments and the phylogenetic tree was generated with the MEGA5 
program using the neighbor-joining method with P distance values. (M), 




IV-5-1-4-5. Host lysis of bacteriophage B4 
 The phage B4 genome encodes an endolysin (BCB4_0006) and a 
putative holin (BCB4_0179). While their respective genes lie unusually 
distant from each other in the genome (14, 28, 34), the highly lytic activity 
of phage B4 is most likely to be attributed to both enzymes. Interestingly, 
the endolysin of phage B4 (LysB4) has two conserved protein domains, 
PF08460 for cell wall binding and PF02557 for cell wall lysis (33). These 
conserved protein domains were frequently found in other bacteriophage 
endolysins against Bacillus and Listeria. Furthermore, LysB4 was 
experimentally characterized as an L-alanoyl-D-glutamate endopeptidase, 
showing optimum temperature and pH are 50°C and 8.5, respectively (33). 
The complete genome sequence of phage B4 also showed two genes, 
BCB4_0248 and BCB4_0249, encoding putative tail-lysins 1 and 2. 
Conserved protein analysis of these two tail-lysins showed that they may 
function in host lysis. Tail-lysin 1 has two conserved domains such as 
cd04129 (encoding Rho2 probably related to cell wall construction) and 
PF00877 (encoding cell wall-associated hydrolase probably related to cell 
wall lysis). Tail-lysin 2 also has a conserved domain, PF002901, coding for 
an endo-β-N-acetylglucosaminidase that is probably involved in 
peptidoglycan hydrolysis. However, it is necessary to experimentally 
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confirm that these tail-lysins are really involved in the host lysis. The broad 
host range and host lysis activity of phage B4 suggests that phage B4 can be 
a candidate as a novel biocontrol agent with its relatively high lysis activity 




 Due to its toxin production and antibiotic resistance, contamination 
with B. cereus is of increasing concern in the food industry and control 
methods other than classic antibiotic treatment are urgently needed. A 
bacteriophage-based approach has been suggested to control this kind of 
food-borne pathogens and one of bacteriophage applications (ListShield
TM
 
for control of Listeria in foods) has been approved by FDA (6, 29). To 
develop a novel biocontrol agent against B. cereus, bacteriophage B4 with 
relatively high host lysis activity was newly isolated and characterized. 
Subsequent complete genome sequence analysis of phage B4 revealed no 
genes associated with bacterial virulence or toxin and the presence of the 
host lysis system, suggesting that this phage may be suitable for host control. 
In this report, we suggest phage B4 as a possible biological candidate to 
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IV-5-2. Characterization and Genome Analyses of the Bacillus cereus-
infecting Bacteriophages BPS10C and BPS13 
(Submitted in Archives of Virology, 2013, In review) 
 
IV-5-2-1. Abstract 
 Due to the emergence of antibiotic-resistant strains, bacteriophages 
are considered to be an alternative approach for the control of pathogens. In 
this study, the bacteriophages BPS10C and BPS13 were isolated and 
characterized to control food-borne pathogenic B. cereus. Phage BPS13 
exhibits slightly higher host lysis activity compared with phage BPS10C. In 
addition, the analysis of their stability at various pH and temperature 
conditions revealed phage BPS13 exhibits higher stability. To extend our 
knowledge of the lysis of B. cereus by these phages, their genomes were 
completely sequenced and analyzed. The genome analysis results revealed 
that these phage genomes encode endolysin and two tail lysins, which are 
likely involved in the host invasion and lysis mechanisms. The combination 
of these host lysis-related proteins may increase the bactericidal activities of 
these phages, which suggests that these may be good candidates for the 




 Bacteriophages are bacteria-specific viruses that can lyse the host 
bacteria (5). Due to their host lysis activity, bacteriophages have been used 
for the control of specific bacteria in research and various other applications. 
Recently, bacteriophages are being studied to determine their potential as 
novel biocontrol agents against food-borne pathogens and antibiotic-
resistant strains (4, 7, 18). These approaches are quite beneficial because 
phages target specific pathogens without affecting other beneficial bacteria 
in foods and even humans (20) , as supported by the US Food and Drug 
Administration (FDA) approval of bacteriophage applications as food 
additives (4, 18). Therefore, the development of novel biocontrol agents 
using bacteriophages has been recently spotlighted. (4, 7, 18, 20). 
 Bacillus cereus is a Gram-positive food-borne pathogen that is 
frequently found in fresh vegetables and fruits grown in soil. This pathogen 
produces enterotoxins and cytotoxins that cause diarrhea and vomiting (3, 
11, 14). Antibiotic treatment is not usually recommended because of the 
antibiotic resistance activity of this pathogen against penicillin-related 
antibiotics (12, 22). Therefore, the bacteriophage approach is an excellent 
candidate for the development of alternative biocontrol agents for the 
control of this pathogen. However, B. cereus phages have never been used 
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or applied for the biocontrol of this pathogen. Recently, a few B. cereus-
targeting virulent phage genomes, such as BCP78, PBC1, Bc431v3, and B4, 
were completely sequenced and analyzed to extend our understanding of 
host-phage interaction and infection mechanisms (9, 13, 16). 
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IV-5-2-3. Materials and Methods 
 
IV-5-2-3-1. Bacterial strains and growth condition 
B. cereus ATCC 10876 was used to isolate and propagate the 
bacteriophages BPS10C and BPS13. The bacteria strains used for the 
determination of the antibacterial spectra of these bacteriophages are 
described in Table 4.5. All of the bacteria were cultivated in Luria-Bertani 
(LB) broth (Difco, Detroit, MI, USA) at 37°C with vigorous shaking, and 
the agar plate was prepared with a final agar (Difco) concentration of 1.5%. 
 
IV-5-2-3-2. Bacteriophage isolation and purification  
Food waste samples were collected from Mok-dong, Seoul in South 
Korea and used for the isolation of B. cereus-infecting bacteriophages. To 
isolate the bacteriophages, 25 g of each sample was mixed with 225 ml of 
Butterfield’s phosphate-buffered dilution water (0.25 M KH2PO4, pH 7.2) in 
sterile bags. After homogenization, 25 ml of each diluted sample was mixed 
with 25 ml of 2X LB broth medium, and the mixture was incubated with 
shaking at 37°C for 12 h. Then, 0.5 ml of chloroform was added to the 
mixture, and the mixture incubated for 5 min at room temperature. The 
supernatant of the culture was collected by centrifugation at 6,000 × g for 10 
min and filtered using 0.22-µm-pore-size filters (Millipore, Billerica, MA). 




 CFU/ml B. cereus ATCC 10876, and the mixture was 
then incubated at 37°C for 12 h with shaking. After the incubation, the 
mixed culture was centrifuged at 6,000 × g for 10 min, and the supernatant 
was filtered through 0.22-µm pore-size filters to remove the B. cereus cells. 
The filtered supernatant was used for plaque formation in molten 0.4% LB 
soft agar containing 10
7
 CFU/ml B. cereus ATCC 10876. Each plaque was 
picked with a sterile tip and eluted with 1 ml of sodium chloride-magnesium 
sulfate (SM) buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 10 mM 
MgSO4·7H2O). This phage purification step was repeated at least five times. 
For phage propagation, either BPS10C or BPS13 was added to a 
culture of B. cereus ATCC 10876 at a multiplicity of infection (MOI) of 1 
when the optical density (OD) of the culture at 600 nm reached 1.0. The 
mixture was incubated at 37°C for 4 h with shaking. After the incubation of 
the mixture, the phage particles were recovered from the B. cereus cell 
debris by centrifugation at 6,000 × g for 10 min and filtration using 0.22-
µm-pore-size filters. The phage particles were then purified by precipitation 
with polyethylene glycol (PEG) 6,000 (Sigma, St. Louis, MO, USA) and 
CsCl density gradient ultracentrifugation (Himac CP 100β, Hitachi, Japan) 
with different CsCl steps (step density = 1.3, 1.45, 1.5, and 1.7 g/ml) at 
78,500 × g and 4°C for 2 h. The purified phage particles were recovered, 
dialyzed using standard dialysis buffer (5 M NaCl, 1 M MgCl2, and 1 M 
Tris·HCl at pH 8.0), and stored at 4°C until further analysis. 
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IV-5-2-3-3. Transmission electron microscopy 
The morphology of phages BPS10C and BPS13 were observed 
using Energy-Filtered Transmission Electron Microscope (EF-TEM). The 
phage samples were diluted with SM buffer, and 5 μl of each phage sample 
was applied to the surface of carbon-coated copper grids. The negatively 
stained samples with 2% uranyl acetate were allowed to absorb for 2 min. 
The prepared samples were observed using an EF-TEM (JEM-1010, JEOL, 
Tokyo, Japan) at 80 kV. The BPS10C and BPS13 phages were identified 
based on their morphology and classified into their relative family according 
to the guidelines of the International Committee on Taxonomy of Viruses 
(10). 
 
IV-5-2-3-4. Bacteriophage host range test 
 Five milliliters of molten 0.4% LB top agar containing 100 µl of 
each test bacterial culture was overlaid on 1.5% LB base agar plates. Then, 




) were spotted on the 
overlaid agar plate and incubated at 37°C. The sensitivity of the test bacteria 
to each of the phages was determined based on whether a phage plaque 
formed. The efficiency of plating (EOP) was determined by a comparison of 
the titers between each selected test bacterium and the propagation strain B. 
cereus ATCC 10876. 
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IV-5-2-3-5. Bacterial challenge test 
To confirm the host lysis activity of the phages, a B. cereus ATCC 
10876 culture at OD600 nm of 1.0 was infected with the corresponding phage 
(BPS10C or BPS13) at an MOI of 1.0. The optical density of the mixture 
was monitored at 600 nm at 1-h intervals. A B. cereus culture without phage 
infection was used as a control. This test was performed in triplicate. 
 
IV-5-2-3-6. Bacteriophage DNA purification  
The genomic DNAs of phages BPS10C and BPS13 were isolated as 
previously described by Wilcox et al. (25). Before the isolation of the phage 
genomic DNA, the phage particles were treated with DNase I and RNase A 
at 37°C for 1 h to remove the bacterial DNA and RNA, respectively. To 
isolate the phage genomic DNA, the phage particles were lysed with lysis 
buffer (1% sodium dodecyl sulfate (SDS), 0.5 mol/l EDTA, and 10 mg/ml 
proteinase K) for 2 h at 56°C. A standard phenol-chloroform DNA 
purification and ethanol precipitation was performed (21). 
 
IV-5-2-3-7. Bacteriophage genome sequencing and bioinformatics 
analysis 
The purified phage genomic DNAs were sequenced using a 
Genome Sequencer FLX (GS-FLX) instrument (Roche, Mannheim, 
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Germany), and the filtered sequence reads were assembled with Newbler 2.3 
(Roche) at Macrogen Inc. (Seoul, South Korea). The prediction of all of the 
open reading frames (ORFs) was conducted using Glimmer v3.02 (8), 
GeneMarkS (2), and FgenesB (Softberry, Inc. Mount Kisco, NY, USA) and 
confirmed by RBSFinder (J. Craig Venter Institute, Rockville, MD, USA). 
The annotation and functional analysis of the predicted ORFs were 
performed using the BLASTP (1) and InterProScan (26) programs. The 
comparative genome analysis of these phages was conducted using the 
BLASTN (1) and Easyfig (24) programs. The phylogenetic analysis was 
conducted using MEGA5 with the neighbor-joining method (15). 
 
IV-5-2-3-8. Nucleotide sequence accession number 
 The complete genome sequences of B. cereus-infecting phages 
BPS10C and BPS13 are available in GenBank database under accession 
number KC430106 and JN654439, respectively. 
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IV-5-2-4. Results and Discussion 
 
To further develop this novel type of biocontrol agents, phages 
BPS10C and BPS13 were isolated in this study from food waste samples 
using B. cereus ATCC 10876 as a host strain due to the high lytic activities 
of this phages against B. cereus (see the supplementary methods). An 
analysis of these phages using an energy-filtered transmission electron 
microscope (EF-TEM) was conducted as previously described (23) . These 
phages are quite similar to each other and have heads and contractile tails, 
which suggests that these phages belong to the Myoviridae family (Fig. 
4.10). The diameters of the heads and tails were approximately 79.9 nm and 
18.7 nm, respectively, and the non-contracted and contracted tail lengths 
were approximately 193.5 nm and 177 nm, respectively (Fig. 4.10). In 
addition, the analysis of their range of hosts revealed that these phages can 
inhibit B. cereus, B. thuringiensis, and B. mycoides but cannot inhibit 
Listeria monocytogenes, Staphylococcus aureus, and S. epidermis, which 
indicates their host specificity at the genus level (Table 4.5). 
 To understand the inhibitory effect of phages BPS10C and BPS13 
against B. cereus, a bacterial challenge test was conducted in liquid culture, 
as described in the supplementary methods. Interestingly, the initial 
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inhibition of phage BPS13 against the B. cereus host strain was slightly 
higher than that of the BPS10C phage at an MOI of 1 (Fig. 4.11a). However, 
at an MOI of 10, the inhibition of both BPS13 and BPS10C against the host 
strain was similar (Fig. 4.11b). This result suggests that phage BPS13 may 
exhibit slightly higher host inhibition at the initial inhibition step against B. 
cereus compared with phage BPS10C. In addition, the phage stability test of 
phages BPS10C and BPS13 revealed that phage BPS13 is more stable at a 
higher range of pH and temperature conditions than BPS10C, which 
suggests that phage BPS13 is a better candidate than phage BPS10C for B. 
cereus inhibition applications (Fig. 4.11c and 11d). 
The genome of phage BPS10C contains 159,590-bp DNA with 
G+C contents of 38.74% and 271 ORFs, whereas the genome of phage 
BPS13 exhibits 158,305-bp DNA with G+C contents of 38.75% and 268 
ORFs. In addition, neither of these genomes contains the tRNA gene (Table 
4.6). The functional ORFs of these two phages were classified into seven 
groups: structure, packaging, host lysis, DNA manipulation, host interaction, 
regulation, and additional functions (Fig. 4.12). The functionally classified 
genes in each group are listed in Table 4.7. 
The phylogenetic analysis of the isolated phages using the major 
capsid proteins of several phages suggested that these two phages belong to 
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the Spounavirinae subfamily. However, these two phages did not belong to 
any known genera (Spo1-like virus and Twort-like virus), similarly to the 
previously reported phage Bc431v3 (9) (Fig. 4.13). To predict the lifestyle 
of the BPS10C and BPS13 phages, the amino acid sequences of predicted 
ORFs were analyzed using the Phage Classification Tool Set (PHACTS) 
program (17). However, this program was unable to predict whether the 
lifestyle of these two phages was virulent or temperate, which suggests that 
these phages have genomes that are significantly different compared with 
the other phage genomes in the GenBank database. The prediction of the 
packaging type (6) showed that the packaging strategies of these two phages 
were not belong to any known packaging strategies of other phages (Fig. 
4.14). 
Interestingly, these two phages have two tail lysins (BPS10C_247 
and BPS10C_248 in phage BPS10C and BPS13_0246 and BPS13_0247 in 
phage BPS13) within the structure group, which are most likely involved in 
the additional host lytic activity against B. cereus (Table 4.7). A previous 
report showed that the endolysin of phage BPS13 (LysBPS13, BPS13_0008) 
exhibits effective lytic activity and remarkable thermostability in the 
presence of glycerol, which suggests that LysBPS13 exhibits high potential 
for the development of a new biocontrol agent (19). Interestingly, due to the 
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high similarity of the endolysin of phage BPS10C (BPS10C_008) to 
LysBPS13, phage BPS10C is predicted to have a host lysis mechanism 
against B. cereus that is similar to that of phage BPS13. Interestingly, the 
ORFs encoding holins (BPS10C_172 and BPS13_0174) are located far from 
the ORFs encoding endolysins in these two phage genomes, which is 
different from the results obtained with other general phages. Thus, this 
finding suggests that their functions as holin proteins are not clearly 
understood and need to be experimentally confirmed. Although tail lysins 
may be associated with endolysin for host lysis, their inhibitory mechanisms 
should be experimentally confirmed. 
The analysis of the DNA manipulation group showed that these 
phages may replicate their own DNA with help from the host DNA 
replication proteins. Interestingly, each phage genome has two transcription 
sigma factors (BPS10C_136 and BPS10C_175 in phage BPS10C 
BPS13_0137 and BPS13_0176 in phage BPS13) in the host interaction 
group, which suggests that these phages may have transcription regulation 
mechanisms that are different from those of the host (Table 4.7). The 
analysis of these two phage genomes revealed the presence of host lysis 
proteins and the absence of toxin-associated genes, which indicates their 
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Bacillus cereus ATCC 10876 CC CC ATCC 
Bacillus cereus ATCC 13061 C C ATCC 
Bacillus cereus ATCC 14579 C C ATCC 
Bacillus thuringiensis ATCC 29730 CC CC ATCC 
Bacillus thuringiensis subsp. kurstaki ATCC 35866 CC CC ATCC 
Bacillus mycoides ATCC 6462 T T ATCC 
Listeria monocytogenes ATCC 19115 - - ATCC 
Staphylococcus aureus ATCC 29213 - - ATCC 
Staphylococcus epidermis ATCC 35983 - - ATCC 
a
, CC, EOP 1 to 0.1 with clear plaque; C, EOP 0.1 to 0.001 with clear plaque; T, turbid 
plaque; -, not susceptible to phage BPS10C or BPS13. 
b











Table 4.6. General genomic features of bacteriophage BPS10C and 
BPS13 
Characteristics 
B. cereus bacteriophage 
BPS10C BPS13 
Length (bp) 159,590 158,305 
Overall G+C content (%) 38.74 38.75 
No. of annotated genes 271 269 
Avg gene length (bp) 539 530 
Gene density (no. of genes/kb) 1.698 1.699 
Gene coding content (%) 91.6 90.1 
Gene GC content (%) 39.11 39.13 
No. of tRNAs 0 0 
No. of putative endolysin protein 1 1 
No. of putative tail lysin protein 2 2 
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          Table 4.7. Functional grouping of predicted ORFs in bacteriophage BPS10C and BPS13 
Functional groups Predicted function 
Locus_tag 
BPS10C BPS13 
Structure adsorption associated tail protein BPS10C_237 BPS13_0236 
 baseplate J protein BPS10C_239 BPS13_0238 
 baseplate protein BPS10C_240 BPS13_0239 
 minor structural protein BPS10C_245 BPS13_0244 
 putative tail fiber BPS10C_246 BPS13_0245 
 tail lysine 1 BPS10C_247 BPS13_0246 
 tail lysine 2 BPS10C_248 BPS13_0247 
 tail sheath protein BPS10C_255 BPS13_0254 
 major capsid protein BPS10C_263 BPS13_0261 
    
Packaging terminase large subunit BPS10C_006 BPS13_0006 
 portal protein BPS10C_266 BPS13_0264 
    
Host lysis endolysin BPS10C_008 BPS13_0008 
 putative holin BPS10C_172 BPS13_0174 
    
DNA manipulation DNA helicase 1 BPS10C_231 BPS13_0230 
 DNA helicase 2 BPS10C_235 BPS13_0234 
 primase BPS10C_224 BPS13_0223 
 possible DNA polymerase BPS10C_167 BPS13_0169 
 putative DNA polymerase BPS10C_193 BPS13_0194 
 exonuclease BPS10C_226 BPS13_0226 




      Table 4.7. Functional grouping of predicted ORFs in bacteriophage BPS10C and BPS13 (continued) 
Functional groups Predicted function 
Locus_tag 
BPS10C BPS13 
Host interaction RNA polymerase sigma factor BPS10C_136 BPS13_0137 
 integration host factor BPS10C_175 BPS13_0176 
    
Regulation transcriptional regulator BPS10C_233 BPS13_0232 
    
Additional function ribose-phosphate pyrophosphokinase BPS10C_009 BPS13_0009 
 nicotinate phosphoribosyltransferase BPS10C_010 BPS13_0010 
 thymidylate synthase BPS10C_018 BPS13_0018 
 dephospho-CoA kinase BPS10C_020 BPS13_0020 
 dihydrofolate reductase BPS10C_023 BPS13_0023 
 metal-dependent hydrolase BPS10C_130 BPS13_0131 
 MazG nucleotide pyrophosphohydrolase BPS10C_156 BPS13_0157 
 thioredoxin BPS10C_207 BPS13_0206 
 flavodoxin BPS10C_211 BPS13_0210 
 ribonucleoside-diphosphate reductase subunit alpha BPS10C_215 BPS13_0214 
 ribonucleoside-diphosphate reductase subunit beta BPS10C_212 BPS13_0211 


























Figure 4.11. A-B. Bacterial challenge assay of phages BPS10C and BPS13 against B. cereus ATCC 10876 at two different 
multiplicities of infection (MOI): 1.0 (A) and 10 (B). Uninfected sample, filled square; phage BPS10C, open square; phage 
BPS13, filled circle. 








Figure 4.12. Comparative genome map of bacteriophages BPS10C (above) and BPS13 (bottom). The similarities between the 
two genomes at the DNA level were determined using the Easyfig program and are represented through gradations in color from red 








Figure 4.13. Phylogenetic analysis of major capsid proteins in the 
Spounavirinae subfamily of bacteriophages. The major capsid proteins 
were compared using the ClustalW program, and the phylogenetic tree was 
generated through the neighbor-joining method with P distance values using 








Figure 4.14. Phylogenetic analysis of the terminase large subunits in 
several bacteriophages. The terminase large subunits were compared using 
the ClustalW program, and the phylogenetic tree was generated through the 
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V-1. Receptor Diversity and Host Interaction of 
Bacteriophages Infecting Salmonella enterica serovar 
Typhimurium 
 
 Twenty-five Salmonella phages were isolated and their receptors 
were identified by screening several mutants of S. Typhimurium SL1344. 
Three receptor groups of 25 newly isolated S. Typhimurium-targeting 
phages were determined. Among them, two subgroups of group F phages 
interact with their host receptors in different manners. In addition, the host 
receptors of group B or group L SPN9TCW phages hinder infection by 
phages in another group, probably due to interaction between receptors of 
their groups. This study provides novel insights into phage-host receptor 
interaction for Salmonella phages and will aid development of optimal 
phage therapy for protection against Salmonella. 
 
 1. Three types of receptors were identified: flagella (11 phages), 
 vitamin B12 uptake outer membrane protein, BtuB (7 phages) and 
 lipopolysaccharide-related O-antigen (7 phages) 
 2. All 25 phages could be categorized into three morphological 
 groups. The phages using flagella (group F) or BtuB (group B) as a 
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 receptor belong to the Siphoviridae family, and the phages using O-
 antigen of LPS as a receptor (group L) belong to the Podoviridae 
 family. 
 3. SPN bacteriophages infect S. Typhimurium strains but not other 
 Gram-negative and Gram-positive bacteria. Exceptively, the group 
 B phages infect E. coli and Shigella flexneri strains as well as 
 Salmonella. 
 4. While some of group F phages (F-I) target FliC host receptor, 
 others (F-II) target both FliC and FljB receptors, suggesting that 
 two subgroups are present in group F phages. 
 5. Group B phage-resistant Salmonella were transiently resistant to 
 re-infection with group B phages, and most group F phage-resistant 
 and group L SPN9TCW phage-resistant strains also showed 
 transient resistance to re-infection with phages from their own 
 group. All group L phage-resistant strains, except for the strain 
 resistant to phage SPN9TCW, showed stable phage resistance to 
 group L phages. 
 6. Cross-infection of group F phages on other phage-resistant 
 strains showed sensitivity to these phages, suggesting no mutual 
 influence between flagellin and other phage receptors on the 
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 sensitivity to the phages 
 7. Group L phages could not infect group B phage-resistant strains 
 and reversely group B phages could not infect group L SPN9TCW-
 resistant strain. 
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V-2. Genomic Investigation of Lysogen Formation and Host 
Lysis Systems of the Salmonella Temperate Bacteriophage 
SPN9CC 
 
 A novel Salmonella Typhimurium-targeting bacteriophage SPN9CC, 
belonging to Podoviridae family, was isolated and characterized. Phage 
SPN9CC showed distinct clear plaques with cloudy centers and was able to 
infect S. Typhimurium via O-antigen of lipopolysaccharide (LPS). 
Phylogenetic analysis revealed that this phage is a member of P22-like 
phage group. However, their lysogeny control regions and host lysis gene 
clusters share very low identities, suggesting that lysogen formation and 
host lysis mechanisms may be diverse among phages in this group. 
Expression of SPN9CC host cell lysis genes encoding holin, endolysin, and 
Rz/Rz1-like proteins revealed that collaboration of these lysis proteins is 
important for host lysis and holin is a key protein. To further investigate the 
role of lysogeny control region in phage SPN9CC, the ΔcI mutant 
(SPN9CCM) of phage SPN9CC was constructed and subsequent 
comparative one-step growth analysis and challenge assay were performed. 
The present work would give temperate phages the possibility of being 
engineered as promising biocontrol agents similar to the virulent phages. 
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 1. Salmonella-targeting phage SPN9CC, belonging to the 
 Podoviridae family, was isolated from a commercially processed 
 broiler skin sample and showed distinct clear plaques with cloudy 
 centers. 
 2. Phage SPN9CC specifically infects certain strains of Salmonella 
 and O-antigen of LPS is a host receptor for phage infection. 
 3. The genome of phage SPN9CC has 40,128-bp length dsDNA 
 with GC content of 47.33%, 63 putative ORFs, and 2 tRNAs. 
 Comparative phylogenetic analysis revealed that phage SPN9CC is 
 closely related to Salmonella-targeting P22-like phages. 
 4. Lysogeny control region (Cro, CI, and CII) of phage SPN9CC is 
 different from phage P22 but similar to ε34 phage, suggesting that 
 SPN9CC and ε34 may share lytic/lysogenic decision and lysogen 
 formation mechanisms. 
 5. The host lysis gene clusters in phages SPN9CC, P22, and ε34 are 
 not conserved among them, suggesting that they probably lyse the 
 host strains in different manners. Interestingly, the host lysis gene 
 clusters of phage SPN9CC are similar to those of ST104 and even E. 
 coli K-12 prophage DLP12, suggesting that they may share the 
 same mechanism for host cell lysis. 
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 6. To elucidate the host cell lysis mechanism of this phage, each 
 gene in this cluster was cloned in pBAD18 and transformed into S. 
 Typhimurium and E. coli hosts, respectively. In S. Typhimurium, 
 the holin is a key protein for lysis. However, expression of these 
 genes in E. coli host showed different host cell lysis patterns. The 
 main difference between E. coli and Salmonella in terms of the 
 SPC9CC lysis gene cluster is the role of Rz/Rz1-like proteins, 
 which functions only in E. coli. 
 7. Effects of cI gene deletion on the life cycle of phage SPN9CC
 was studied by constructing the ΔcI mutant phage (SPN9CCM) 
 with BRED method. SPN9CCM does not make cloudy centers in 
 the plaques, suggesting that the phenotype of ΔcI mutant phage may 
 be converted from temperate to virulent. In a comparative one-step 
 growth analysis, while phage SPN9CC showed relatively long 
 eclipse/latent periods and small burst size, phage SPN9CCM
 exhibited much shorter eclipse/latent periods and bigger burst sizes. 
 Furthermore, bacterial challenge assays of phages SPN9CC and 
 SPN9CCM with S. Typhimurium SL1344 showed that inhibition 
 activity of phage SPN9CCM is much higher than that of phage 
 SPN9CC.  
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V-3. Characterization and Comparative Genomic Analysis of 
Bacteriophages infecting the Bacillus cereus Group 
 
 According to recent development in genome sequencing and 
bioinformatics technologies, bacteriophage studies at the genomic level 
investigating possible applications of phages for phage therapy and as novel 
biocontrol agents have boomed. To date, 30 complete genome sequences of 
B. cereus group bacteriophages (18 for B. cereus phages, four for B. 
anthracis, and eight for B. thringiensis) are available in the GenBank 
database. The general features of B. cereus group phages as well as 
comparative and functional genomic analyses and insights are described. 
This genomic information is useful for extending our understanding of their 
general genomic characteristics and their various applications in the control 
of bacterial pathogens and for phage therapy. 
 
 1. The comparative phylogenetic analyses of 30 B. cereus group 
 bacteriophages revealed that they are categorized into three 
 different phage groups (Group I, Group II, and Group III) with 
 different morphology (Myoviridae for group I, Siphoviridae for 
 group II, and Tectiviridae for group III), genome size (group I > 
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 group II > group III), and life style (virulent phenotype for group I 
 and temperate phenotype for group II and III). Subsequent phage 
 genome comparison using dot plot analysis showed that phages in 
 each phage group are highly homologous, substantiating the 
 grouping of B. cereus phages. 
 2. The functions of proteins encoded by 34.9 to 93.8% of the genes 
 in the phage genomes are still unknown. Especially, more than 69% 
 of the genes in the Myoviridae phage genomes are hypothetical, 
 probably due to insufficient annotation information for their 
 genomes. 
 3. The annotation information about core genes of the B. cereus 
 sensu lato phage group I, generally involved in host 
 infection/interaction and phage replication/reconstruction, is 
 available, and the core genes are shared in all phages in group I, 
 suggesting that they may have been evolved from a common 
 ancestor 
 4. In B. cereus sensu lato phage group I, four different endolysin 
 groups were detected, according to combinations of two types of 
 cell wall binding domain (CBD) and four types of enzymatic 
 activity domain (EAD). 
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 5. More than 36% of the B. cereus group phages are not assigned in 
 this grouping, based on the comparative phylogenetic and dot plot 
 analyses. When more phage genome sequences are available in the 
 GenBank database, new phage groups could be generated from a 
 further comparative phylogenetic analysis, and the phages that are 









Chapter VI. Appendix :  










VI-1. Complete Genome Sequence of the Opportunistic Food-
borne Pathogen, Cronobacter sakazakii ES15 




 Cronobacter sakazakii has recently been issued due to its high risk 
to powdered milk formula-fed infants. To characterize its physiology and 
pathogenicity in molecular level, C. sakazakii ES15 was isolated in South 
Korea and its genome was completely sequenced and analyzed. Here, the 
complete genome sequence and its analysis result of C. sakazakii ES15 are 
announced and major findings from its annotation data are reported. 
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VI-1-2. Main text 
 Cronobacter sakazakii is a Gram-negative opportunistic food-borne 
pathogen especially contaminating powdered milk formula for infants (4, 9). 
Recently, it has come into the spotlight due to the incredibly high risk to 
powdered formula-fed infants with 50 to 80% mortality (6, 13). Interestingly, 
its production of capsular material was reported (7), suggesting that this 
capsule formation may contribute to the host strain with high survival rate in 
extremely dried conditions. In addition, it causes meningitis, bacteremia, 
and necrotizing enterocolitis in infants probably due to its effective invasion 
into intestinal epithelial cells and brain microvascular endothelial cells 
(BMEC) (15). To further understand the physiology and pathogenicity of 
this pathogen in molecular level, its genome was completely sequenced and 
analyzed. 
 C. sakazakii ES15 was originally isolated from the ground whole 
grains and the genomic DNA was sequenced using GS-FLX pyrosequencer 
(Macrogen, South Korea). Prediction of the open reading frames (ORFs) 
was first performed using GeneMarkS (2) and Glimmer3 (3). The functional 
analyses of ORFs were conducted using BLASTP and InterProScan (1, 17). 
Transfer RNA and CRISPR repeat regions were predicted using tRNAscan-
SE (12) and CRISPR finder (5). The functional categorization and metabolic 
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pathway analyses were carried out using COG and KEGG databases (10, 
16), respectively.  
 The complete genome of C. sakazakii ES15 revealed 4,268,675-bp 
containing 3,916 ORFs, seven rRNA operons, and 80 tRNAs with GC 
content of 57.11%. In addition, this genome has two prophages and two 
CRISPR loci containing 9 and 16 CRISPR repeats, respectively. 
Interestingly, one of the prophages, phiES15 is UV-inducible and its genome 
sequence was recently analyzed to elucidate the interaction between the host 
strain and this phage. The metabolic/biosynthetic pathway analysis using 
KEGG database showed that this genome has complete set of genes for 
glycolysis and TCA cycle as well as for flagella assembly, substantiating 
that this bacterium is really facultative aerobic and motile (8). In addition, it 
also has essential genes for biosynthesis of 20 amino acids. However, two 
aminoacyl-tRNA synthetases, such as glutaminyl-tRNA and asparaginyl-
tRNA synthetases, are missing, suggesting that C. sakazakii may have 
alternative routes for successful translations of glutamine and asparagine 
(14). Interestingly, this genome has relatively many ABC transport systems 
and phosphotransferase systems (PTS), suggesting that C. sakazakii could 
uptake nutrients efficiently in the extremely dried conditions. It is intriguing 
that C. sakazakii ES15 genome encodes an outer membrane protein A 
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(OmpA, ES15_2832), probably involved in its invasion into BMEC, 
suggesting its pathogenicity. However, IbeB, a component of the 
copper/silver resistance cation efflux system, was not detected in this 
genome, which is different from C. sakazakii BAA-894 (11). While the 
complete genome sequence analysis of C. sakazakii increases our 
knowledge on the characteristics of this pathogenic bacterium in the extreme 
condition, further study of its pathogenicity in molecular level with this 
complete genome annotation needs to be elucidated in near future. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of Cronobacter sakazakii ES15 is available in GenBank under the 
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VI-2. Complete Genome Sequence of Cronobacter sakazakii 
Temperate Bacteriophage phiES15 




 While most of phage genome studies have been focused on the 
virulent phages, the inducible temperate bacteriophage genome study 
provides more detailed information about interaction between the host strain 
and the phage. To study this detailed interaction, UV-induced phiES15 
bacteriophage was isolated from the host strain Cronobacter sakazakii ES15 
and its genome was completely sequenced. Here we announce the genome 
sequence of phiES15 and report major findings from the annotation. 
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VI-2-2. Main text 
 Cronobacter sakazakii has been recognized as critical pathogenic 
bacteria especially for powdered formula-fed infants, due to high mortality 
up to 80% (6, 7, 12). While various antibiotics have been used to control 
this pathogen, recent studies reported emergence of antibiotic-resistant 
strains (14). Therefore, bacteriophage therapy using C. sakazakii-targeting 
phages has been suggested as alternative treatment to control this pathogen 
(8, 15). To optimize this phage therapy, the molecular interaction study 
between C. sakazakii host and its specific phages needs to be done. 
Furthermore, unlike virulent phages targeting C. sakazakii, the interaction 
study between the C. sakazakii host and its temperate phage will provide 
more detailed information about interaction between them. To study this 
detailed interaction, prophage-harboring C. sakazakii ES15 was isolated 
from the powder of ground whole grains and its temperate phage, 
designated phiES15, was also isolated from the host strain after UV 
induction. Here the genome of phage phiES15 was completely sequenced 
and analyzed. 
 Isolated and purified genomic DNA of phiES15 was sequenced 
using GS-FLX 454 pyrosequencer by Macrogen, Seoul, South Korea and 
the qualified reads were assembled using GS De Novo Assembler 2.3. The 
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prediction of open reading frames (ORFs) were conducted using three major 
gene prediction programs, GeneMarkS (2), Glimmer3 (5), and FgenesB 
(Softberry, Inc., Mount Kisco, NY) and confirmed by their ribosomal 
binding site analyses using RBS finder (J. Craig Venter Institue, Rockville, 
MD). The functions of ORFs were predicted by BLASTP analyses using 
Conserved Domain Database (CDD) (1, 10) and conserved protein motif 
analyses using InterProScan (13). Transfer RNA was predicted by 
tRNAscan-SE program (9) and the annotated genome information was 
handled using Artemis14 (3). 
 The phiES15 genome has 39,974-bp containing 52 ORFs and no 
tRNA with GC content of 53.54%. While twenty-three ORFs among them 
(43.3%) were hypothetical proteins, other ORFs were predicted to be 
functional and they were categorized into seven groups such as integration 
(integrase and excisionase), DNA modification & recombination (adenine-
specific DNA methyltransferase and crossover junction 
endodeoxyribonuclease RusA), host interaction (host-nuclease inhibitor 
protein Gam and host division inhibitor protein Kil), transcription regulation 
(transcriptional repressor DicA, CII and antitermination protein Q), 
replication (replication protein O & P), host lysis (endolysin and Rz/Rz1), 
phage packaging (terminase small & large subunits). It is intriguing that the 
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phiES15 genome encodes host interaction proteins such as Gam (probably 
involved in protection of phiES15 phage genome from the foreign DNA 
degradation by host nucleases) (11) and Kil (probably involved in utilization 
of the host resources for phage reconstruction by inhibition of the host cell 
division) (4). In addition, 26-bp attP sequence is shared between the phage 
phiES15 and the host strain ES15, substantiating that this phiES15 is a 
temperate phage and it serves as phage integration site into the host genome. 
The complete genome study of this phage phiES15 would provide further 
information about the interaction between C. sakazakii host and its 
temperate phage. 
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VI-3. Complete Genome Sequence of Cronobacter sakazakii 
Bacteriophage CR3 




 Due to high risk of Cronobacter sakazakii to powdered milk 
formula-fed infants and emergence of antibiotic-resistant strains, an 
alternative biocontrol agent using bacteriophage is needed to control this 
pathogen. To further develop this, C. sakazakii-targeting bacteriophage CR3 
was isolated and its genome was completely sequenced. Here we announce 
the genome analysis result of this largest genome sequence among C. 




VI-3-2. Main text 
 Cronobacter sakazakii is an opportunistic food-borne pathogen 
often contaminating powdered infant milk formula, vegetables, and fruits 
and causes septicemia, meningitis and necrotizing enterocolitis in neonates 
(3, 6, 9). It has recently attracted public attention due to extremely high risk 
with 50-80% fatality rates to contaminated formula-fed infants (5, 9). High 
resistance of C. sakazakii to unusual dry condition supports high survival 
rate in the powdered infant formula (4). However, emergence of antibiotic-
resistant C. sakazakii has limited antibiotic usage to control this pathogen 
(12), suggesting that development of alternative biocontrol agents like 
bacteriophage is urgently needed. Here, a novel C. sakazakii bacteriophage 
CR3 was isolated from an environmental sample and its genome was 
completely sequenced. 
 Genomic DNA was isolated using standard alkaline lysis method 
(10) and was sequenced using the GS-FLX Titanium by Macrogen, Seoul, 
South Korea. The quality-filtered reads were assembled using Newbler 2.3 
and the prediction of open reading frames (ORFs) was performed using 
GeneMarkS (1), Glimmer3 (2), and FgenesV (Softberry, Inc., Mount Kisco, 
NY). Transfer RNAs were predicted using tRNAscan-SE (8) and conserved 
protein motif analyses of the predicted ORFs were conducted using 
302 
InterProScan (11). Comparative codon preference analyses of the C. 
sakazakii BAA-894 (7) and phage CR3 genomes were carried out using 
CodonW 1.4.4 in MOBYLE portal website (Pasteur Institute, Paris, France). 
 Complete genome of C. sakazakii phage CR3 belonging to 
Myoviridae family consists of 149,273-bp length with a GC content of 
50.95%, 265 ORFs, and 18 tRNAs, indicating the largest genome among C. 
sakazakii bacteriophages to date. Interestingly, this phage genome contains 
many tRNAs and comparative codon preference analyses between the phage 
and C. sakazakii BAA-894 showed different codon preference of valine, 
serine, alanine, lysine, asparagine, arginine, and glycine, suggesting that 
these extra phage tRNAs may play a role in translation of phage mRNA, not 
host mRNA (data not shown). The genome of phage CR3 encodes 
structure/packaging proteins (major capsid protein, head 
stabilization/decoration protein, tail fiber proteins, tail fiber assembly 
protein, tape measure protein, and terminase), DNA manipulation proteins 
(polymerases, methylases, primase, helicase, ligase, methlytransferase, and 
endonucleases), and many additional functional proteins such as a 
thymidylate synthase and a cell wall hydrolase SleB. Although this genome 
encodes many ORFs, most of them are hypothetical proteins (84.5%), 
probably due to insufficient information about C. sakazakii phage genes in 
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GenBank database. This phage CR3 has two copies of tail fiber proteins 
targeting flagella of C. sakazakii, experimentally confirmed by non-
infection of CR3 to the flagella-deletion mutant (data not shown). While this 
phage genome does not encode endolysin for host lysis, it encodes a cell 
wall hydrolase SleB, suggesting that this protein may be involved in the host 
lysis. The complete genome analysis of C. sakazakii phage CR3 provides 
further information of C. sakazakii phages and extends its application as a 
natural biocontrol agent to control C. sakazakii. 
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VI-4. Complete Genome Sequence of Phytopathogen 
Pectobacterium carotovorum subsp. carotovorum 
Bacteriophage PP1 




 Peptobacterium carotovorum subsp. carotovorum is a 
phytopathogen causing soft rot and blackleg of potatoes. To control this 
plant pathogen, P. carotovorum-targeting bacteriophage PP1 was isolated 
and its genome was completely sequenced to develop a novel biocontrol 
agent. Interestingly, the 44,400-bp genome sequence does not encode any 
gene involved in the formation of lysogen, suggesting that this phage may 
be very useful as a biocontrol agent because it does not make lysogen after 
host infection. This is the first report on the complete genome sequence of P. 
carotovorum-targeting bacteriophage and it would increase our knowledge 




VI-4-2. Main text 
 Pectobacterium carotovorum subsp. carotovorum (formerly 
Erwinia carotovora subsp. carotovora) is a phytopathogenic Gram-negative 
bacterium, causing soft rot and blackleg of various potato and Chinese 
cabbages (5, 8, 10). This bacterial soft-rot causes serious loss of produce 
quality during their growth, transit and even storage. Recently, a novel 
bacteriocin, carocin D was isolated from P. carotovorum Pcc21 to develop a 
biocontrol agent to control this phytopathogen (9). Furthermore, to increase 
this antibacterial activity, additional biocontrol agent such as bacteriophage 
treatment is needed. This approach could be one of the best biocontrol 
agents to maximize the growth inhibition of this pathogen in plants. Here, 
we isolated P. carotovorum-targeting bacteriophage PP1 and fully 
sequenced its genome to understand its inhibition mechanism against this 
pathogen. 
 The genome of phage PP1 was isolated using alkaline lysis and 
phenol extraction method (11) and completely sequenced using GS-FLX 
pyrosequencing technology (Macrogen, Seoul, Korea). The open reading 
frames (ORFs) were bioinformatically predicted using Glimmer3 (4), 
GeneMarkS (2), and FgenesB (Softberry, Inc., Mount Kisco, NY) and 
confirmed by RBS finder (J. Craig Venter Institute, Rockville, MD). The 
308 
functions of ORFs were predicted by BLASTP (1) and InterProScan with 
protein motif databases (12). The complete genome sequence and annotation 
information was edited and handled using Artemis14 (3). 
 The genome of P. carotovorum-targeting phage PP1 consists of 
44,400-bp length with 49.74% GC content, encoding 48 ORFs with no 
tRNA. Although six phage genomes are available in GenBank database 
infecting Erwinia amylovora, E. tasmaniensis, and E. pyrifoliae to date (6, 
7), there is no report on the complete genome sequence of P. carotovorum-
infecting phage. Therefore, more than 50% of the annotated ORFs (26 of 48) 
encode hypothetical proteins due to insufficient genome annotation 
information on this phage. The genes encoded in this genome are 
categorized into five groups, DNA replication/manipulation (DNA-directed 
RNA polymerase, DNA primase, DNA polymerase, HNH endonuclease, 5’-
3’ exonuclease, and DNA ligase), phage structure (head-tail connector, 
scaffolding protein, major capsid protein, tail tubular proteins, and internal 
virion proteins), phage packaging (terminase large and small subunits), host 
lysis (lysozyme-domain protein and holin), and host specificity (tail fiber 
protein). Interestingly, this genome has only one gene encoding tail fiber 
protein for host specificity, suggesting that this gene may be important to 
recognize and to infect the host. After infection of this host, the genes 
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encoding lysozyme and holin may play important roles in the host lysis. 
However, this genome does not encode proteins involved in lysogen 
formation, suggesting that this phage probably does not make lysogen after 
phage infection. The absence of genes involved in lysogen formation may 
be very useful to develop an effective biocontrol agent with this phage. This 
is the first report on the complete genome sequence of P. carotovorum- 
targeting bacteriophage and it would extend our understanding about 
bacterial pathogenesis to plants and its control between P. carotovorum and 
its infecting phages. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of P. carotovorum-targeting bacteriophage PP1 is available under 
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VI-5. Complete Genome Sequence of Marine Bacterium 
Pseudoalteromonas phenolica Bacteriophage TW1 




 For molecular study of marine bacteria Pseudoalteromonas 
phenolica using bacteriophage, a novel bacteriophage TW1 belonging to the 
Siphoviridae family was isolated, and its genome was completely sequenced 
and analyzed. The phage TW1 genome consists of 39,940-bp length double-
stranded DNA with GC content of 40.19% and it was predicted to have 62 
open reading frames (ORFs) and they were classified into functional groups 
such as phage structure, packaging, DNA metabolism, regulation, and 
additional function. The phage life style prediction using PHACTS showed 
that it may be a temperate phage. However, genes related to lysogeny and 
host lysis were not detected in phage TW1 genome, indicating that 
annotation information about P. phenolica phages in the genome databases 
may not be sufficient for the functional prediction of encoded proteins. This 
is the first report of P. phenolica-infecting phage and this phage genome 
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study would provide useful information for further molecular research of P. 
phenolica host and its phage as well as their interactions. 
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VI-5-2. Main text 
 The genus Pseudoalteromonas is generally found in eukaryotic 
hosts (8) associated with marine animals (i.e. tunicates and mussels) (9, 11) 
and marine algae (6). This genus was firstly suggested after division of 
Alteromonas into Alteromonas and Pseudoalteromonas by Gauthier et al. (7) 
with comparative analysis of 16S rRNA sequences. This genus is aerobic, 
Gram-negative and motile with a single polar flagellum. Among this genus, 
P. phenolica attracted the public attention because the strain P. phenolica O-
BC30
T
 produces the phenolic antimicrobial compound against methicillin-
resistant Staphylococcus aureus (MRSA) (10). In addition, a novel agarase 
to digest agarose for DNA gel extraction was recently found in P. phenolica 
JYBCL1 (14). Therefore, due to its usefulness in various applications, 
further molecular study and application of this species would be required. 
 Bacteriophage is a bacterial virus to infect specific bacterial host 
strain. After host infection, it lyses the host strain as a virulent phage or 
integrates its phage genome into the host genome as a temperate phage. 
Because of this genome integration, phage has been considered as a useful 
gene delivery carrier or a molecular tool for functional study of the host 
bacterial genome. The P. phenolica-infecting bacteriophage TW1 was 
isolated from the sea water in Taepyung salt pond of Shinan, South Korea. 
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This phage TW1 (multiplicity of infection (MOI) at 1) was enriched with 
the culture of P. phenolica CL-TW1 at 30°C for 24 h with vigorous shaking. 
To obtain the phage solution, the mixture was centrifuged at 1,036 × g for 
20 min and filtered with 0.22 µm pore size filters (Millipore, Billerica, MA, 
USA). To concentrate and purify the phage from the filtrate containing the 
phage TW1, it was centrifuged with Amicon Ultra-15 centrifugal filter units 
(Millipore) and extracted using CsCl gradient ultracentrifugation from 1.2 to 
1.55 g/ml densities at 25,000 × g, 4°C for 2.5 h. The genomic DNA was 
isolated following the procedure by Wilcox et al. (17). The phage particle 
was lysed using the phage standard lysis buffer containing 0.5% SDS and 
100 µg/ml of proteinase K and the mixture was incubated at 37°C for 30 
min. To purify the phage genomic DNA, subsequent phenol-chloroform 
extraction and ethanol precipitation were conducted using the standard 
protocols by Sambrook et al. (16). The purified phage genomic DNA was 
sheared and randomly sequenced using GS-FLX pyrosequencer at 
Macrogen, Seoul, South Korea, and the qualified sequence reads were 
assembled using Newbler v2.3. The open reading frames (ORFs) in the 
genome were predicted using GeneMarkS (2), Glimmer3 (5), and FgenesB 
(Softberry, Inc., Mount Kisco, NY, USA) and confirmed using RBSFinder 
(J. Craig Venter Institute, Rockville, MD, USA). Annotation and functional 
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analysis of the predicted ORFs were performed using BLASTP (1) and 
InterProScan (18) programs. The genomic DNA sequence and annotation 
result were edited using Artemis14 (3), and the lifestyle of the phage TW1 
for virulent or temperate phage was predicted using PHACTS program with 
all protein sequences from Artemis14 (13). Phylogenetic analysis of 
terminase large subunit of bacteriophages including phage TW1 was 
conducted using MEGA5 based on the neighbor-joining method with P 
distance values (12). 
Morphological observation of phage TW1 using transmission 
electron microscopy (TEM) revealed that it has 103 ± 7 nm non-contractile 
tail and 73 ± 2 nm capsid, belonging to the Siphoviridae family (Fig. 6.1A). 
Pedulla et al. previously suggested that phage tail length is proportional to 
the size of gene encoding tape measure protein only in Siphoviridae-family 
phages (15). Based on this theory, the tail length of phage TW1 containing 
2,028-bp tail measure protein gene (TW1_014) is predicted to be 101.4 nm. 
Consistently, the actual tail length of phage TW1 was observed to be 103 ± 
7 nm, supporting this idea. 
The complete genome sequence analysis of phage TW1 showed that 
the double-stranded genomic DNA consists of 39,940-bp length (GC 
content of 40.19%) with 62 predicted ORFs and no tRNA gene (Fig. 6.1B). 
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The average gene length is 586-bp and the gene coding percentage is 91.0%. 
The annotation results of all predicted ORFs were listed in Table 6.1. The 
complete genome sequence analysis showed that the predicted functions of 
all ORFs in phage TW1 was classified into five functional groups such as 
phage structure, packaging, DNA metabolism, regulation, and additional 
function. These functional groups and conserved protein domain analysis of 
predicted ORFs in phage TW1 were listed in Table 6.2 and Table 6.3, 
respectively. However, even though some core genes are functionally 
predicted, functions of more than 77% predicted ORFs are still unknown 
and host-lysis-related genes are undetected, probably due to insufficient 
annotation data of P. phenolica-infecting phages in the sequence databases. 
Interestingly, BLASTP analysis result showed that about 65% of 
functionally predicted ORFs are slightly similar to the proteins encoded in 
various bacterial genomes, not in phage genomes, supporting this 
insufficient sequence data. To predict the lifestyle of phage TW1, PHACTS 
analysis was conducted with amino acid sequences of all predicted ORFs. 
While phage TW1 genome does not have genes encoding integrase or 
recombinase for phage genome integration into the host genome, the 
analysis result showed that phage TW1 may be a temperate phage (data not 
shown). These core genes for phage genome integration may be not properly 
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annotated, probably due to absence of similar integrase or recombinase 
genes in the sequence databases. An additional experiment to confirm the 
lifestyle of phage TW1 may be required. To further elucidate type of phage 
TW1, additional comparative phylogenetic analysis of phage TW1 was 
performed with phage terminase large subunits according to Casjens and 
Gilcrease’s method (4). The result showed that phage TW1 may belong to 
Mu-like headful group (Fig. 6.2). 
To our knowledge, this is the first report of a P. phenolica-infecting 
bacteriophage and its complete genome sequence. This phage genome 
sequence analysis result would be useful basic information about further 
molecular research of P. phenolica host and its phage as well as their 
infection/interaction mechanisms. 
 
 Nucleotide sequence accession number. The complete genome 
sequence of bacteriophage TW1 is available in GenBank database under 
accession number KC542353. 
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Table 6.1. List of all predicted ORFs in the genome of phage TW1 
Locus_tag Start End Strand Predicted function 
TW1_001 1 558 + hypothetical protein 
TW1_002 574 816 + hypothetical protein 
TW1_003 869 1102 + hypothetical protein 
TW1_004 1084 1428 + hypothetical protein 
TW1_005 1429 1821 + hypothetical protein 
TW1_006 1818 2180 + hypothetical protein 
TW1_007 2180 2464 + hypothetical protein 
TW1_008 2469 3002 + hypothetical protein 
TW1_009 2999 3439 + hypothetical protein 
TW1_010 3436 3873 + hypothetical protein 
TW1_011 4133 4435 + hypothetical protein 
TW1_012 4909 5415 + hypothetical protein 
TW1_013 5417 6058 + hypothetical protein 
TW1_014 6059 8086 + tail tape measure domain-containing protein 
TW1_015 8086 8556 + hypothetical protein 
TW1_016 8559 9059 + hypothetical protein 
TW1_017 9056 9463 + hypothetical protein 
TW1_018 9463 11964 + phage tail domain-containing protein 
TW1_019 11993 13969 + hypothetical protein 
TW1_020 13966 14166 - hypothetical protein 
TW1_021 14249 14515 + hypothetical protein 
TW1_022 14717 15430 - HNH endonuclease domain-containing protein 
TW1_023 15530 16561 - possible head morphogenesis protein 
TW1_024 16551 17930 - possible portal protein 
TW1_025 17989 18285 - hypothetical protein 
TW1_026 18443 18640 - hypothetical protein 
TW1_027 18640 19143 - hypothetical protein 
TW1_028 19140 19583 - possible phosphoribosyl-ATP pyrophosphohydrolase 
TW1_029 19585 20043 - hypothetical protein 
TW1_030 20040 20210 - hypothetical protein 
TW1_031 20207 20677 - hypothetical protein 
TW1_032 20844 21317 - hypothetical protein 
TW1_033 21350 21916 - single-stranded DNA-binding protein 
TW1_034 21957 22361 - hypothetical protein 





Table 6.1. List of all predicted ORFs in the genome of phage TW1 
(continued) 
Locus_tag Start End Strand Predicted function 
TW1_036 23281 25092 - possible ATP-dependent helicase 
TW1_037 25085 25864 - possible DNA primase 
TW1_038 25868 27403 - hypothetical protein 
TW1_039 27403 27651 - hypothetical protein 
TW1_040 28170 28349 + hypothetical protein 
TW1_041 28352 28549 + hypothetical protein 
TW1_042 28759 29295 + putative N-6-adenine-methyltransferase 
TW1_043 29285 29467 + hypothetical protein 
TW1_044 29670 30245 + hypothetical protein 
TW1_045 30462 30725 + hypothetical protein 
TW1_046 30729 31217 + possible terminase small subunit 
TW1_047 31204 32814 + possible terminase large subunit 
TW1_048 32959 33129 - hypothetical protein 
TW1_049 33163 33333 - hypothetical protein 
TW1_050 33320 34228 - hypothetical protein 
TW1_051 34647 34931 + hypothetical protein 
TW1_052 34928 35131 + hypothetical protein 
TW1_053 35131 35304 + hypothetical protein 
TW1_054 35301 35921 + hypothetical protein 
TW1_055 35978 37120 + hypothetical protein 
TW1_056 37123 37569 + hypothetical protein 
TW1_057 37583 38641 + possible phage coat protein 
TW1_058 38641 38808 + hypothetical protein 
TW1_059 38821 39018 - hypothetical protein 
TW1_060 39008 39202 - hypothetical protein 
TW1_061 39252 39578 - hypothetical protein 
TW1_062 39589 39837 - hypothetical protein 
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Table 6.2. Functional grouping of predicted ORFs in phage TW1 
Functional 
group 
Locus_tag Predicted function BLASTP best match Identity 
Structure TW1_014 tail tape measure domain-containing protein hypothetical protein EcolC_1230 [Escherichia coli ATCC 8739] 28% 
 TW1_018 phage tail domain-containing protein phage tail protein [Cronobacter sakazakii ES15]  27% 
 TW1_023 possible head morphogenesis protein head morphogenesis protein [Salmonella phage vB_SosS_Oslo] 28% 
 TW1_057 possible phage coat protein putative coat protein [Salmonella phage E1] 28% 
     
Packaging TW1_024 possible portal protein unnamed protein product [Pseudomonas phage phi297] 25% 
 TW1_046 possible terminase small subunit terminase small subunit [Escherichia coli O83:H1]  40% 
 TW1_047 possible terminase large subunit putative TerL [Burkholderia phage Bups phi1] 44% 
     
DNA  TW1_022 HNH endonuclease domain-containing protein HNH endonuclease [Cronobacter phage vB_CsaM_GAP32] 27% 
manipulation TW1_035 exodeoxyribonuclease 8 domain-containing protein recE protein [Enterobacteriaceae bacterium 9_2_54FAA] 29% 
 TW1_036 possible ATP-dependent helicase putative ATP-dependent helicase [Salmonella phage E1]  43% 
 TW1_037 possible DNA primase DNA primase [Pseudogulbenkiania ferrooxidans 2002]  22% 
 TW1_042 putative N-6-adenine-methyltransferase phage DNA methyltransferase [Alteromonas macleodii AltDE1] 43% 
     
Regulation TW1_033 single-stranded DNA-binding protein 
ssDNA-binding protein [Glaciecola arctica BSs20135]  
ssDNA-binding protein [Pseudoalteromonas sp. BSi20652] 
55% 
48% 
     
Additional  TW1_028 possible phosphoribosyl-ATP pyrophosphohydrolase Phosphoribosyl-ATP pyrophosphohydrolase [Gallibacterium anatis]  48% 
Function     
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Table 6.3. Functional analysis of predicted ORFs using InterProScan program 




TW1_010 hypothetical protein PF11351 DUF3154 : Protein of unknown function 
TW1_014 tail tape measure domain-containing protein PF06791 TMP_2 : Bacteriophage lambda, GpH, tail tape measure, N-terminal 
TW1_017 hypothetical protein PF00877 NLPC_P60 : NLPC/P60 domain 
TW1_018 phage tail domain-containing protein PF13550 Phage-tail_3 
TW1_022 HNH endonuclease domain-containing protein PF13392 HNH_3 
TW1_023 possible head morphogenesis protein PF04233 Phage_Mu_F : Phage head morphogenesis domain 
TW1_024 possible portal protein PF06381 DUF1073 : Protein of unknown function 
TW1_028 possible phosphoribosyl-ATP pyrophosphohydrolase PF01503 PRA-PH : Phosphoribosyl-ATP pyrophosphohydrolase-like 
TW1_033 single-stranded DNA-binding protein PF00436 SSB : Primosome PriB/single-strand DNA-binding 
TW1_035 exodeoxyribonuclease 8 domain-containing protein PF12684 DUF3799 : Putative exodeoxyribonuclease 8, PDDEXK-like domain 
TW1_036 possible ATP-dependent helicase PF00271 Helicase_C : Helicase, C-terminal 
TW1_036 possible ATP-dependent helicase PF04851 ResIII : Helicase/UvrB domain 
TW1_037 possible DNA primase PF01807 zf-CHC2 : Zinc finger, CHC2-type 
TW1_038 hypothetical protein PF13148 DUF3987 : Protein of unknown function 
TW1_042 putative N-6-adenine-methyltransferase PF05869 Dam : DNA N-6-adenine-methyltransferase 












Figure 6.1. TEM morphological observation and genome map of P. phenolica-infecting phage TW1. (A) TEM morphological 
observation of P. phenolica-infecting phage TW1. Size bar is 50 nm. (B) The inner circle with red line indicates the GC content. The 
outer circle indicates predicted ORFs by strand. The categories of functional ORFs were indicated by the following colors. Blue, 














Figure 6.2. A comparative phylogenetic analysis of terminase large 
subunits in phage TW1 with other bacteriophages. Amino acid sequences 
of terminase large subunits were compared using ClustalW program and the 
phylogenetic tree was generated by the neighbor-joining method with P 
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 Salmonella enterica subspecies enterica serovar 
Typhimurium 균은 그람 음성의 병원균으로 살모넬라증을 
유발한다. 이에 S. Typhimurium 균을 특이적으로 감염하는 
박테리오파지는 항생제 대체제로서 주목받고 있다. 이러한 S. 
Typhimurium 균의 저해제로서 박테리오파지 사용 가능성을 
규명하기위해, 파지와 숙주 사이의 감염 기작 및 상호 작용 
기작에 대한 분자적 수준의 이해가 필수적이다. 이에 본 
연구에서는 25 종의 S. Typhimurium 균 특이성 파지를 새롭게 
분리하고, 다양한 유전자 결여 S. Typhimurium SL1344 균주를 
이용하여 각 파지들의 수용체를 파악하였다. 그 결과, 총 세가지 
종류의 수용체 (flagella, vitamin B12 uptake outer membrane 
protein, BtuB 및 lipopolysaccharide (LPS) O-antigen)로 
구분할 수 있었다. TEM 관찰을 통한 morphology 연구 결과, 
flagella 를 수용체로 사용하는 group F 파지들과 BtuB 를 
수용체로 사용하는 group B 파지들은 Siphoviridae family 에 
속함을 파악하였고, LPS 의 O-antigen 을 수용체로 사용하는 
파지들은 Podoviridae family 에 속함을 알 수 있었다. 더불어 
group F 파지들의 경우, FliC 만을 수용체로하는 subgroup F-I 과 
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FliC 및 FljB 를 모두 수용체로 사용하는 subgroup F-II 로 
구분할 수 있었다. Cross-resistance assay 를 통해, group B 
파지 저항성을 가지는 균주에 group L 파지가 감염을 하지 
못함과 반대로 group B 파지가 group L 의 SPN9TCW 파지 
저항성을 가지는 균주에 감염을 하지 못함 파악하였다. 이는 BtuB 
및 LPS 의 O-antigen, 두 수용체 사이에 특수한 상호작용 존재 
가능성을 시사하였다. 본 수용체 다양성에 대한 연구는, 파지와 
숙주 사이의 수용체 상호작용에 대한 정보를 제공하였고, 
Salmonella 균을 목표로 하는 최적의 파지 칵테일 개발에 기반이 
되는 정보를 제공하였다. 
 더불어 파지의 감염 및 숙주 용해 기작을 연구하기 위하여, 
S. Typhimurium 균을 숙주로 하는 새로운 파지 SPN9CC 를 
분리 및 동정하였다. 이 파지는 Podoviridae family 에 속하며, 
LPS 의 O-antigen 을 수용체로 사용함을 확인하였다. 또한 
SPN9CC 는 투명한 plaque 을 형성하지만, plaque 내부에 
불투명한 환을 형성하는 독특한 plaque morphology 를 보였으며, 
이는 SPN9CC 가 lysogen 을 형성할 수 있음을 시사하였다. 
파지의 major capsid protein 의 아미노산 서열을 이용한 
phylogenetic analysis 를 통해 SPN9CC 가 lysogen 을 형성하는 
P22-like 파지에 속함을 파악하였다. 하지만, SPN9CC 와 P22-
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like 파지 사이의 comparative genomic analysis 결과, lysogeny 
control region 및 host lysis gene cluster 의 유사성이 거의 
없음을 확인하였다. 이 결과는, P22-like 파지 사이의 lysogeny 
형성 기작 및 숙주 용해 기작이 다양할 수 있음을 시사하였다. 
SPN9CC 의 host lysis cluster (holin, endolysin, Rz/Rz1) 
유전자들을 각각 혹은 여러 조합으로 S. Typhimurium 및 E. 
coli 에서 발현을 시켜본 결과, 이 lysis protein 들 사이의 협동 
작용이 균주 용해에 필수적임을 확인하였고, 이 협동 작용에 
holin 이 중추적인 역할을 함을 파악하였다. SPN9CC 의 lysogeny 
control region 에 대한 후속 연구를 위해서, SPN9CC 의 ΔcI  
뮤턴트 (SPN9CCM)를 구축 하였다. SPN9CCM 는 plaque 내부에 
불투명한 환을 형성하지 않았고, 이는 SPN9CCM 가 용원성 
파지에서 용균성 파지로 전환 되었음을 시사하였다. 추가적으로 
one-step growth 분석 및 challenge assay 를 통해, 
SPN9CCM 가 기존의 SPN9CC 보다 eclipse/latent period 가 
감소하고 burst size 가 증가함을 확인하였고, 균 저해 능력 또한 
높아졌음을 파악하였다. 본 연구 결과를 통해, engineering 용원성 
파지의 항균 물질 개발 가능성을 시사하였다. 
 Bacillus cereus, Bacillus anthracis, 및 Bacillus 
thurigiensis(Bt) 균을 감염시키는 Bacillus cereus group 
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파지들에 대한 연구는, 병원성 균주인 B. cereus 및 B. 
anthracis 를 제어하는 목적과 천연 살충제로 사용되는 Bt 의 생산 
중 파지 오염을 방지하는 목적으로 분자적인 수준의 연구 및 
최근들어 유전체학적인 연구가 진행되고 있다. 모든 Bacillus 
cereus group 파지들의 genome 에 대한 comparative 
phylogenetic 분석을 진행한 결과, 세가지의 group 으로 구분할 
수 있었다. 이러한 구분은 morphology 의 차이 (Myoviridae 은 
group I, Siphoviridae 은 group II, Tectiviridae 는 group III), 
genome size 의 차이 (group I > group II > group III) 및 
생활사의 종류 (용균성은 group I, 용원성은 group II 및 group 
III)에도 연관이 있음을 알 수 있었다. 파지들의 genome 에 대한 
추가적인 dot plot analysis 를 통한 비교 분석 결과, 각각 
group 의 파지들 사이에 DNA 수준에서 상등성이 큼을 알 수 
있었다. 또한 group I 파지들에 대한 endolysin 비교 분석 결과, 
두 종류의 cell wall binding domain 과 네 종류의 enzymatic 
activity domain 의 조합으로 구성됨을 파악하였다. Group II 
파지에 대한 연구는 B. anthracis 특이적인 파지에 대해 집중되어 
진행되었으며, typing 및 신속 검출 방법으로 응용이 시도되고 
있다. Group III 파지의 경우, Bam35 및 GIL01 파지들에 대한 
연구가 대표적이며 파지의 entry 기작 및 lytic switch regulation 
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기작에 대한 연구가 진행되었다. 본 연구를 통해, Bacillus cereus 
group 파지들에 대한 추후 연구는, B. cereus 및 B. anthracis 에 
대한 제어, typing 및 신속 검출, Bt 생산 중 파지 오염을 막는 
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